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Abstract 
 
Due to an increase in consumer awareness on environmental and health 
problems that can arise with synthetic materials and processes used within the 
textile industry there is a need for novel ‘green’ textiles. The rise in antibiotic-
resistant microorganisms within recent years has led to 30,000 deaths in the EU 
every year, this has led to an increased need for novel antimicrobials (Cassini, 
Alessano et al., 2016).  Synthetic biocides like triclosan and silver have been 
extensively used in the textile industry but new regulations by the EU Directive 
98/8/EC, have now enforced the elimination and withdrawal of many commonly 
used biocides which are toxic and harmful to humans and the environment (Gao 
and Cranston, 2008; Gouveia, 2010; Kramer et al., 2006). Plant derived 
antimicrobials like essential oils (EOs) are therefore an attractive eco-friendly 
alternative for use in textile finishing (Alihosseini, 2016). Although EOs have 
regained popularity in recent years, with many studies dedicated to the 
antimicrobial potentials, (especially citrus-based EOs), few have been focused 
on their use in blends and encapsulation methods for their application on textiles. 
Due to EOs physicochemical properties, their development of functional fabrics 
is met with formulation challenges such as volatility and oxidative degradation 
and must therefore be protected before they can be used functionally. Screening 
of ten EOs by disk diffusion and subsequent evaluation of minimum inhibitory 
concentrations (MICs) and fractional inhibitory concentrations (FICs) showed that 
a 1:2 blend of L. cubeba (litsea) and Citrus Limon (lemon) EO respectively had 
the most efficacy in synergy, being inhibitory against Staphylococcus aureus, 
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Escherichia coli, Staphylococcus epidermidis, Pseudomonas aeruginosa and 
Trichophyton rubrum compared to the individual EOs. The litsea-lemon EO blend 
was encapsulated (30% concentration) with natural biopolymers chitosan (0.05-
1% w/v) and sodium alginate (0.1 % w/v) by using an emulsification method, 
without the presence of a surfactant. Gas Chromatography-Mass Spectroscopy 
(GC-MS) analysis revealed citral and limonene to be the major compounds found 
in the EOs, their presence also confirmed by Fourier Transform Infrared (FTIR) 
analysis. In vitro, the release of citral and limonene from the emulsion was 
examined using a dissolution method and the release profiles were characterised 
by initial burst release, followed by a slow controlled release of citral and limonene 
from emulsions; 70.11% of limonene was released within 10 min for a 1% w/v 
chitosan emulsion, whilst only 4.91% of citral was released within the same time. 
Fresh 1% chitosan-EO blend emulsions were then used to treat cotton and 
polyester using a soak-pad-dry method. Promising results were observed when 
time-kill assays were carried out on the treated fabric using the plate count 
method adapted from BS EN ISO 20743:2013, with 100% reductions observed 
at zero contact time (CT) for S. epidermidis, at 5 min for S. aureus and E. coli. 
Mosquito repellency was also assessed for EO-emulsion treated cotton which 
demonstrated 71.43% repellency to female mosquito Aedes aegypti compared to 
a repellency of 52.94% by neat EO-impregnated cotton. EOs show promise in 
their application as antimicrobials for the development of natural and eco-friendly 
functional textiles and should be further explored as alternatives to current 
synesthetic based finishing. 
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Chapter 1. Introduction 
 
The skin is the natural barrier of the body, protecting us from the external 
environment and microorganisms that want to invade it (Brodell and Rosenthal, 
2008; Venus et al., 2011). When this barrier is compromised by wounds, burns 
or ulcers, organisms can penetrate into the skin and soft tissues, invading and 
sometimes causing an infection (Dryden, 2009). Skin infections such as surgical 
site infections (SSIs) are an extremely common cause of death and morbidity, 
affecting 6 million people around the world and they are the third most common 
type of hospital acquired infection (Dryden, 2010; PHE, 2015a; Ranzato et al., 
2011).  Hospital acquired infections (HAIs) have been estimated to affect 300,000 
patients in England with an annual cost of £1 billion to the NHS (Jenkins, 2017). 
Within the European Union and European Economic Area (EU/EEA), around 
2,600,000 new cases of healthcare-associated infections (HCAIs) are reported 
every year, 426,000 of which have been linked to antimicrobial resistant 
microorganisms. Antimicrobial resistance (AMR) has been attributed to over 
30,000 deaths in the EU per annum (Cassini, Alessandro et al., 2019; Cassini et 
al., 2016). Since 2002, in the US, 1.7 million cases of HCAI have been reported 
yearly, with up to 20% of associated organisms being multidrug resistant (MDR) 
to common antibiotics (Haque et al., 2018; Klevens et al., 2007). Results from 
epidemiological studies have shown that there is a relationship between overuse 
of antibiotics and the emergence of antibiotic resistant bacteria (Ventola, 2015). 
Resistance can be a spontaneous process through the process of mutation or 
can be caused by gene transfer between bacterial species (Read and Woods, 
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2014). Wrong prescription of antibiotics has also been deemed as a contributor 
of antibiotic resistance, with a study showing that in 30-50% of cases, the 
antibiotic prescribed, and the duration of therapy are incorrect (CDC, 2013; Luyt 
et al., 2014). Multidrug resistance is worldwide problem which requires new 
strategies and solutions, one of which is the need for novel antimicrobials; this 
has led to an increased interest in natural products such as plant essential oils 
(EOs). EOs have shown promise in inhibiting and preventing the growth of Gram-
positive and Gram-negative bacteria, fungi and dermatophytes (Behmanesh et 
al., 2015; Cavaleiro et al., 2006; Grierson and Afolayan, 2005; Orchard et al., 
2017; Rath and Mohapatra, 2015; Zhang et al., 2016).  
 
Many synthetic biocides used to confer antimicrobial activity within the 
textile industry, such as quaternary ammonium compounds (QACs), silver and 
triclosan, have been reported to have impressive bactericidal activity however, 
many also are toxic to the environment, have led to resistance and can cause 
skin irritation (Gao and Cranston, 2008; Gouveia, 2010; Kramer et al., 2006). The 
few reported incidences of biotoxicity and low cost associated with natural 
products such as EOs render them an attractive eco-friendly alternative to 
synthetic antimicrobials for use in textile product (Alihosseini, 2016). Additionally, 
due to their complex composition, there is also a reduced expectation for 
microbial organisms to develop resistance to EOs (Becerril et al., 2012). 
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Chapter 2. Literature Review  
 
2.1 Healthcare-associated Infections  
 
Healthcare-associated infections are described as those acquired in a 
healthcare setting such as a hospital (usually presenting after 48-72 hours) or 
those that develop after a treatment such as surgery, including  infections which 
occur after discharge (4 weeks) from a healthcare facility (Hensley and Monson, 
2015; NHS, 2016; WHO, 2016). HCAIs affect millions of people worldwide each 
year, worsening morbidity and mortality, and financially effecting healthcare 
systems such as the NHS, as the management of these infections may require 
further antimicrobial treatment or surgery resulting in longer inpatient stays 
(Hensley and Monson, 2015; Jenkins, 2017; NHS, 2016; WHO, 2016). In 
England, it is estimated that 300,000 patients are affected by HCAI, costing the 
NHS around £1 billion per annum (Jenkins, 2017). In the EU and EEA, over 2 
million patients are estimated to acquire HCAI yearly, costing healthcare systems 
around €7 billion annually, whilst in the US, it is estimated that they incur a yearly 
cost of $9.8 billion (Babayani et al., 2018; Cassini et al., 2016; Hay, 2005; Judith, 
2005; Mei et al., 2015; Porche, 2006). Infections of the urinary tract (27%), lower 
respiratory tract (24%), surgical sites (17%) and blood stream (10.5%) were the 
main HCAI observed in Europe in 2008, 19.3% represent other HCAI such as 
gastrointestinal infections and skin and soft tissue infections. 
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 HCAI are commonly associated with resistant healthcare-associated 
pathogens such as Methicillin-Resistant Staphylococcus aureus (MRSA), 
Methicillin-Susceptible S. aureus (MSSA), Clostridium difficile, Escherichia coli, 
and Pseudomonas aeruginosa (ECDC, 2008; Hensley and Monson, 2015; PHE, 
2015b). Infection numbers of hospital acquired bacteraemia caused by S. aureus 
in England is rising; a total of 11,405 cases have been reported to the PHE in 
2015 and 2016, this represents an increase of 7.1% compared to 2014/2015 
(n=10,645) and an increase of 15.4% compared to 2011/2012 reports (n=9,883). 
The incidence of MSSA bacteraemia has increased over time, whilst that of 
MRSA bacteraemia has fallen, although MRSA is still significant and difficult to 
eradicate; in 2003/2004, 40% of all bacteraemia related to S. aureus was caused 
by MRSA but only 7.2% of S. aureus bacteraemia in 2015/2016 is due to MRSA 
(PHE, 2016). This, however, is based on data which is limited to one setting (the 
hospital) and MRSA burden outside a healthcare setting has not been considered 
(Brusselaers et al., 2011). Decline in MRSA isolation rates have been attributed 
to infection control measures (e.g. hand hygiene, personal protective equipment 
and patient care equipment, environmental cleaning and waste disposal) and 
changes in specific MRSA strains such as ST22 and ST36 which have 
respectively increased and decreased between 2006-2010 (WHO, 2006; Wyllie 
et al., 2011).  
 
 Primary focus and priority have been and still are currently associated 
with MRSA, which may be a contributor to the rise in MSSA bacteraemia 
incidences. Cases of bacteraemia caused by E. coli are also increasing, with the 
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rate of cases per 100,000 population increasing from 60.4 in 2012 to 70.1 in 
2015/2016. HCAI caused by C. difficile have precipitated over the last years 
(74.5% since 2007), although this rate of decline has been slowing down, with 
only a decrease of 0.4% (n=14,192) in 2016 (PHE, 2016). MDR, particularly in 
Intensive Care Units (ICUs), is considered a significant threat to public health all 
over the world and is thought to incur additional costs per patient of about $6,000 
- $30,000 per annum (Brusselaers et al., 2011). Up to 1.7 million HCAI cases 
were reported in the US since 2002 with 16-20% of associated organisms found 
to be MDR, and as the pipeline for novel antibiotics for the treatment of MDR 
infections is drying out, new strategies and solution must be developed to combat 
the rising problem (Haque et al., 2018; Klevens et al., 2007). 
 
SSIs are the third most common type of HAI and most SSIs are associated 
with Staphylococcus species, although this notion is being challenged as a study 
found that on average 6 different genera could be found in any SSI, including 
staphylococci and Pseudomonas spp. (Abboud et al., 2014; Dryden, 2010; PHE, 
2015). The number of reported cases of inpatient SSIs caused by S. aureus have 
decreased from 39% to 13% since 2006/2007, which can be contributed to the 
decrease in MRSA SSIs, which now account for 3% of cases. The number of 
reported cases of MSSA SSIs have seen very little change in the last years and 
still account for 10% of SSIs; MSSA is the leading causative organism for hip and 
knee prosthesis SSIs, neck femur repair SSIs, coronary artery by-pass graft SSIs 
and spinal SSIs. MRSA, however, is still of concern as a study found that patients 
with MRSA SSIs were more likely to die within 3 months compared with patients 
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with MSSA infections (Nelson et al., 2015). Skin infections such as SSIs are the 
most commonly encountered infections and affect around 6 million people 
worldwide, making them one of the major causes of death and morbidity around 
the world (Dryden, 2010; Ranzato et al., 2011).  
 
2.2 The Skin and Infection 
 
The skin is made of two major layers called the epidermis (the uppermost layer) 
and dermis. The epidermis is then further subdivided into four structurally and 
functionally diverse layers: the stratum corneum (outer most layer), stratum 
granulosum, stratum spinosum and the stratum basale. Underneath is the 
dermis, a tough and resilient structure bound to the epidermis both internally and 
externally; it becomes very permeable once the epidermis is removed e.g. due to 
injury. The skin covers the entire body and acts as a barrier to protect us from 
our external environment; it is described as the “first line of defence against 
invading microorganisms” (Brodell and Rosenthal, 2008; Venus et al., 2011). The 
barrier function of the skin is mostly dependent on the stratum corneum and when 
this barrier is disrupted by a break in the skin such as a burn, wound or ulcer, 
then a range of organisms can penetrate and colonise the skin and soft tissues 
and sometimes progress into an infection (Dryden, 2009).  
 
The normal skin of a healthy human-being is usually colonised with a 
mixture of microorganisms which reside on the skin – this is referred to as the 
skin flora or microbiota (Dryden, 2010; Egawa and Kabashima, 2016; Gulati and 
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Nobile, 2016). The type of organism found in the flora of a healthy host will vary 
based on site, moisture, pH, temperature and salt and lipid levels among others; 
Staphylococcus species and fungal yeast species such as Candida are 
commonly present on the skin as normal commensals (Dryden, 2009; Egawa and 
Kabashima, 2016; Hensley and Monson, 2015). Other organisms, such as 
cutaneous mycoses can invade and cause disease in the skin, such as 
dermatophytic fungi (dermatophytes), which are keratinophilic, having high 
affinity for the keratin found in tissues of the epidermis, hair and nails (Babayani 
et al., 2018; Hay, 2005; Judith, 2005; Mei et al., 2015; Porche, 2006).   
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Table 2.1 Skin structure, functions and infections 
Skin layer Structure Function  Common infections References 
Stratum 
corneum 
Made of keratin 
filaments and 
corneocytes – 
flattened cells that 
have lost their nuclei 
and cytoplasmic 
organelles. 
 
Acts as a barrier.  
Main role is 
protection – 
regulates entry of 
particles (microbes, 
chemicals etc.) and 
loss of salt and 
water 
Impetigo – a 
contagious pyogenic 
infection caused by S. 
aureus  
 
Folliculitis – an 
inflammation of the 
hair follicles. 
Infectious causes can 
be bacterial e.g. S. 
aureus (barber’s itch); 
or fungal (Tinea 
barbae).  
 
Tinea capitis (scalp 
ring worm), Tinea 
pedis (athlete’s foot) 
– fungal infections 
caused by 
Trichophyton 
tonsurans and 
Trichophyton rubrum 
respectively  
 
(Bhagavatula and 
Powell, 2011; 
Dryden, 2009; 
Dryden, 2010; 
Ramsay and 
Török, 2017)  
Stratum 
granulosum 
Cells in the layer 
(keratinocytes) 
contain intracellular 
granules of 
keratohyalin. 
Cytoplasm contains 
lamellated granules. 
Adhesion, cytokine 
production, keratin 
production, 
production of 
vitamin D 
Stratum 
spinosum 
Made of a layer of 
polyhedral cells 
connected by 
desmosomes 
Responsible for 
skin’s strength and 
flexibility. 
Stratum 
basale 
Layer is one cell 
thick made of 
keratinocytes and 
melanocytes present. 
Responsible for 
replication and 
repair of cells  
Dermis Made of fibroblast 
cells which 
synthesise collagen 
(75% type I and 15% 
type III collagen) and 
elastin fibres 
Shock absorption 
(providing 
protection from 
injury), 
Insulation, strength 
 
Ecthyma – a 
contagious infection, 
with similarities to 
impetigo but 
penetrating deeper 
into the dermis, 
usually caused by 
group A streptococci 
Cellulitis – caused 
by S. aureus or group 
A streptococci is an 
inflammation of the 
deep dermis which 
causes swollen, 
tender and red skin. 
(Ki and Rotstein, 
2007; Rabionet et 
al., 2016; Wilson, 
M., 2005)  
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2.2.1 Wounds, Skin and Soft Tissue Infections  
 
Health complications can arise during a wound healing process, which 
delays wounds healing resulting in them becoming severely infected (Sienkiewicz 
et al., 2017; Song et al., 2016). This delay in healing can occur when 
microorganism overcome the skin barriers and infect deeper tissues by 
increasing bacterial load, therefore, causing further damage to the wound and 
hindering the healing process (Abdel-Mohsen et al., 2016; Said et al., 2014). 
Biofilms can especially delay healing and their presence in infected wounds can 
increase mortality, morbidity and treatment cost of infected patients (Song et al., 
2016). 
 
Skin and soft tissue infections (SSTIs) are common among hospitalised 
patients; they occur when microbes invade the skin and underlying soft tissues 
causing an inflammatory response. SSTIs vary in severity, ranging from mild to 
life-threatening.  SSTIs are hard to diagnose as they can hide behind other clinical 
symptoms and, due to the increases of bacterial resistance, they are becoming 
increasingly challenging to treat (Esposito et al., 2016; Ki and Rotstein, 2007). 
Esposito et al (2016), classified soft tissue infections into two groups, superficial 
and deep; superficial SSTIs caused by S. aureus include impetigo, folliculitis, 
carbuncles and abscesses, whilst deep SSTIs included cellulitis, myositis, ulcers 
and wound infections such as skin burns. Complicated SSTIs represent an 
important clinical and economic burden to the NHS; they often result in 
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hospitalisation with the need for antibiotic treatment and at times, surgery 
(Esposito et al., 2016; Lipsky et al., 2014). 
 
The development of measures that will reduce the bacterial load in chronic 
wounds, as well as new antimicrobial preparations, could be an effective strategy 
to control chronic wound infections. One of the methods employed to treat 
wounds is the use of wound dressings that have antibacterial agents, such as 
antibiotics. Many antibiotics are available, but resistance poses a real threat to 
wound healing and highlighting the need for developing novel wound care 
systems (Anjum et al., 2016).  
 
2.2.1.1 Staphylococcus aureus  
 
S. aureus is a Gram-positive, facultative anaerobe that can be found (often 
harmlessly) in the throat, nose, on mucous membranes and on the human skin 
in areas such as the groin and the axillae (Agha, 2012). S. aureus is a leading 
cause of nosocomial (hospital acquired) infections; it is able to cause a vast range 
of infections, such as skin infections, urinary tract infections (UTIs), SSIs, 
pneumonia, gastroenteritis, and bacteraemia (Ghidey et al., 2014; Hensley and 
Monson, 2015; Nelson et al., 2015; Wiese et al., 2013). Due to its ability to rapidly 
develop resistance to antimicrobial drugs, S. aureus infections are difficult to treat 
(Ghidey et al., 2014). MRSA has highly contributed to in-hospital mortality over 
the years; its resistance to penicillin is facilitated by the production of 
penicillinase, the enzyme that breaks down part of the penicillin molecule 
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(Chakraborty et al., 2012).  MRSA systemic infections have been linked to 
mortality rates of up to 40% both in ICUs and non-intensive care settings (He et 
al., 2013; McDanel et al., 2014; Nelson et al., 2015). 
 
Hospital patients are most susceptible to MRSA infections due to surgical 
procedures, weaker immune system and indwelling devices (McDanel et al., 
2014). Frequently found on healthcare surfaces where it easily lives and 
proliferates, S. aureus has been estimated to be linked to 9000 yearly deaths 
connected to healthcare contamination (Nan et al., 2015). Not only does S. 
aureus thrive on healthcare surfaces, it also begins to form biofilms, by attaching 
to the surface and then forming layered cell clusters by a process called 
intercellular adhesion; once formed, the biofilm is able to give the bacterial strain 
a greater resistance to antibacterial agents due to the exopolymeric substances 
(EPS) which make up 90% of the biofilm (Nan et al., 2015; Vickery et al., 2012). 
Biofilms constitute a problem in places such as healthcare settings where they 
are thought to be responsible for about 65% of the healthcare acquired infections 
(Otter et al., 2015). S. aureus is commonly associated with wound infections 
being one of the most commonly isolated bacterial species from chronic wounds, 
and it has been found to have resistance against vancomycin, erythromycin, 
quinolones and tetracyclines (Cardona and Wilson, 2015; Gade and Qazi, 2013; 
Gardete and Tomasz, 2014; Piątkowska et al., 2012). A study by Condò reported 
antibiofilm activity by cinnamon EO against mature biofilms of Gram-negatives E. 
coli, P. aeruginosa, Proteus mirabilis and Klebsiella pneumoniae, though the 
biofilms were not completely destroyed (Condò et al., 2018).  
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2.2.1.2 Staphylococcus epidermidis 
 
Staphylococcus epidermidis is an opportunistic non-motile coagulase-
negative, Gram-positive cocci that is part of the normal human skin commensal 
flora and is in fact is one of the most predominant species found on the skin and 
superficial mucosal membranes (El Farran et al., 2013; Gomes et al., 2012; 
Gordon et al., 2012; Hellmark et al., 2009; Hellmark et al., 2013; Lai et al., 2010; 
Otto, 2012). S. epidermidis has become one of the leading pathogens found on 
devices such as catheters, artificial heart valves and prosthetic joints because of 
its ability to form a biofilm over the surfaces of these devices, causing infections 
that are persistent or recurrent (El Farran et al., 2013; Gomes al., 2012; Prasad 
et al., 2012). S. epidermidis was previously considered to be a harmless 
commensal microorganism but is now regarded as an opportunistic pathogen due 
to its high incidence in hospitals and its resistance to antibiotics such as 
methicillin and antimicrobials like benzalkonium chloride (Otto, 2009). Methicillin-
Resistant S. epidermidis, (MRSE), has been found in 70% of hospital isolates 
(Gordon et al., 2012) and its intermediate resistance to vancomycin has been on 
the rise (Otto, 2012). S. epidermidis is one of the most prevalent bacteria found 
on the skin, therefore, when it is isolated from skin infections like wounds, it is 
usually not considered a pathogen, but dismissed as a contaminant; however, it 
has been found that S. epidermidis could be a carrier of antibiotic resistant genes 
that can enhance the effect of other pathogens like S. aureus (Brackman et al., 
2013; Otto, 2009; Otto, 2012).  
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2.2.1.3 Pseudomonas aeruginosa  
 
Pseudomonas aeruginosa is an opportunistic Gram-negative non-
fermentative rod that is found widely in humid environments and is sometimes 
found as part of the human microflora (Loveday et al., 2014). The pathogen is 
found in hospital settings and can cause a large range of infections such as 
infected wounds, respiratory, gastrointestinal infections, UTIs and bacteraemia 
(Kayabas et al., 2008). Reports on bacteraemia in the UK show that 
Pseudomonas spp. are one of the most frequent causes of the disease, and 
between 2017 and 2018, 37.8% of 4,286 P. aeruginosa bacteraemia reported 
cases were hospital-onset. P. aeruginosa is a major cause of infections in 
immunocompromised cystic fibrosis patients, causing chronic lung infections due 
to its ability to initiate infection in individuals whose immune system is weak 
(Breidenstein et al., 2011; Nichols et al., 2013).  
 
Cutaneous injuries such as wounds and burns are often worsened due to 
colonisation by P. aeruginosa, causing infections; P. aeruginosa accounts for 
over 50% of all severe burn infections and is the second most common organisms 
isolated from chronic wounds like diabetic ulcers, pressure ulcers and in burn 
wounds (Nichols et al., 2013). With the emergence of multidrug resistant P. 
aeruginosa infections, burn wounds infected with P. aeruginosa are becoming 
difficult to treat. P. aeuruginosa is also intrinsically resistant to various 
antimicrobials such as the common antibiotics ampicillin and amoxicillin (Bessa 
et al., 2015; Nichols et al., 2013). This microorganism has therefore been 
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associated with high morbidity and mortality within patients in ICUs, burn units 
and surgery wards (Kayabas et al., 2008). P. aeruginosa can grow successfully 
in the environment, even in nutrient poor circumstances and over a wide range 
of temperatures (Loveday et al., 2014). Its ability to thrive and exist in the form of 
a biofilm on surfaces has contributed to its extreme resistance to several 
antimicrobials (Breidenstein et al., 2011; Kerr and Snelling, 2009; Knezevic et al., 
2013).  
 
2.2.1.4 Escherichia coli  
 
Escherichia coli is a Gram-negative bacillus that is part of the 
Enterobacteriaceae family (Meybeck et al., 2008). E. coli is often associated with 
UTIs, bacteraemia, soft tissue infections, SSIs and community acquired 
infections (Ferjani et al., 2015; Niranjan and Malini, 2014; Soto et al., 2006). 
Strains of E. coli are frequently isolated from soft tissue and skin infections; a 
study found that E. coli is the third most isolated bacterium (Petkovšek et al., 
2009). It is one of the most common causes of hospital-acquired (over 30%) 
infections (Smanthong et al., 2015). A study by D’avignon et al (2010) found that, 
of 3751 patients admitted into a burn unit, 13.8% of deaths associated to bacterial 
infection were attributable to E. coli.  A different case study found that within 41 
cases of surgical wound infection, 27.1% were related to E. coli (Alonso-Isa et 
al., 2017). 
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The widespread use of antibiotics for the treatment of infection has led to 
resistance by organisms such as E. coli; a study found that of 161 E. coli isolates 
from wound infection more than 50% were resistant to the antibiotics tetracycline, 
ampicillin, cefuroxime, ciprofloxacin, cefazolin, mezlocillin and piperacillin. 
Additionally, 70% of the isolates produced extended-spectrum beta-lactamase 
(ESBL), an enzyme which causes resistances to antibiotics (Alharbi et al., 2018). 
Resistance of E. coli to antimicrobials has also been linked biofilm formation, as 
the microorganism is less susceptible to the antimicrobial compared to the 
planktonic form (Rivardo et al., 2010). Some strains of E. coli are highly resistant 
to penicillin antibiotics (e.g. ampicillin), with a study on the antimicrobial 
resistance of E. coli reporting 82.79% of tested E. coli isolates to show resistance 
to ampicillin (Tompkins, 2011; Vranic and Uzunovic, 2016).  
 
2.2.2 Trichophyton rubrum 
 
The dermatophyte Trichophyton rubrum is the most prevalent cause of 
skin (tinea pedis, tinea corporis) and nail (onychomycosis) infections worldwide 
and accounts for about 70% of all dermatophytoses in human beings (Hammer 
et al., 2012; Osborne et al., 2003; Vena et al., 2012). Dermatophytes are 
filamentous fungi, which can infect tissues in which keratin is abundant, such as 
hair, nail and skin (Baltazar et al., 2012; Mohammadi et al., 2015; Morton et al., 
2014). Dermatophytoses (infections caused by dermatophytes) affect millions of 
people every year and is transmitted by close contact with those infected; it is 
recognised as a significant public health problem with children in particular 
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(Bajpai et al., 2009; Feuilhade, 2012; Mohammadi et al., 2015). Dermatophytes 
like T. rubrum are not usually considered opportunistic pathogens, but they 
occasionally invade soft tissues and organs causing aggressive infections, 
especially in the immunocompromised (Hay, 2017).  
 
Antibiotics prescribed for T. rubrum dermatophytoses (antimycotics) 
usually include terbinafine, itraconazole, amorolfine and ciclopirox; however, 
following the completion of antifungal therapy, relapses can occur due to acquired 
resistance to the antimycotics (Ghelardi et al., 2014; Mukherjee et al., 2003). A 
study by Ghelardi et al. (2014) observed that T. rubrum developed resistance to 
terbinafine, itraconazole and amorolfine, and concluded that sub-inhibitory drug 
concentrations can aid in the rise of drug resistant strains (Mukherjee et al., 
2003).  
 
2.2.2.1 Tinea Pedis  
 
Tinea pedis (or athlete’s foot) is a common and contagious superficial 
fungal infection (Feuilhade, 2012; Hay, 2013); it is caused by dermatophytes and 
it is the second most common skin condition in the U.S. and it has been estimated 
that around 15% of the population suffers from tinea pedis which has significant 
economic consequences (Ghannoum et al., 2010; Hammer et al., 2012). Tinea 
pedis usually manifests between the toes (interdigital tinea pedis), on the soles, 
heels and sides of feet and although not life threatening, the diseases can cause 
discomfort, may be hard to treat and could spread to other parts of the body 
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(Zatcoff et al., 2008). Interdigital tinea pedis is the most common form and can 
make the web spaces between the feet dry, scally, white, macerated and soggy, 
giving the unpleasant (Zatcoff et al., 2008) sensation of itching, burning or pain 
and slight odours (Porche, 2006). 
 
Close skin to skin contact among athletes, allows transmission of the 
fungus from person to person and hyper perspiration, the composition of sweat, 
temperature and humidity inside of shoes promotes the growth of 
microorganisms such as T. rubrum. Most athletic shoes are made of synthetic 
materials that poorly absorb water leaving the foot skin exposed to moisture, 
microorganisms and their by-products for extended durations (Decker, 2010). 
Textiles that come in contact with infected skin can then be carriers for the 
propagation of the fungus; contaminated clothing such as socks, shoes, towels 
and bed linen can therefore be a source of T. rubrum infection (Gnanasundaram 
et al., 2013). It is therefore important that foot insoles in athletic footwear are 
made of absorbent materials and are also able to fight against microbial growth 
with the aid of an incorporated antimicrobial agents. Topical antifungals such as 
imidazoles are usually necessary, with treatment times ranging from 1-4 weeks 
(Hay, 2005). Some of the most potent topical antifungals are able to destroy the 
fungi without adverse reactions, but they have drawbacks in that they can be 
difficult to use, daily application is required as medication is easily removed from 
the skin through bathing and natural dermal cell turn over (Ikeda et al., 2013).  
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Few studies have focused on alternative or natural treatment of tinea 
pedis. Treatment of patients with athlete’s foot using copper-oxide impregnated 
socks over a 9-day period, has shown promising results, with all 56 patients 
showing improvement or resolution of erythema, vesicular eruptions, scaling and 
itching associated with the disease (Zatcoff et al., 2008). However, studies have 
shown that dermatophytes are susceptible to the action of (plant derived 
antimicrobials) and therefore more investigations need to be dedicated to the 
treatment of tinea pedis using natural agents (Bajpai et al., 2009; Pereira et al., 
2011).  
 
2.2.3 Eczema 
 
Eczema or atopic dermatitis (AD), is one of the most common 
inflammatory skin diseases in the general population and affects approximately 
15-20% of children and 10% of adults in the UK. In up to 50% of patients AD will 
improve before adolescence, whilst for others which present AD until adulthood, 
the disease is chronic and recurrent (Archer, 2013; de la Fuente-Núñez et al., 
2013; Orfali et al., 2013). Patients with AD, are more to susceptible to infection 
or colonization by various organisms including S. aureus; which is consistently 
found in patients (80-100%) with AD skin lesions and therefore, plays a significant 
role in the exacerbation of AD (Barnes and Greive, 2013; Boguniewicz and 
Leung, 2013; Gong et al., 2006). AD is often treated with topical or systemic 
antibiotics, however, the emergence of antibiotic resistance and concerns about 
antibiotic abuse, has posed a challenge for treating AD infections. The use of 
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bleach baths (sodium hypochlorite) in the treatment of AD is being explored but 
the safety and efficacy still needs to be proven by further clinical trials and 
alternatives are still being sought (Barnes and Greive, 2013). AD can have a 
significant impact on the quality of life of the families involved; sleep loss, absence 
from school and pruritus (itching) discomfort are often consequences of AD. 
Atopic dermatitis is a chronic disease that has no cure and requires effective 
preventative measures (de la Fuente-Núñez et al., 2013).   
 
2.2.4 Wound Management 
 
While most wounds heal without complications, there are some chronic 
and acute wounds in which the healing process is delayed, leading to increase in 
patient mortality and leaving serious scars (Singh et al., 2017). Wound 
management forms a critical step in the care of patients, and this is especially 
true with surgery patients. The possibility of wound complications, such as SSI, 
means that the at the basic level, a dressing should provide an environment that 
is clean, provide a barrier to protect the patient from microbial contamination, 
absorb any extensive exudate, reduce pain and the risk of scarring and may also 
actively intervene in the healing process (Koehler et al., 2018; Vowden and 
Vowden, 2017). Factors such as stress, nutrition, immunity and patient health or 
lack thereof all contribute to wound healing and they must all be managed 
together to achieve optimal wound healing. Due to bacterial activity, wound 
healing is also accompanied by odour production, most especially in patients with 
chronic wounds (Vowden and Vowden, 2017).  
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With the aim of improving wound healing, various types of wound 
dressings have been developed with both natural and synthetic materials, such 
as membranes, hydrogels, films, hydrocolloids and sponges, however not all are 
suitable for every type of wound (Simões et al., 2018). For example, hydrogels 
are mechanically weak when swollen (due to water absorption) and often require 
a second dressing but are able to keep a moist environment around the wound 
due to their ability to store water within a polymeric network (Kamoun et al., 2017; 
Koehler et al., 2018). Sponges are also possess good ability to keep wounds 
moist during healing due to their high porosity but are not suitable for the 
protection of third-degree burns and may cause softening and breaking down of 
the skin tissue due to the prolonged exposure to moisture (Ramos-e-Silva and 
Ribeiro de Castro, 2002). Films used as wound dressings provide adequate 
protection from contamination and bacteria but can be hard to manage and may 
not effectively prevent exudate build up (Kamoun et al., 2017). Membranes also 
provide good protection, acting as barriers between the wounds and the 
environment and ensuring normal gas exchange and cell production can take 
place, however, the materials (such as polymers) and solvents used in producing 
the membranes may cause issues with biocompatibility (Bhattarai et al., 2004).  
 
As such, natural polymers are being used in the production of bioactive 
wound dressing; alginate based wound dressings (such as sodium alginate) have 
been explored and have become commercially available (e.g. Algisite™). 
Alginate dressings are characterised by a high water (or exudate) uptake and 
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sustained drug release which promote rapid wound healing (Aderibigbe and 
Buyana, 2018; Boateng et al., 2008; Dhivya et al., 2015). It has been reported 
that alginate-based dressings are able to either initiate or accelerate the healing 
of wounds due to the activation of macrophage and the production of TNFalpha 
protein which aids in the resistance to infection (Thomas et al., 2000).  
 
2.2.4.1 Antimicrobial Wound Dressings  
 
Due to the high rates of morbidity and mortality attributed to wound 
infections there has been an increase in the development of wound dressings 
which incorporate antimicrobials with the aim of preventing microbial 
contamination in wounds (Simões et al., 2018; Woodford and Livermore, 2009).  
 
 Silver biomaterials have been successfully used in the process of wound 
healing with several silver-containing products having been developed for use in 
dressings. Silver nanoparticles are thought to be able to interact with bacteria cell 
structures, such as the cell wall; they are able to penetrate the cell wall and cause 
structural changes which affect the cell membrane permeability and cause cell 
death (McShan et al., 2014). Another mode of action considered is cell 
membrane damage caused by contact with free radicals formed by the 
nanoparticles (Prabhu and Poulose, 2012).  Their broad antimicrobial activity 
against MRSA, vancomycin-resistant enterococci (VRE), yeasts and moulds 
have been the driving force behind research in silver-based products. However, 
tissue irritation (due to non-specific binding of silver ions) and delayed healing of 
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burn wounds (especially silver sulfadiazine) are some of the disadvantages faced 
with silver wound dressings (Ashtikar and Wacker, 2018; Atiyeh et al., 2007). 
Additionally, the effectiveness of silver-based wound dressings has been 
challenged by Wang et al (2007) as a study on their use on chronic wounds found 
that treatment duration for patients using silver-dressings was greater (p>0.0001) 
compared to those using other dressings (Wang et al., 2007). The emergence of 
resistant strains of E. coli after prolonged use of silver-based dressings also 
means that new products need to be developed which will have less harmful 
effects on humans (Ashtikar and Wacker, 2018; Atiyeh et al., 2007). 
 
Natural antimicrobials are therefore being researched; manuka honey 
wound dressings are being used for the management MRSA infected wounds, 
with a clinical study by Visavadia et al (2008) observing healing of MRSA infected 
wounds within 4 weeks of treatment without complications (Visavadia et al., 
2008).  
 
 
2.3 Essential Oils 
 
Plants naturally protect themselves against microbes and pests by 
producing secondary metabolites such EOs, which are products of this secondary 
metabolism of aromatic plants (Yap et al., 2013). EOs are produced within the 
organs of aromatic plants, such as flowers (rose, violet, litsea, lavender, jasmine), 
herbs (mint), buds (clove), leaves (thyme, salvia, eucalyptus), zest (citrus), and 
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roots (ginger). Due to their hydrophobic nature and lower density (compared to 
water), EOs are immiscible with water but are soluble in organic solvents such as 
alcohols and in the presence of surfactants (Asbahani et al., 2015). EOs are 
usually obtained from hydrodistillation, steam distillation and solvent extraction 
and they are comprised of a complex mixture several individual compounds 
(Okoh et al., 2010).  
 
EOs are known for their characteristic strong fragrances and for their 
antimicrobial (fungicidal, bactericidal and virucidal) and anti-inflammatory 
properties (Asbahani et al., 2015; Bakkali et al., 2008; Calo et al., 2015; Pandey 
et al., 2014; Raut and Karuppayil, 2014). EOs have been increasingly studied for 
their antimicrobial efficacy since the 1990s, in fields such as food, dentistry, 
agriculture, disinfection and pharmaceutics and their use is increasing in industry 
due to consumer demand for more natural ingredients based on health and 
environmental awareness (Asbahani et al., 2015; Carvalho et al., 2015; Fisher 
and Phillips, 2006; Khani and Asghari, 2012; Pattnaik et al., 1996; Quintas et al., 
2015; Vital et al., 2016; Yangui et al., 2009).  
 
2.3.1 Antimicrobial Activity of EOs 
 
Due to the increasing prevalence of multi-drug resistant pathogenic 
microorganisms, there is a need for more effective antimicrobials that have 
different modes of action; this has led to an increased interest in natural products 
antimicrobial activity (Pandey et al., 2014; Wong et al., 2014).  
 44 
 
 
 It has been found that not only are EOs able to effectively kill bacteria in 
the planktonic phase, but they are also able to eradicate bacteria within biofilms 
(Kavanaugh and Ribbeck, 2012). EOs are naturally occurring antimicrobials and 
their activity is directly correlated to the presence of bioactive compounds such 
as alcohols, terpene compounds, esters, ketones amines, sulphides and 
aldehydes; these are grouped into terpene compounds and aromatic (or 
phenolic) compounds  (Calo et al., 2015; Patel and Gogna, 2015). Though, these 
compounds usually only represent a small fraction of the plant composition 
(Asbahani et al., 2015). Antimicrobial sensitivity is for EOs can be measured 
using various methods such as the diffusion method (either disc diffusion or agar 
diffusion), the dilution method (either by microdilution using 96-well plater or by 
macrodilution using test tubes) and the time-kill method (Orchard and van 
Vuuren, 2017).  
 
Some EOs have shown promising antibacterial activity against nosocomial 
Gram-positive bacteria; cinnamon oil, for example, has antimicrobial efficacy 
against S. aureus, with a MIC of 1.0 mg/ml and MBC of 2.0 mg/ml., 
cinnamaldehyde (92.40%) was thought to be the main component responsible 
for this antimicrobial activity (Zhang et al., 2016). The content of cinnamaldehyde 
is much higher in the study by Zhang et al (2016) compared to studies by Li, Kong 
and Hong (2013) and Li et al (2011) where the compositions were 81.97% and 
77.35% respectively (Li et al., 2013; Lv et al., 2011; Tian et al., 2016). A study on 
oregano EO showed activity against S. aureus although MICs observed in the 
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dilution method were high (>256 mg/ml) indicating low sensitivity to the EO 
(Alexopoulos et al., 2011). S. aureus has also been found to be susceptible to 
lemon grass EO (zones of inhibition >8.50 cm) also inhibiting biofilm formation at 
0.125% v/v (Adukwu et al., 2012). Carvacrol an antimicrobial phenol that often 
occurs in EOs has also been reported to have biofilm activity against S. 
epidermidis (MIC value not reported) biofilm formation and established biofilms, 
with a great reduction in biomass (>50%) though activity was only studied at 
acidic pH (Nostro et al., 2012). 
 
Cinnamon EO was found to have antimicrobial against nosocomial Gram-
negatives, including those that are antibiotic-resistant including carbapenem-
resistant P. aeruginosa and A. baumannii isolates; with the highest zones of 
inhibition observed being 4mm and 35mm respectively. Only one isolate of P. 
aeruginosa was found to be resistant to cinnamon EO, when compared to CLSI 
standard break points. Results showed promise; however, no MIC or MBC values 
were determined (Kaskatepe et al., 2016). Gram-negatives such as K. 
pneumoniae, P. aeruginosa, and S. marcescens, have shown susceptibility to 
Salvia namaensis (Namibian sage) EO with low MIC values of 1.24, 1.25 and 
0.63 mg ml-1 respectively (Grierson and Afolayan, 2005). P. aeruginosa has 
demonstrated resistance to some EO; in a study by Demo et al (2005), 14 plants 
EOs were analysed against P. aeruginosa and other organism, and none of the 
oils tested were able to inhibit P. aeruginosa (Demo et al., 2005). Cinnamon and 
coriander (Coriandrum sativum) EOs have also been found to be antibacterial 
against E. coli with a study by Zhang et al (2016) reporting at an MIC of 1.0 mg/ml 
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and an MBC of 4.0 mg/ml for cinnamon EO and another study by Bazargani and 
Rohloff (2016) reporting an MIC value of 1.6 μl/ml for coriander (Bazargani and 
Rohloff, 2016; Zhang et al., 2016).   
 
Studies conducted on EOs, against fungi and dermatophytes have also 
demonstrated promising antimicrobial efficacy. Lavender EO has showed 
antifungal activity against C. albicans demonstrating similar efficacy to antifungal 
agent clotrimazole (Behmanesh et al., 2015). However, Ocimum basilicum 
(basil), Rosmarinus officinalis (rosemary) and Salvia officinalis (sage) EOs were 
found to not have any antifungal activity against Candida isolates at a range of 
concentrations (50 – 3200 µg/ml). Nigella sativa (black cumin), Murraya koienigii 
(curry leaf), Piper betel (betel lead) and Trachiyspirum ammi (ajwain) EOs were 
all found to be antimicrobial against Candida strains, even after a heat treatment 
of the EOs, with MIC values ranging from 15.62 – 250µl/ml; of the four EOs, 
ajwain and black cumin leaf showed the greatest antifungal activity with MIC 
values as low as 31.25 µl and 15.62 µl respectively. Ajwain EO also showed the 
fastest Minimum Killing Time (MKT) against C. albicans, with a kill time of 10 mins 
at 37°C and at room temperature. Interestingly, the MKT is reduced when the test 
is carried out at lower temperatures (4°C), and instant kill was observed at this 
temperature against C. albicans (Rath and Mohapatra, 2015). This could be due 
to volatility of major antimicrobial compounds at higher temperatures which could 
have an adverse effect on antimicrobial activity of the EOs; Turek and Stintzing 
(2012) reported characteristic changes and degradation of EO component (α-
terpinene) in rosemary EO when stored at 38°C (Turek and Stintzing, 2012). A 
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reduction in biofilm adherence of C. albicans has been also been observed in the 
presence of coriander EO at concentration below MIC 15.6µg/ml (Freires et al., 
2014). Juniperus (juniper) EOs were evaluated against fungi, including Candida 
strains, Aspergillus strains and the dermatophytes T. rubrum and T. 
mentagrophytes. Both dermatophytes were found to be susceptible to the 
antimicrobial activity of all juniper EOs, with EOs of juniper leaves (Juniperus 
oxycedrus) being the most active, giving an MIC and Minimum Lethal 
Concentrations (MLC) values of 0.08-0.16 µl/ml for T. rubrum and T. 
mentagrophytes. In comparison, Juniper leaves EO showed very little activity 
against Aspergillus strains compared to activity against dermatophytes, with MIC 
and MLC values between 1.25 – 5.0 µl/ml (Cavaleiro et al., 2006).  
 
The composition of EOs is thought to be responsible for the antimicrobial 
activity observed in the various studies carried out in literature and their 
composition can easily change during storage and processing due to the 
degradative effects of light, temperature and oxygen on the compounds found in 
EOs (Nguyen, H. et al., 2009). The volatility and susceptibility to degradation by 
the environmental of these individual compounds means that the EOs need to be 
protected if their antimicrobial properties are to be used effectively; one of the 
most effective ways of protecting EOs is through encapsulation.  
 
2.4 Encapsulation of EOs 
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Encapsulation technology has become a useful method in pharmaceutical, 
textile, fragrance, agricultural and food industries. It provides protection for the 
core material against degradation, allows a controlled release of the active agent 
and can lower the loss or extend the flavour of food over time (Fernandes et al., 
2014; Haidong et al., 2012; Martins et al., 2014). EOs comprise compounds that 
are prone to react with light (photosensitive), oxygen and are sensitive to high 
temperatures; such reactions can lead to degradation and therefore reduce the 
activity of EOs. Thus, there is a need to encapsulate EOs to prevent such 
reactions; encapsulating EOs can also increase the stability of the volatile 
compounds during heating process (Dima et al., 2016). 
 
In the last decade; there has been an increased use of natural 
biodegradable polymers, within various industries; polysaccharides in particular 
have gained interest due to their favourable properties in terms of safety (FDA 
approval), toxicity, biocompatibility, availability and cost (Liu et al., 2015; Yang et 
al., 2015). Polysaccharides with biological activity (such as gum Arabic, chitosan 
and sodium alginate) have been of interest in recent years, for novel biomedical 
applications such as wound healing, drug delivery and tissue engineering (de 
Barros Fernandes et al., 2014; Hsieh et al., 2006; Kanakdande et al., 2007; Pedro 
et al., 2009). In addition, the ability to control their molecular weight and their 
chemical composition to achieve the microcapsule properties desired make them 
a favourable choice (Gong et al., 2014). Microencapsulation allows the protection 
of a substance allowing easier handling for application; the system allows large 
amounts of lipophilic substances to be loaded within the lipid core and the shell 
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membrane to protect the core ingredients from unfavourable environmental 
conditions during processing or storage and can control the release rate of the 
core material through the wall membrane (Butstraen and Salaün, 2014; Lv et al., 
2014; Nakagawa and Nagao, 2012).  
 
2.4.1 Microencapsulation Technology 
 
In simple terms, a microcapsule is comprised of a core (usually the active 
component needing protection) and wall materials (also referred to as the coating 
or shell) which are commonly polymers, carbohydrates or proteins (Bakry et al., 
2016; Haidong et al., 2012). Methods of encapsulating the active material vary 
and their use will be depended on the nature of the core material, the desired 
particle size, desired release of the core and intended the application of the final 
product (Ghayempour and Montazer, 2016; Haidong et al., 2012). The process 
of microencapsulation involves the coating of droplets or particles of a substance 
(e.g. drugs, hormones, proteins, fertilizers, cosmetics, oils) with a thin wall of 
natural or synthetic polymers that acts as a protective barrier, to create individual 
particles (Butstraen and Salaün, 2014). 
 
There are various methods of microencapsulation including physical (e.g. 
spray-drying and freeze-drying), chemical (e.g. solvent evaporation and in situ 
polymerization) and physicochemical (e.g. ionic gelation, coacervation and 
emulsification) methods (Tomaro-Duchesneau et al., 2013). 
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2.4.1.1 Complex Coacervation 
 
Complex coacervation is based on the coacervation from an oil-in-water 
(o/w) emulsion, in which the emulsion, which contains an anionic surfactant, is 
added to an aqueous solution (e.g. of chitosan); after which an electrolyte (e.g. 
alginate) is added to form microcapsules (Butstraen and Salaün, 2014). 
Microencapsulation requires the cross-linking of the wall polymers to increase the 
thermal and mechanical properties of the capsules (Butstraen and Salaün, 2014; 
Zhang et al., 2012). Most of the cross-linking agents used to create 
microcapsules are toxic in nature and have to be washed out with a solvent to 
reach a biologically acceptable level, restricting its use in many applications; such 
cross-linkers include aldehydes i.e. glutaraldehyde and formaldehyde (Butstraen 
and Salaün, 2014; Yang et al., 2014; Zhang et al., 2012). Sodium 
tripolyphosphate (TPP) is non-toxic cross-linker that has been proposed as an 
alternative to aldehyde crosslinkers (Butstraen and Salaün, 2014). 
 
Figure 2.1 Complex coacervation process (Madene et al., 2006). 
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Complex coacervation, illustrated in Fig 2.1, is achieved under specific 
conditions that are dependent on the charge and charge density of the wall 
polymers used, the processing temperature and the process itself, such as 
cooling and stirring (Piacentini et al., 2013). During complex coacervation a 
spontaneous reaction occurs between two polymers of opposite charge, leading 
to a phase separation in which an aqueous phase and a polymer phase are 
formed once the charges are neutralized (Piacentini et al., 2013). Complex 
coacervation is a promising technique for the production of micro/nanoparticles 
within industry; it is simple, allows high payloads, good controlled release and 
heat resistant properties, high efficiency and does not require a solvent (Lv et al., 
2014; Nakagawa and Nagao, 2012; Yang et al., 2015). In a microencapsulation 
process based on coacervation, the pH is a key parameter. Aziz et al (2014), 
evaluated the effects of core material (krill oil) to wall material (gelatin-gum 
Arabic) ratio, stirring speed and pH on the encapsulation efficiency, and found 
that pH had the most significant effects on the encapsulation efficiency (EE). 
Stable microcapsules, with 92% EE were synthesised using optimal conditions of 
pH 3.8, stirring speed 3, and a ratio (of core material to wall material) of 1.75:1 
(Aziz et al., 2014). Stirring speed is important because the microcapsules can be 
significantly affected by the homogenization rate during the process of 
emulsification; when a lower rate is used during preparation, the microcapsules 
release the core material more rapidly than those prepared with a higher rate 
during the process (Zhang et al., 2012). Microcapsules produced by complex 
coacervation are also affected by the polymer properties including molecular 
mass, ionic charge density and concentration, all of which are determined by the 
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formulation (Nakagawa and Nagao, 2012). Microencapsulation of Melaleuca 
alternifolia (tea tree) EO by complex coacervation led to an increase in the 
evaporation temperature of tea tree EO from 140°C to 230 – 260°C because of 
the core protection provided by the polymers gelatine (G) and sodium 
carboxymethyl-cellulose (C). The ratio of these polymers (G/C), affected the 
formation of the coacervate during synthesis and the EE of tea tree EO. The 
increase in G/C ratio lead to an increase in EE (63.3 ± 1.4%) up to G/C=10, 
because of the amount of coacervate formed, and above this value, the amount 
of oil in the microcapsules decreased again (Pérez-Limiñana et al., 2014). The 
process, however, is not without its challenges; aggregation and release 
problems (burst) have been reported, which are not desirable for most of its 
applications (Yang et al., 2014).  
 
2.4.1.2 Ionic-Gelation 
 
Ionic-gelation is a method that has received a lot of attention specifically 
in the preparation of chitosan and TPP microcapsules, which are used for the in 
vivo administration of drugs (Fàbregas et al., 2013). The process is non-toxic, 
convenient, controllable, and does not require the use of organic solvents The 
method involves the complexation between the positively charged amino groups 
of a polymer and the oppositely charged groups of a cross linking agent to form 
a system that is sensitive to ionic strength (Dong et al., 2013; Fàbregas et al., 
2013; Fan et al., 2012). By using this method, the use of chemical cross-linkers 
and emulsifiers is avoided; this is especially useful as most of these chemicals 
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are usually toxic (Fan et al., 2012).  Spray drying, although economical and widely 
used, uses high temperatures up to 160 °C, which accelerates the oxidation of 
oils, and requires the combination of different wall materials to minimise lipid 
oxidation (Abang et al., 2012; Carneiro et al., 2013). The coacervation method, 
compared to the ionic gelation method, although efficient, is expensive; this 
method was proposed by Abang et al (2012), however, their study, using inverse 
gelation produced spherical capsules with diameters around 3 mm, the 
production of smaller microcapsules or nanocapsules was not demonstrated 
(Abang et al., 2012). Martins et al (2015) optimised the process by adjusting the 
experimental conditions (wall material ratio and concentration, curing time, 
stirring rate) and achieved core-shell microcapsules with a smaller 500µm mean 
diameter (Martins et al., 2015). 
 
2.4.1.3 Freeze-Drying 
 
Freeze-drying is also known as lyophilization, a method used to dehydrate 
heat-sensitive substances such as oils; it has been used to encapsulate fish oil 
and olive oil (Calvo et al., 2012; Heinzelmann et al., 2000). It operates by lowering 
pressure and freezing the material; the ice is then removed by sublimation as the 
material transitions directly from a solid phase to gas phase (Krokida and 
Philippopoulos, 2006). Advantages of freeze-drying include ease of operation, 
simplicity and protection of heat sensitive materials (Bakry et al., 2016). Velasco 
et al (2003) found that freeze-drying reduced sensitivity of oils to oxidation but 
decreased the encapsulation efficiency (Velasco et al., 2003).  Freeze drying, 
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uses high amounts of energy, is high cost and involves a long process. 
Additionally, the material (e.g. the oil) could be more exposed to the environment 
when freeze-dried because of the resulting powders are highly porous, though 
this feature is advantageous when a high drug release is required (Bakry et al., 
2016; Sinha et al., 2007). 
 
2.4.1.4 Spray Drying 
 
Spray drying is one of the oldest and most established process of 
encapsulation and has been used to prepare pharmaceutical products such as 
granules, suspensions and dry powders. Spray drying involves forming an 
emulsion by dispersing the core material in a polymer solution; this is then 
homogenized and atomized into a drying chamber (Ixtaina et al., 2015). The 
method is commonly used to encapsulate core materials that are sensitive to 
heat, and functional lipophilic ingredients (Berendsen et al., 2015; Dima et al., 
2016; Munoz-Ibanez et al., 2016). A disadvantage of spray drying is that the 
release properties can be affected due to the formation of amorphous systems, 
which are thermodynamically unstable and can change back to the crystalline 
state on storage. Spray drying can also affect particle size; dexamethasone 
acetate containing PLGA nanoparticles were formulated and spray dried, the 
spray drying processes significantly (p< 0.05) increased the nanoparticle sizes. 
The mean particle size increased from 200 ± 60 nm to 230 ± 100 nm, however 
particle density and size distribution seemed to be unaffected (Gómez Gaete et 
al., 2008).  
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2.4.1.5 Emulsification 
 
Emulsification is a simple and cheap method used to encapsulate 
bioactives (such as EOs and extracts) within aqueous solutions. These solutions 
are then ready to be used in liquid form but can be further processed using the 
methods described above. Emulsions comprise two phases, usually oil and 
water, which are immiscible (hydrophilic and hydrophobic); the hydrophobic (oil) 
phase can be dispersed within an aqueous phase, forming an oil-in-water (O/W) 
emulsion or the opposite can be true forming a water-in-oil (W/O) emulsion (Bakry 
et al., 2016). Polymer microcapsules have been created using this method with 
polymethyl-methacrylate (PMMA) and jasmine EO; spherical PMMA 
microcapsules, with smooth surfaces were achieved when the PMMA to jasmine 
EO weight ratio was 2:1 and 3:1. At a 1:1 ratio, the polymer capsules could not 
be achieved, as the capsules comprised holes, possibly due to insufficient 
amounts of PMMA required to coat the jasmine oil droplets.  Encapsulation 
efficiency was determined to be 72%, as 4.78mg of jasmine oil was found, when 
analysing 20 mg of dried capsule (Teeka et al., 2014).  
 
2.4.1.6 Release of the Core Material 
 
The release of the core material from the microcapsule is measured by 
using gentle agitation to achieve a well-mixed dispersion and then the changes 
in the solute concentrations over time are measured either in intervals or 
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continuously. The release kinetics and the diffusion coefficient can therefore be 
calculated (Gray et al., 2015). The release rate of an active ingredient within a 
microcapsule depends on different factors including: the wall material, the core 
material itself, the morphology and geometry of the particle, the degree of cross-
linking, the conditions (e.g. pH, temperature, ionic strength) and the method of 
microencapsulation e.g. spray drying (da Silva et al., 2014; Dima et al., 2016). A 
study on chitosan-encapsulated menthol microcapsules observed that the 
crosslinkers used (TPP) had an effect on the release time of menthol when used 
at different concentrations, and generally the higher the TPP concentration, the 
slower the release time. At 1% w/w TPP, 95% of menthol was release within 60 
h, whilst at 15% w/w TPP, only 38.3% was released at 60 h (Nuisin et al., 2013). 
It is important that the release of the core material occurs at the appropriate time 
and place; a study by Nuisin et al (2013) shows that the release rate is mainly 
related to interactions between the core and wall material (da Silva et al., 2014). 
The pH of the microcapsule environment can also have an effect on the release 
rate of the core material; drug containing alginate-pectin microcapsules showed 
higher drug release percentages in acidic pH 1.2 compared to an alkaline pH 8.2, 
with maximum drug release of 75.6% and 42% respectively (Jaya et al., 2009). 
The characteristics of the core material, including amount can also affect release 
rate; Dürrigl et al (2011) found that their calcium loaded microparticles, showed 
greater drug release with a higher drug load and a 2:1 drug: polymer ratio (Dürrigl 
et al., 2011). Release studies are conducted using mathematical models that 
describe the different ways that molecules are transported across the capsule 
wall. Larger microcapsules are more suited to controlled release applications 
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because there is a reduced protection of the core material by the wall material 
and therefore the release rate of the core material is improved (Dong et al., 2011). 
 
2.4.1.7 Biodegradable Polymer Materials  
 
Natural polymers are divided into polysaccharides, nucleic acids, proteins 
and lipids (Yang et al., 2015). Polysaccharides have attracted a lot of recognition 
as promising wall materials for encapsulation, due to their ‘superior 
physicochemical and biological properties; they are safe, non-toxic, 
biodegradable, biocompatible, are abundant in nature, can be modified easily and 
low cost (Amin et al., 2014; Liu et al., 2015; Yang et al., 2015). They are made of 
long chains of monosaccharide units linked by glycosidic bonds; included on their 
chains can be reactive groups such as hydroxyl, carboxyl, and amino groups on 
their chains, which are reactive, and allow the molecules to be modified (Amin et 
al., 2014; Liu et al., 2015; Yang et al., 2015). Chitosan is a renewable natural 
marine-derived polysaccharide that is extremely abundant (Banerjee et al., 2002; 
Rodrigues, Susana et al., 2012; Yang et al., 2015). Chitosan is already being 
used within the pharmaceutical industry because it is biocompatible, 
biodegradable, non-toxic and has bio adhesive and antibacterial properties 
gained through the alkaline deacetylation of chitin (Avadi et al., 2010; Banerjee 
et al., 2002; Butstraen and Salaün, 2014; Dima et al., 2016; Dong et al., 2013; 
Du et al., 2009; Qi et al., 2004; Trapani et al., 2009). Alginate is another natural 
and abundant polysaccharide (Pawar and Edgar, 2012). Alginates are used in 
industry based on their viscosifying, stabilizing and gelling properties; they are 
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used as stabilizers and thickeners within the food industry; medically, alginates 
have been popular in wound care (as wound dressings), as alginate dressings 
can provide an acceptably moist environment for the wounds exudate whilst 
absorbing great amount of secretions (Draget and Taylor, 2011; Goh et al., 2012). 
Cellulose is a biopolymer found abundantly in vascular plants as well as in algae, 
and some bacterial species (Kumar and Turner, 2015). It is the most widely used, 
most abundant, renewable, biodegradable, and biocompatible polymer, and its 
derivatives include carboxymethyl cellulose (CMC), hydroxyethyl cellulose 
(HEC), hydropropyl-cellulose (HPC) and hydropropylmethyl cellulose (HPMC); all 
have been recognised for the biocompatibility (Amin et al., 2014; Song and Chen, 
2015). 
 
2.4.2 Characterisation of Microcapsules  
2.4.2.1 Particle Size and Size Distribution 
 
Microcapsules often come in different sizes and size distributions 
depending on the methods used and their size are related to their mechanical 
properties e.g. smaller microcapsules will have lower rupture force compared to 
a larger microcapsule. A study by Sun and Zhang (2002) showed that the bursting 
force and deformation of melamine-formaldehyde, urea-formaldehyde and 
gelatine microcapsules increased proportionally with their diameter (Sun and 
Zhang, 2002). To determine the particle size of microcapsules, dynamic light 
scattering (DLS), laser diffraction and microscopy are used. There are limitations 
with the use of laser diffraction, as the refractive index of the shell material must 
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be known for the measurement. Microscopy has an advantage over laser 
diffraction as it gives the true image of the microcapsule but it time consuming 
and is therefore, mostly used for individual size analysis rather than size 
distribution (Gray et al., 2015). DLS a method that gives you the average particle 
size and the size distribution within the sample elucidating the homogeneity of 
particles being analysed. 
 
2.4.2.1 Surface Charge  
 
The zeta potential (the charge at the interface between a particle and the 
medium surrounding it) needs to be controlled to prevent microcapsule 
aggregation. The zeta potential should be analysed to identify what needs to be 
done to move the zeta potential away from the isoelectric point in order to prevent 
aggregation; electrophoresis is one of the methods used to calculate the zeta 
potential by measuring the electrophoretic mobility of the microcapsules in a 
medium (Gray et al., 2015).  A study on chitosan coated microemulsions (CH-
MEs) evaluated the zeta potential of CH-MEs was increased after being coated 
with chitosan solution but decreased when surfactant concentrations increased; 
results were then used to develop CH-MEs with optimal stability and acceptable 
physicochemical behaviour (Kesavan et al., 2013).  
 
  
 60 
 
2.5 Application of Microcapsules in the Textile Industry 
 
The textile industry has been a major generator of employment and 
income through the years; in the European Union (EU), 2.45 million people were 
employed in 2006 within the textile industry. However, it has been deemed one 
of the most polluting industries in the world, with harmful chemicals being used, 
high water and energy consumption, large generation of waste, high fuel 
consumption from transportation and the use of non-recyclable packaging 
materials have all contributed to the unsustainable life cycle of textiles 
(Hasanbeigi and Price, 2012; Jena et al., 2015; Parisi et al., 2015). The various 
stages of textile production generate waste into the environment and require vast 
amounts of water, energy and chemicals contributing to environmental problems 
such as water pollution (Jena et al., 2015; Parisi et al., 2015). All stages of the 
production process of textiles use vast amounts of water, energy, fuel and 
chemicals, especially the preparation process, dyeing and finishing. A textile mill 
that produces 8 tonnes of fabric a day will use an average of 1.6 million litres; 
16% of this is used for dyeing and 8% for printing (Parisi et al., 2015; Sinclair, 
2014). Also, each stage generates waste, which ends up being injected into the 
environment, effectively polluting it (Jena et al., 2015). More sustainable 
processes are being investigated to reduce this environmental impact and create 
more sustainable products Manufacturers are faced with the task of making a 
sustainable product that is produced with the environment, fair trade and human 
rights in mind (Parisi et al., 2015). In the recent years, there have been 
improvements in environmental law enforcement, and increased demand for 
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sustainable clothing from ethical consumers, and importantly, a greater 
compliance by manufacturers as the awareness of the need for sustainability 
increases. 
 
Increased knowledge of the environmental issues associated with the 
textile industry has led to increased demand for natural-fibre based textiles like 
cotton, and natural dyes and finishes (Jena et al., 2015; Shahid-ul-Islam et al., 
2013).  Greater awareness has also led textile processors to try and reduce their 
environmental impact (Jena et al., 2015). Consumer demand for textiles that offer 
functional properties, such as insect-repellence, flame retardation, UV protection 
and antimicrobial protection; such textiles are called ‘functional textiles’ has also 
increased, in addition, textiles that provide protection from infection by pathogenic 
microorganisms have become increasingly sought after (Hui et al., 2013; Shahid-
ul-Islam et al., 2013; Specos et al., 2010). 
 
The current focus in the textile industry, involves the microencapsulation 
of phase change materials (PCM) to produce textiles with an added value, such 
as medical textiles and thermo-regulating fabric (Sánchez et al., 2010). 
Consumers are however, becoming increasingly aware that bacteria can grow 
and survive on fabrics, especially those that are used in environments such as 
hospitals, contributing to disease transmission, but also contributing fabric 
deterioration, skin irritation and development of foul smell (Riley et al., 2017). 
There is an increasing interest in producing antimicrobial finishes using natural 
sources, such as plant extracts containing active compounds; not only are these 
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eco-friendly but also are derived from sources that are renewable (Sumithra and 
Raaja, 2012). There is potential application of natural antibacterial fabrics in 
arenas such as healthcare and sportswear but only a few published studies have 
been carried out on the incorporation EOs to textiles to create antimicrobial 
fabrics. Sayed et al (2017) applied a nanoemulsion encapsulating neem EO on 
cotton fabric using the padding technique and reported 71.73% and 65.69% 
reduction of S. aureus and E. coli after 4 washes (Sayed et al., 2017). 
 
2.5.1 Antimicrobial Finishes 
 
Finishes are important in increasing the usage characteristics and the 
appeal of a textile product (Jena, et al. 2015). Textiles made of natural fibres are 
a good medium for microbial growth as they provide the conditions and nutrients 
required for growth. Synthetic fibres, however have been found to be resistant 
against microbial degradation and discolouration, due to high hydrophobicity; for 
instance polyester (PE) has a lower moisture absorbance than cotton and 
therefore, it is more likely that microbial growth will occur on the skin causing 
odour problems (Dev et al., 2009; El-Ola, 2008). Deterioration of fabric is often 
linked to microbial growth, therefore antimicrobial finishes are being sought to 
prevent the growth of microorganisms on textiles, and within medical field, with 
an added aim of preventing cross-infection by pathogens to patients, healthcare 
workers and the environment (El-Ola, 2008). 
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A number of chemical agents have been used to impart antimicrobial 
activity to textiles, which include antibiotics, nanometals, onium salts, nitro 
compounds, inorganic salts, phenols and thiophenols, but many of these are toxic 
to humans and are not easily degradable within the environment; finishing’s 
involving chitosan and EOs are therefore being explored (Fu et al., 2011).  
Fabrics, like cotton can be treated with natural finishes that would potentially 
combat hospital-acquired infection like chronic wounds, dermatophyte infections 
such as athlete’s foot and even secondary infections from eczema.  
 
There is evidence that EOs have promise as antimicrobial agents within 
various fields and industries and an increased interest and demand for 
antimicrobial finishes, with the textile industry looking for more eco-friendly 
processes especially those processes that can reduce the chemical burden.  To 
date, there are limited studies on how biopolymers such as chitosan can be used 
in combination with natural antimicrobials like EOs for the purpose of 
antimicrobial finishes on fabrics. The principal aim of this thesis is to investigate 
the possibility of using natural antimicrobials to provide antimicrobial properties 
to textiles in an eco-friendly manner. The vision, upon fabrication of an effective 
antimicrobial eco-friendly textile, is that the textile would have potential both in 
the healthcare and sports arenas against healthcare associated infections and 
sports related infections.   
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2.6 Scope of Works 
 
Although increasing evidence has been reported that EOs show potential 
as antimicrobial agents, there is limited data on the use of blends of citrus EOs, 
in particular litsea and lemon blends, as an antimicrobial for the application in 
textile finishing. With an increasing demand for eco-friendly finishes within the 
textile industry, studies on the use of biopolymers such as chitosan and sodium 
alginate for the encapsulation of EOs, (with the intention of bestowing 
antimicrobial properties) are limited.  
 
2.7 Aims and Objectives 
 
The aim of this study is to develop an antimicrobial coating for textiles 
using a novel green microencapsulation process (with the exclusion of toxic 
processes and substances) for EOs that could be utilised in the clinical and sports 
arenas for skin related conditions and malodour. 
 
Objectives: 
 
• To identify effective antimicrobial EOs and EO blends against bacterial 
strains of S. aureus, E. coli, S. epidermidis, P. aeruginosa and the 
dermatophyte T. rubrum; 
• To formulate EOs and eco-friendly microcapsule wall materials 
(biodegradable polymers) into a stable emulsion; 
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• To apply the formulated emulsion onto textiles using a simple and toxic 
free process; 
• To assess treated fabric for antimicrobial activity and durability. 
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Chapter 3. Materials and Methods 
 
3.1 Universal Methods 
3.1.1 Microorganisms and Culturing Methods 
 
The test microorganisms, S. aureus (NCTC 8327) isolated from skin, P. 
aeruginosa (NCIMB 8626), E. coli (NCTC 8003) isolated from gastro-enteritis and 
S. epidermidis (NCTC 5955) isolated from skin lesions, were obtained from Public 
Health England, UK. T. rubrum (ATCC 28188) isolated from human lesions was 
obtained from Thermo Scientific, UK.  
 
All bacterial organisms were cultured in Brain Heart Infusion (BHI) broth 
(53286) and maintained on BHI agar (70138) from Sigma Aldrich (Gillingham, 
UK). All bacterial organisms were grown under aerobic conditions at 37°C.  T. 
rubrum was cultured in Sabouraud dextrose broth (SDB) (CM0147) and 
maintained on Sabouraud dextrose agar (SDA) (CM0041) from Oxoid 
(Hampshire, UK). T. rubrum was grown under aerobic conditions at 30°C. All 
cultures were stored on beads at -80°C.  
 
3.1.2 EOs  
 
Bergamot (Citrus bergamia), citronella (Cymbopogon nardus), lemon 
(Citrus limon), litsea (Litsea cubeba), bitter orange (Citrus aurantium var amara), 
sweet orange (Citrus aurantium var sinensis), peppermint (Mentha piperita), 
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rosemary (R. officinalis), rosewood (Aniba rosaeodora) and wild thyme (Thymus 
serpyllum) EOs were obtained from Penny Price Aromatherapy Ltd (Hinckley, 
UK).  
 
3.1.3 EO Blend 
 
The combination of the EOs litsea/lemon (1:2 ratio) were prepared before 
each experiment. 
 
3.1.4 Growth Curves 
 
100 ml of BHI broth in conical flasks was inoculated with a colony of either 
S. aureus, S. epidermidis or E. coli and incubated at 37°C for 24 hours. The 
optical density of the cultures was recorded every hour at 590 nm using an 
Evolution 60S UV-Visible spectrophotometer (Thermo Fisher Scientific, UK). 
Samples of the cultures were taken hourly for 10 hours and then again at 24 
hours. Serial dilutions were carried out, aliquots of 0.1 µl were plated and 
incubated at 37°C for 24 hours before enumeration of viable counts.  
 
T. rubrum was pre-cultured on SDA and plugs were collected from the 
cultured plates using a metal corer and transferred onto the centre of fresh SDA 
plates. Plates were incubated at 30°C for 15 days. The radial growth of T. rubrum 
was recorded using a digital calliper every day for 5 days, on day 8, 9, 10 and 
finally on day 15.  
 68 
 
Examples of typical growth curves for S. aureus, S. epidermidis, E. coli 
and T. rubrum can be seen in Appendix I. 
 
3.1.5 Chemicals used in Emulsion Preparation and Characterisation 
 
Authentic standard of analytical grade citral (99%), (R)- limonene and (S)- 
limonene were obtained from Sigma Aldrich (Gillingham, UK). Polymers of 
chitosan (low molecular grade) and sodium alginate were obtained by Sigma-
Aldrich (Dorset, UK). Calcium chloride was obtained from Fisher Scientific 
(Loughborough, UK).  
 
3.1.6 Statistical Analysis 
 
All statistical analysis was carried out using SPSS version 25 for Windows 
with significance set at p = 0.05 (unless stated otherwise). The Kolmogorov-
Smirnov test was used to test assumptions of normality and variances of 
homogeneity were assessed using Levine’s test. If all assumptions were met, 
data was analysed using one-way analysis of variances (ANOVA). Tukey post-
hoc tests were used to determine if there were any significant differences 
between group means. If any assumptions were violated the Welch test was 
performed. ANOVA output example can be found in Appendix III. All 
investigations were carried out in triplicate on at least two separate occasions, 
unless stated otherwise and data is presented as mean ± standard deviation 
(SD).  
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3.2 Screening EOs for Antimicrobial Activity 
3.2.1 Inoculum Preparation 
 
Bacterial suspensions of S. aureus, P. aeruginosa, E. coli, and S. 
epidermidis were prepared by transferring a colony from a freshly grown plate of 
bacteria into 10 mL of BHI broth; inoculate broths were then incubated at 37°C 
for 18 hours. Fungal spore suspensions of T. rubrum were prepared by releasing 
1ml of sterile distilled water (SDW) containing 0.01% Tween 80 in the centre of a 
pre-cultured SDA plate and gently scraping the spores with a glass spreader. The 
spore suspension was then made up to 5ml with SDW and filtered using a ply of 
5 sheets of muslin cloth sheets of 5 cm x 5 cm squares to remove the hyphae 
and spore thread. After filtration, the spores were washed 3 times by centrifuging 
the suspension at 2000 x g for 5 mins at room temperature, supernatant removed, 
adding 5 ml of SDW and resuspending the spores by mixing with a shaker; this 
was repeated three times. The spore count was then adjusted using a 
haemocytometer/nephelometer and microscope to (107) CFU/ml with SDW. 
 
3.2.2 Disc Diffusion Method 
 
The disc diffusion method was used to assess the antimicrobial activity of 
all 10 EOs. Aliquots of 50μl of overnight cultures of S. aureus, P. aeruginosa, E. 
coli, and S. epidermidis at a concentration of 108 CFU/ml, or of a 107 spore 
suspension of T. rubrum, were spread over the surface of BHI agar plates. Filter 
discs (20 mm) were then placed over the center of the agar plates and 
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impregnated with 25 μl of EO by directly pipetting onto the filter disc after 
placement. All plates were incubated at 37°C for 18 hours for bacteria and at 
30°C for 7 days for fungi; the ZOIs were then measured and recorded using digital 
callipers. Controls were plates without oil impregnated filter discs.  
 
3.3 Determination of the Minimum Inhibitory Concentration (MIC) 
and Minimum Bactericidal Concentrations (MBC) of 
Antimicrobial EOs 
 
Doubling dilutions of EOs with final concentrations between 40 μl/ml and 
0.1 μl/ml were prepared for litsea, lemon and rosemary EO in BHI/SD broth, with 
the addition of 10% v/v DMSO solvent (Fisher Scientific) to make a final volume 
of 9.9 ml. Aliquots of 100 μl of an overnight culture of either S. aureus, P. 
aeruginosa, E. coli or S. epidermidis (108 CFU/ml) were then added were then 
transferred into 96 well plates. For fungal organism 100 μl of a fresh spore 
suspension (107 CFU/ml) was transferred to test tubes. Optical density (595 nm) 
readings were taken at 0 hour and again at 24 hours after incubation of bacterial 
organisms at 37°C, on a SpectraMax Plus 384 microplate reader and results were 
analyzed using SoftMax Pro version 6.4 software (Molecular Devices, USA). 
Readings for the fungal organism were taken visually by checking for visible 
growth. The MIC for each EO was defined as the lowest concentration of EO that 
inhibited the visible growth of the microorganism. The MBC was determined by 
spread plating inoculated EO solutions onto BHI, incubating at 37°C for 24 hrs 
and enumerating. The same method was carried out for T. rubrum, using SDA 
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and incubating at 30°C for 7 days. Controls were microorganism in the presence 
of 10% v/v DMSO only. 
 
3.4 Assessment of Synergism between EOs 
 
To investigate the potential of synergistic interactions between the EOs in 
double and triple combinations, the checkerboard method was used; the 
fractional inhibitory concentration (FIC) and the FIC Index (or FICI) were then 
determined for rosemary, lemon and litsea EOs. The EOs were combined in 96 
well plates, to yield varying concentrations ranging from several dilutions below 
the MIC to double the MIC.  Serial concentrations were prepared with BHI or SDB 
broth (for fungi) with 10% (v/v) DMSO emulsifier for bacterial organisms or 10% 
(v/v) Tween 80 emulsifier for fungi. These were then inoculated with either S. 
aureus, P. aeruginosa, E. coli, S. epidermidis (BHI) or T. rubrum (SDB). Double 
combinations and triple combinations of the different concentrations of EOs were 
produced and MIC was determined as described above in Section 3.3. The FIC 
and FICI of each combination of EOs was then calculated for the double and triple 
concentrations according to Equations (1)  and (2) respectively: 
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𝐹𝐹𝐹𝐹𝐹𝐹𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖/𝐵𝐵 = 𝑀𝑀𝐹𝐹𝐹𝐹 (𝑜𝑜𝑜𝑜𝑜𝑜 𝐴𝐴 )𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐𝑀𝑀𝐹𝐹𝐹𝐹 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜 𝐴𝐴 𝑎𝑎𝑜𝑜𝑜𝑜𝑐𝑐𝑐𝑐 + 𝑀𝑀𝐹𝐹𝐹𝐹 (𝑜𝑜𝑜𝑜𝑜𝑜 𝐵𝐵 ) 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐𝑀𝑀𝐹𝐹𝐹𝐹 𝑜𝑜𝑜𝑜𝑜𝑜 𝐵𝐵 𝑎𝑎𝑜𝑜𝑜𝑜𝑐𝑐𝑐𝑐  
 
 (1) 
   
  
𝐹𝐹𝐹𝐹𝐹𝐹𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖/𝐵𝐵/𝐶𝐶 = 𝑀𝑀𝐹𝐹𝐹𝐹 (𝑜𝑜𝑜𝑜𝑜𝑜 𝐴𝐴)𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐𝑀𝑀𝐹𝐹𝐹𝐹 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜 𝐴𝐴 𝑎𝑎𝑜𝑜𝑜𝑜𝑐𝑐𝑐𝑐 + 𝑀𝑀𝐹𝐹𝐹𝐹 (𝑜𝑜𝑜𝑜𝑜𝑜 𝐵𝐵) 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐𝑀𝑀𝐹𝐹𝐹𝐹 𝑜𝑜𝑜𝑜𝑜𝑜 𝐵𝐵 𝑎𝑎𝑜𝑜𝑜𝑜𝑐𝑐𝑐𝑐+ 𝑀𝑀𝐹𝐹𝐹𝐹 (𝑜𝑜𝑜𝑜𝑜𝑜 𝐹𝐹) 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐
𝑀𝑀𝐹𝐹𝐹𝐹 𝑜𝑜𝑜𝑜𝑜𝑜 𝐹𝐹 𝑎𝑎𝑜𝑜𝑜𝑜𝑐𝑐𝑐𝑐  
 
 
 (2) 
 
 
The synergistic, additive, non-interactive (or indifferent) and antagonistic 
effects were determined from these limits: FICI ≤ 0.5 indicates a synergistic effect, 
whilst 0.5 ≤ FICI ≤ 1 indicates an additive effect, 1 ≤ FICI ≤ 4 indicates no 
interaction and FICI > 4 indicates an antagonistic effect (Hossain et al., 2016; 
Stein et al., 2015).  
 
3.5 Emulsion Preparation and Microencapsulation 
 
Emulsions of 10% final EO-blend (litsea/lemon) concentration containing 
20% v/v Tween 80 surfactant (Fisher Scientific, UK) and emulsions containing 
10% EO but no Tween 80 were prepared. Emulsions containing 20% v/v Tween 
80 were prepared by mixing the surfactant with 5 ml of litsea-lemon EO blend 
(1:2 ratio) using a magnetic stirrer. A solution (5 ml) of 0.025% sodium alginate 
was then added into the oil phase and mixed with gentle stirring at room 
temperature. Subsequently, 5 mL of calcium chloride solution (18 mM) was 
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added dropwise into the polymer-oil mixture and mixed for 5 min until a gel was 
formed. Once the gel was formed, a solution of chitosan in various concentrations 
(0.05 – 1.5 % w/v in final o/w emulsion) was added dropwise into the gel and the 
solution was mixed for 45 minutes to form an o/w emulsion. Once formed, the 
primary emulsion was homogenized (IKA Ultra-Turrax T25 Homogenizer) at 8000 
rpm for 1 hour.  
 
Surfactant-free emulsions were prepared by first mixing 5 ml of the EO-
blend with 1.25 ml of a 0.025% sodium alginate solution for 5 min using a 
magnetic stirrer. After which, a solution of chitosan in various concentrations 
(0.05 – 1.5 % w/v in final o/w emulsion) was then added to the mixture and pre-
homogenised for 5 minutes at a speed of 8000 rpm. An 18 mM solution of calcium 
chloride (5 mL) was then added to the EO-polymer mixture, dropwise, under 
further homogenisation at 8000 rpm for 1 hour. The o/w emulsions were stored 
at room temperature for 24 h before being analysed.  
 
Once it was determined the formulations did not display visual instability 
(separation) without the addition of a surfactant but displayed complete 
separation with the addition of Tween 80 (Figure 3.1), 50 mL batches were 
produced with the final concentration of EO in the o/w emulsions of 30% v/v. The 
amount of sodium alginate used was increased to 5mL of 1% v/v solution and the 
calcium chloride concentration was also increased by using 5mL of a 1% v/v 
solution. All emulsions were tested for pH measurements using a FG2-Kit pH 
Meter (Mettler Toledo, USA) 24 hours after preparation. The pH meter was 
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calibrated using buffer solutions and pH measurements were carried out on 
samples at room temperature to ensure pH of emulsions was below 5.  
 
 
 
 
 
 
 
 
  
A B 
 
Figure 3.1 Photographs of chitosan-sodium alginate emulsions 
with 10% litsea-lemon EO blend prepared a) without surfactant b) 
with 20% Tween 80 surfactant 
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Table 3.1 Litsea-lemon EO blend o/w emulsions and concentrations of 
chitosan, sodium alginate and calcium chloride in the water phase used 
for emulsion preparation.   
Batch EO blend (%v/v) 
Sodium 
Alginate 
(%w/v) 
CaCl2 (%v/v) Chitosan (%w/v) 
F1 30 0.1 0.1 2.00 
F2 30 0.1 0.1 1.25 
F3 30 0.1 0.1 1.00 
F4 30 0.1 0.1 0.75 
F5 30 0.1 0.1 0.50 
F6 30 0.1 0.1 0.25 
F7 30 0.1 0.1 0.125 
F8 30 0.1 0.1 0.05 
 
3.6 Antimicrobial Activity of Litsea-Lemon EO O/W Emulsions 
 
Assessment of the antimicrobial activity of the surfactant-free emulsion 
batches with 30% EO final concentrations (F1-F8) and the activity of the individual 
emulsion components (1% chitosan solution, litsea-lemon EO blend (1:2 ratio), 
1% sodium alginate solution and standards of citral, (R) and (S) limonene) were 
assessed individually against S. aureus, S. epidermidis and E. coli using the disk 
diffusion method as described in Section 3.2. For all emulsions tested 20 mm 
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Whatman filter paper disks (Scientific Laboratory Supplies, UK) were used while 
6 mm disks were used for EOs, polymers and standards.  
 
3.7 Identification of Main Compounds in L. cubeba and C. limon EOs 
 
GC-MS analysis of litsea and lemon EOs was performed using a Bruker 
450-GC coupled with a CP-8400 autosampler (Bruker Corporation, USA) and 
300-MS SQ signal electron ionisation. Both EOs were diluted (1:100) in n-hexane 
(Fischer Scientific, Loughborough, UK) and filtered through a 0.45 µm 
polyethylene (PET) filter (Sigma-Aldrich, Gillingham, UK). The injected sample 
volume was 1 µL with a split ratio of 1:100. The GC was coupled with a Rxi-5ms 
column (Restek, Pensylvannia, USA) column (30 m x 0.25 mm i.d. x 0.25 µm film 
thickness). The ionizing energy of the MS was -70 eV, with CID gas pressure of 
1.5 mTorr and a detector voltage of 1000 V. The injector and transfer 
temperatures were 280°C and 250°C respectively. Source temperature was at 
230°C analysing mass range (50 – 350 M/z).  Helium was used as a carried gas 
at a constant flow rate of 1.5 ml/min. The oven temperature program was 60°C 
for 5 min, followed by a 4°C /min ramp to 220°C and finally an 11 °C/min ramp to 
250°C  held for 15 min. EO components citral and limonene (were identified by 
comparing with retention time and mass of pure standard reference compounds 
(Sigma-Aldrich, UK). Data was analysed using a Bruker MS workstation software 
(version 7.0). Calibration curves for citral and limonene compounds between 
0.78125 – 200 mmol were created to allow for the quantification of the 
compounds within the emulsions.  
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3.8 Rheology  
 
Emulsion rheological behaviour and the viscosity of 1% w/v chitosan and 
1% w/v sodium alginate were measured using a Physica MCR 501 Rheometer 
(Anton Paar GmbH, Austria). A CP25-1 diameter measuring cone with a 25 mm 
cone angle (Anton Paar, GmbH, Austria) was used to carry out oscillatory 
rheological measurements at a gap size of 0.047 mm. Shear rate sweep with an 
up ramp from 0.05 s-1 to 50 s-1 was carried out at 20 ˚C. Undiluted samples of 
0.5-1% CS emulsions were evaluated 24 hr after preparation. Average viscosity 
is reported as a function of shear rate. 
 
3.9 Zeta Potential  
 
A NanoBrook Omni Zetasizer (Brookhaven Instruments, UK) was used to 
measure the zeta potential of the emulsions. The emulsions were diluted 1:100 
using distilled water prior to analysis to measure the zeta potential of the 
emulsions (0.5-1% CS) after 24 h of storage at 4°C. Analyses were carried out at 
25°C and 8 scans were performed for each sample.  A quartz cuvette was used 
for analysis. 
 
3.10  Particle Size Determination  
 
The particle size of the emulsions and its distribution were determined 
using a dynamic light scattering (DLS) technology using a NanoBrook Omni 
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Particle Sizer (Brookhaven Instruments, UK). The emulsions (0.5-1% CS) were 
diluted in distilled water to 1:100 and the measurements were performed five 
times (each with 3 runs) at 25°C. The width of distribution, defined by the 
polydispersity index (PI) was determined according to Equation (3). 
 
  
PI = 𝑐𝑐(90) − 𝑐𝑐(10)
𝑐𝑐(50)  
 
(3) 
 
 
Where d(90), d(50) and d(10) and) are the particles diameter at 90%, 50% 
and 10% cumulative volume, respectively (Campelo et al., 2017). 
 
3.11 Optical Microscopy  
 
After 24 h of storage, the structure of the litsea-lemon emulsions (0.5-1% 
CS) was observed using an optical microscope (DM750 Brightfield Microscope, 
Leica Microsystems, Germany). The emulsion samples were diluted 1:10 with 
purified water and the observation was performed at room temperature. 
 
3.12  Fourier Transform Infrared Spectroscopy 
 
Fourier Transform Infrared (FTIR) analyses were carried out on a Bruker 
Alpha FTIR spectrometer (Bruker Corporation, Germany) with an attenuated total 
reflectance (ATR) platinum diamond sampling stage. The infrared radiation (IR) 
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analyses were conducted on emulsions, pure chitosan, pure sodium alginate, 
litsea EO, lemon EO and reference standards of limonene and citral with a 
scanning range of 400-4000 cm-1. For each spectrum 10 scans at a resolution of 
2 cm-1 were obtained and spectra were obtained with OPUS software version 7.5 
(Bruker Corporation, UK).  
 
3.13  Thermogravimetric Analysis  
 
The thermal properties, stability and decomposition of the prepared 
emulsions, its individual components (litsea EO, lemon EO, chitosan, sodium 
alginate and calcium chloride) and standards of citral, (R) and (S) limonene were 
investigated using a thermogravimetric analysis (TGA) apparatus (PerkinElmer, 
USA). Samples were analysed using a temperature range of 25 – 400 °C at a 
heating rate of 10 °C/min in the presence of nitrogen gas as an inert atmosphere.  
 
3.14  Differential Scanning Calorimetry  
 
Differential Scanning Calorimetry (DSC) experiments were carried out 
using a Jade DSC (PerkinElmer, USA) to analyse the thermal properties, stability 
and decomposition of the L. cubeba/C. limon emulsions, it’s individual 
components and reference standards. The aluminium pans containing the solid 
samples were placed inside the DSC in addition to an empty reference pan. Solid 
samples were sealed with perforated lids, whilst liquid samples were sealed with 
non-perforated lids. Samples were first cooled down to -50°C and then heated 
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back up to 400°C. The heat flow rate used was 20˚C/min in the presence of 
nitrogen purge gas at a rate of 20 mL/min.  
 
3.15  Release Studies 
 
A dialysis system was used to assess the release of limonene and citral 
from the litsea-lemon emulsions (0.5 – 1% CS) using a paddle dissolution 
apparatus. The emulsions (20 mL) were transferred into 43 mm wide cellulose 
membrane dialysis tubes (14,000 kDa molecular weight cut off, Sigma-Aldrich). 
The emulsion-loaded (20 mL) dialysis bags were suspended release medium of 
acetate buffer (pH 5) with 2% v/v Tween 80; temperature and stirring were set at 
32°C (to mimic normal skin temperature) and 50 rpm respectively.  Aliquots of 5 
mL were withdrawn at specific time intervals (0, 5, 10, 15, 20, 25, 30, 40, 50 and 
60 min), filtered and analysed by GC-MS for the amount of limonene and citral 
released; theoretical concentrations of limonene and citral are 1.53 mmol/ml and 
114.33 mmol/ml respectively. Each sample withdrawn was replaced with 5 ml of 
fresh acetate buffer of equal temperature. The cumulative percentage of citral 
and limonene released in the medium was obtained by dividing the cumulative 
amount of citral and limonene released at each sampling time point (Mt) to the 
theoretical initial concentration of citral and limonene in the sample (M0) 
according to Equation (4). 
 
 % Cumulative Release= �𝑀𝑀𝑡𝑡
𝑀𝑀0
𝑡𝑡
𝑡𝑡=0
 ×  100  
(4) 
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3.16  Stability of Litsea-Lemon EO O/W Emulsions 
3.16.1  Determination of Emulsion Physical Stability  
 
The creaming stability was assessed by measuring 5 mL of the o/w 
emulsions into measuring cylinders, storing the cylinders at room temperature as 
well as observing and recording daily the volume of creaming during storage for 
5 weeks. The creaming index (CI) was estimated according to the Equation (5). 
 
 % Creaming Index = Η𝑐𝑐
Η𝑡𝑡
 ×  100  
(5) 
                                                                          
Where Hc is the height of clear layer below the sample and Ht is the total 
emulsion height. The measurement of creaming index indicates the kinetic 
formation of a clear layer (separation) caused by droplet aggregation and its 
increase can provide indirect information on the stability of the emulsion.  
Emulsions tested were those containing 0.5%, 0.75% and 1% chitosan 
concentration.  
 
3.16.2 Determination of Emulsion Long-term Physical Stability 
 
To predict the long-term stability of the emulsions an accelerated 
centrifugation test was also carried out to observe the degree of creaming. The 
centrifugation test was carried out by taking 10 mL samples of emulsions and 
centrifuging (Rotanta 460s Heltich-Zentifugen) at 4600 rpm for 2 hours. The 
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emulsions were observed every 5 min for separation and the percentage 
Creaming Index under stress conditions was characterized using Equation (5). 
Emulsions samples tested were those containing 0.5%, 0.75% and 1% chitosan 
concentration. All samples were analysed in triplicate. 
 
3.16.3 Determination of Emulsion Chemical Stability 
 
The chemical stability of emulsions of 0.5%, 0.75% and 1% chitosan at 
15°C and at 40°C was assessed for 4 weeks and assessed for chemical changes 
upon storage (only values at time 0 and day 28 are shown). The emulsions were 
stored in dark temperature regulated cabinet and the changes in concentration of 
citral within the emulsions after 28 days was assessed by taking 1 ml samples 
and carrying out solvent extractions using up to 5 mL of n-hexane (Fisher 
Scientific, UK) and by shaking for 5 minutes. Samples (1 mL) from the extraction 
mixture were filtered through a 0.45 µm PET filter and the filtered extractions were 
analysed for the presence of citral using the same method described in Section 
3.7. 
 
3.17  Treatment of Polyester and Cotton Fabric  
 
Prior to treatment, knitted cotton and knitted polyester fabric samples were 
first washed using a detergent scouring solution of 2 g/L of non-ionic wetting 
agent Ultravon PL (Ciba Specialty Chemicals, UK) for 30 min at 60°C, followed 
by a hot and cold-water rinse. The fabric was then sterilized at 160°C for 2 hours 
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by dry heat sterilization. Once sterile, the fabric samples were soaked for 15 
minutes into fresh emulsions prepared as described in the method in Section 3.5. 
Each soaked fabric sample was passed through a two-roller laboratory pad (Ernst 
Benz, Switzerland) at a pressure of 35 kg/cm at a speed of 1 m/min; samples 
were then re-soaked into the emulsions and passed through the padding machine 
a second time. The process was repeated for each antimicrobial emulsion (0.5 
%, 0.75% and 1% CS). The weights before soaking and after padding were 
recorded to calculate the percentage liquid pick up (LPU) according to Equation 
(6): 
 
  % 𝐿𝐿𝐿𝐿𝐿𝐿 =  (𝑤𝑤𝑐𝑐𝑜𝑜𝑤𝑤ℎ𝑡𝑡 𝑜𝑜𝑜𝑜 𝑤𝑤𝑐𝑐𝑡𝑡 𝑜𝑜𝑎𝑎𝑐𝑐𝑓𝑓𝑜𝑜𝑐𝑐) − (𝑤𝑤𝑐𝑐𝑜𝑜𝑤𝑤ℎ𝑡𝑡 𝑜𝑜𝑜𝑜 𝑐𝑐𝑓𝑓𝑑𝑑 𝑜𝑜𝑎𝑎𝑐𝑐𝑓𝑓𝑜𝑜𝑐𝑐)(𝑤𝑤𝑐𝑐𝑜𝑜𝑤𝑤ℎ𝑡𝑡 𝑜𝑜𝑜𝑜 𝑐𝑐𝑓𝑓𝑑𝑑 𝑜𝑜𝑎𝑎𝑐𝑐𝑓𝑓𝑜𝑜𝑐𝑐)  100 
 
 
 (6) 
 
 
 The fabric samples were then left to dry overnight at room temperature, 
before being used for antimicrobial testing. 
 
3.18  Quantification of Distribution of Major EO Components on 
Polyester and Cotton Fabric Treated with 1% CS Emulsion 
 
Polyester and cotton fabric samples were treated as described in Section 
3.17 and cut into samples of 4 x 4 cm, 2 x 2 cm and 1 x 1 cm size taken from 
throughout the textile, each were then weighed to determine the density of the 
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treated fabric. Solvent extractions were carried out on each sample using 5 mL 
of n-hexane (Fisher Scientific, UK) and by shaking vigorously for 5 minutes. 
Aliquots of 1 mL from the extraction mixture were filtered through a 0.45 µm PET 
filter and the filtered extractions were analysed for the presence of citral and 
limonene using the same method described in Section 3.7. The remaining treated 
fabric samples were stored at 4°C for 7 days and the extraction process was 
repeated as above.  
 
3.19  Toxicity Test and Dilution Neutralisation Validation for Treated 
Fabric  
 
Validation of dilution-neutralisation and toxicity test were adapted from 
Annex C of the BS EN 1276:2009 standard. A bacterial or fungal working culture 
(107-108 CFU/mL) was prepared and the suspension serially diluted (in PBS for 
bacterial organisms or SDW for the dermatophyte) and enumerated.  
 
Neutralizing solution  
- 10 g/L Tryptone 
- 5 g/L sodium chloride 
- 30 g/L Saponin  
- 1 g/L L-histidine 
- 30 g/L Tween 80 
- 3 g/L Asolectin from soybean 
- 5g/L Sodium Thiosulphate  
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3.19.1  Toxicity Test  
 
To ensure that the neutraliser is not toxic to the microorganisms, a 
neutraliser toxicity test was carried out by adding 1 mL of working culture to 9 mL 
of neutraliser. The solution was mixed and incubated in a water bath at 20°C for 
30 min and then mixed again. After the contact time (CT), the solution was serially 
diluted, and the plates incubated at 37°C for 18-24 h (bacteria) or 30°C for 7 days 
(fungi), after which colonies were observed and enumerated. Absence of toxicity 
was confirmed by comparing the growth of the control and that within the test 
conditions. 
 
3.19.2  Dilution Neutralisation Validation 
 
To ensure the neutraliser is effective against the emulsion treated fabric, 
the dilution-neutralisation validation (DNV) test was performed by adding 9 mL of 
neutraliser to 0.40 g fabric samples placed in vials. This was left in contact for 5 
min on a water bath at 20°C. After the CT 1 mL of bacterial/fungal working culture 
was added to the neutraliser mixture and left in contact for 30 min at 20°C in a 
water bath and mixed at the end of the CT. Serial dilutions were then carried out, 
plated and incubated at 37°C for 18-24 h for bacteria or 30°C for 7 days for fungi, 
after which colonies were observed and enumerated. Neutralising efficacy was 
confirmed by comparing the growth of the control culture and the test conditions. 
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3.20  Qualitative Determination of Antibacterial and Antifungal Activity 
of Polyester and Cotton Fabric Treated with 1% CS Emulsion 
 
The antimicrobial and antifungal activity of the treated fabric (100% 
polyester and 100% cotton) against E. coli, S. aureus, S. epidermidis, T. rubrum, 
E. coli (clinical isolate 390685Q), S. epidermidis (clinical isolate PLO 21862) and 
MRSA (antibiotic resistant strain NCTC 12497) was determined using the agar 
diffusion plate test adapted from BS EN ISO 20645:2004. This qualitative method 
was used to screen the treated fabric for bacteriostatic activity.  Polyester and 
cotton test samples with diameters of (25 ± 5) mm were cut out of treated and 
untreated fabric. A lower layer (not inoculated) for each petri dish was prepared 
by either pouring 10 ml of molten BHI (bacteria) agar or SDA (fungi) in sterile petri 
dishes, these were then left to congeal. Agar for the upper layer was prepared 
and cooled to 45 ± 1°C in a water bath and then 150 ml of the molten agar was 
inoculated with 1 ml of an overnight working culture (108 CFU/ml). The inoculated 
agar was mixed to distribute the bacteria evenly. Aliquots of 5 ml were then 
poured into each petri dish and left to congeal. Once set the test samples of 
treated and untreated fabric were pressed onto the surface of the medium with a 
pair of sterilized forceps to ensure good contact between the fabric sample and 
the agar. The plates were then incubated for 18-24 h at 37°C for bacteria and for 
7 days at 30°C for fungi and then assessed for bacterial or fungal growth. 
Qualitative assessment of antibacterial and antifungal activity was carried out at 
24 h and 1-week post-treatment.  
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3.21  Qualitative Determination of Antibacterial and Antifungal Activity 
of Emulsion Treated Polyester and Cotton Fabric post 40°C 
Wash 
 
Treated polyester and cotton fabric samples and untreated (control) 
samples were washed on a standard 40°C wash using 4.4 g of sodium perborate 
tetrahydrate and 24.08 g of ECE non-phosphate reference detergent (A) sodium 
perborate tetrahydrate (SDC enterprises, Bradford UK). The temperature of the 
wash cycle was measured using an iButton Thermocron temperature logger and 
data was read using OneWire Viewer software. After washing fabric samples 
were left to dry overnight and then the antibacterial and antifungal activity post-
wash was determined against E. coli, S. aureus, S. epidermidis and T. rubrum 
using the method described in Section 3.20. 
 
3.22  Qualitative Determination of Antibacterial Activity of Emulsion 
Treated Polyester and Cotton Fabric (Plate Count Method) 
 
The antibacterial activity of treated fabric (polyester and cotton) against E. 
coli, S. aureus and S. epidermidis was determined using the plate count method 
adapted from BS EN ISO 20743:2013. The absorption method was employed by 
cutting six fabric (treated) and six control (untreated) samples of mass 0.40 ± 0.05 
g and placing them into separate vials. Aliquots of 0.1 ml of bacterial working 
culture (107-108 CFU/ml) were pipetted at several points on each fabric sample. 
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At zero hour, immediately after inoculation, 10 ml of neutraliser was transferred 
into three of the inoculated test vials and three of the control vials which were 
mixed by shaking with a vortex mixer for 1 min x 5 cycles. The other three test 
and control vials were incubated at 37°C for 18-24 h and neutralised after 
incubation with 10 ml of neutraliser and mixed again by shaking with an incubator. 
Both shake-out solutions (0 h and 48 h) were serially diluted and plated on BHI 
agar and these were incubated at 37°C for 18-24 h after which colonies were 
observed and enumerated. The percentage reduction (R) was calculated using 
Equation (7): 
 % 𝑅𝑅 = (𝐴𝐴 − 𝐵𝐵)
𝐴𝐴
 x100  
(7) 
 
 
Where A is the number of microorganisms in the shake-out solution for 
control cotton or polyester fabric samples immediately after inoculation (zero CT). 
B is the number of microorganisms in the shake-out solution from test 
(treated) cotton or polyester fabric samples after each contact period (zero, 24 h 
or 48 h) before neutralisation. 
 
3.23  Qualitative Determination of Antifungal Activity of Emulsion 
Treated Polyester and Cotton Fabric (Plate Count Method) 
 
The antifungal activity of the treated fabric (polyester and cotton) against 
the dermatophyte T. rubrum was determined using the plate count method 
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adapted from BS ISO 13629-2:2014. T. rubrum spores inocula were prepared 
using the method described in Section 3.2.1. The absorption method was 
employed, and six treated fabric samples and six control (untreated) samples 
were cut and weighted to a mass of 0.40 ± 0.05 g and placed into separate vials. 
Then 0.1 ml of spore inoculum (107) was pipetted at several points on each fabric 
sample, for zero-hour test, immediately after inoculation, 10 ml of neutraliser was 
transferred into three test and three control vials and the solution was mixed by 
shaking with a vortex mixer for 1 min for five cycles. The remaining control and 
test samples were incubated at 30°C for 48 h and after incubation 10 ml of 
neutraliser was transferred into the vials and the solutions were again mixed by 
shaking. Both shake-out solutions (zero hour and 48 h) were serially diluted and 
plated on SDA, incubated at 30°C for 48 h – 7days to observe the fungal colony 
growth. After incubation the colonies were enumerated. The percentage 
reduction was calculated using Equation (7).  
 
 
3.24  Antibacterial and Antifungal Activity of a 1% CS EO-Emulsion 
(Time-Kill Assay) 
 
The antibacterial and antifungal activity of the EO emulsion (1% CS) 
against E. coli, S. aureus and S. epidermidis was assessed using a time-kill 
assay. An aliquot of 0.1 ml of emulsion was mixed with 0.1 ml of DMSO to 
solubilise the emulsion. This solution was added to 9.7 mL of SDW (test solution), 
mixed and then the solution was inoculated with 0.1 mL of working 
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bacterial/fungal culture (107 – 108 CFU/mL). Aliquots (1 ml) of this (test mixture) 
were added immediately (zero CT) into 9 mL of neutraliser to inactivate the 
emulsion and the remaining test solution was incubated at 37° for bacteria or 
30°C for fungi. The test mixture was neutralised again after a contact period of 5 
min for bacteria and after 10 min, 20 min, 30 min, 40 min, 50 min, 60 min and 120 
min for the dermatophyte T. rubrum. Neutralised test solutions were serially 
diluted, plated and incubated at 37°C for 18-24 h (bacteria) or 30°C for 7 days 
(fungi) for observation and enumeration. The time-kill assay was conducted as 
above without the presence of the antimicrobial emulsion as a control. 
 
3.25  Evaluation of Repellency of Litsea-Lemon EO Blend and 
Emulsion Treated Cotton Fabric against Aedes aegypti 
Mosquitos 
 
The repellency of 10x10 cm cotton samples impregnated with 400 µl litsea-
lemon EO blend and cotton samples padded with a 30 % litsea-lemon EO was 
assessed against female mosquitos belonging to the species Aedes aegypti 
using the Olfactometer test. An acrylic Olfactometer unit (Ross Lifescience, India) 
was used, comprised of a clear cylinder (base leg), equipped with a holding port 
and connected to two test branches (chambers) each equipped with a trapping 
port; one chamber designated for the control and the other for the treatment test. 
Modifications from WHO original dimensions were made to the Olfactometer, 
these can be seen in Appendix IV. During the test, odours in the air diffuse into 
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the branches through the base leg and its holding port, from which the mosquitos 
are released upon starting the test (WHO, 2013).  
 
The Olfactometer unit was assembled in a 30-meter cubic room chamber 
equipped with a central top exhaust fan for decontamination of the air within the 
chamber. Clean air lines supplied both the test and control ports of the 
Olfactometer with clean airflow; this airflow was checked with an anemometer 
prior to starting the test and was measured to be 0.20 ± 0.05 m/s; air velocity 
through the base leg of the cylinder was measured to be 0.40 ± 10 m/s. The 
Olfactometer test chambers were checked for contamination before each test and 
repeats by performing a test under chemical-free conditions; ten mosquitos were 
released and checked for knock-down for a duration of 10 minutes. After the 
exposure time, if no knock-down was recorded, the Olfactometer was considered 
ready for use.  
 
The repellency test was carried out by releasing ten A. aegypti female 
mosquitos (12-hour starved) through the base leg of the Olfactometer using 
aspirators, the mosquitos were allowed to acclimatize for 15 minutes without 
treatment. After acclimatization, treated (1% CS litsea-lemon EO emulsion) and 
control (impregnated with 400 µl of litsea-lemon 1:2 EO blend) 10 x 10 cm cotton 
samples were placed in the test chamber and control chamber respectively and 
their trapping ports opened for 30 seconds to allow the mosquitos to migrate to 
either of the aforementioned chambers. After which, the holding port was closed 
and the number of mosquitos that migrated towards the control chamber or 
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treatment chamber was recorded every minute for a total of 3 minutes. Mosquitos 
that were physically injured and/or incapable of flying or walking were ignored in 
the results. Each test was repeated three times and the Olfactometer unit was 
cleaned with 10% isopropyl alcohol and clean airflow passed through for 3 
minutes before each new test.  
 
The percentage of mosquitos repelled to the treatment port was calculated 
by dividing the number of mosquitos in the trapped in the treatment (test) port by 
the overall number of mosquitos in the test, according to Equation (8): 
  
𝐿𝐿𝑐𝑐𝑓𝑓𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡𝑎𝑎𝑤𝑤𝑐𝑐 (%) 𝑅𝑅𝑐𝑐𝑅𝑅𝑐𝑐𝑜𝑜𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐𝑑𝑑 =  𝑀𝑀𝐹𝐹 −𝑀𝑀𝑀𝑀
𝑀𝑀𝐹𝐹 + 𝑀𝑀𝑀𝑀  𝑥𝑥 100 
 
 (8) 
 
Where, MC is the number of mosquitos in the control port and MT is the number 
of mosquitos in the treatment port (WHO, 2013). The method was conducted by 
Ross Lifescience Private Limited, Maharashtra, India.  
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Chapter 4. The Antimicrobial Activity of Ten EOs Against 
Skin Infection Related Pathogens 
 
4.1 Introduction 
4.1.1 Skin Infections 
 
The skin, the largest organ in the human body, is an ecosystem whose 
primary role is to act as a physical barrier that protects the body from the external 
environment, preventing attack from foreign microorganisms and toxic 
substances. The stratum corneum (the uppermost layer of the skin) produces a 
hostile environment for microorganisms, by the secretion of acidic sebum and the 
constant shedding of keratinocytes that make up the stratum corneum, leading to 
the removal of microorganisms in the process (Grice and Segre, 2011; Wilson, 
2005). The skin consists of microorganisms that are present on a semi-
permanent basis without causing disease (the natural microflora); they also 
provide protection by competing with invading microorganisms for space 
(attachment sites) and available nutrients, producing metabolic compounds and 
lowering the pH of the environment which inhibits the growth of microorganisms.  
Those most commonly found microorganisms on the skin’s surface belong to the 
genera Corynebacterium spp., Staphylococcus spp., Cutibacterium (formerly 
Propionibacterium) spp., Acinetobacter spp., and Brevibacterium spp. (Wilson, 
2005). 
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When a break in the skin occurs (such as with burns, wounds, and ulcers), 
the defence becomes compromised and the skin can become colonised with 
microorganisms that are not indigenous to the skin and can lead to mild or even 
serious infections of the surrounding tissues (Dryden, 2009). The common SSTIs 
caused by microorganisms include impetigo, cellulitis (S. aureus), folliculitis (P. 
aeruginosa, S. aureus), ringworm, tinea pedis (Trichophyton rubrum) and acne 
(Cutibacterium acnes) among others (Orchard and van Vuuren, 2017). Non-
infectious skin diseases like atopic dermatitis (eczema) can also cause 
pathogenic infections by damaging the skin and making eczema patients more at 
risk of colonization and secondary infections by S. aureus or the herpes simplex 
virus (Boguniewicz and Leung, 2013; Orchard and van Vuuren, 2017). It has 
been found that S. aureus plays a role in exacerbating eczema by producing 
super-antigens (Barnes and Greive, 2013; Gong et al., 2006; Jinnestål et al., 
2014; Kozman et al., 2010; Petry et al., 2014). 
 
It has been reported that 10% of hospital patients in the UK develop HAIs 
9% of which are related to surgical wound infections (Abboud et al., 2014; 
Breathnach, 2013; Jhass et al., 2017). When wound healing does not progress 
normally, SSI can become a chronic wound with the bacterial infections affecting 
the healing rate. SSIs and chronic wounds can double the time a patient spends 
in hospital thus increasing the cost of healthcare, due to additional costs related 
to re-operation, extra nursing care, drug treatment and other indirect costs like 
patient dissatisfaction and litigation (NICE, 2017). 
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Typically, skin infections are treated topically, however, the ability of 
microorganisms to become resistant to antimicrobials like antibiotics, due to 
overuse and misuse of drugs has led to the emergence of antibiotic resistant 
bacteria such as MRSA, and multi-drug resistant Gram-negatives like 
Pseudomonas spp., Escherichia spp. and Klebsiella spp. which have created 
problems in the management of wound infections, by reducing the number 
effective antibiotics. Therefore, treatment is often challenging and unsuccessful, 
requiring the development of new agents active against these resistant strains of 
bacteria (Abboud et al., 2014; Breathnach, 2013; Visavadia et al., 2008).  
 
Fungal infections have not been prioritized within medical, clinical and 
laboratory research, but these infections are now occurring more frequently 
among immunocompromised cancer patients and transplant patients. Though 
considered superficial infections, they can have serious psycho-social effects and 
can no longer be viewed as a ‘cosmetic’ issue (Cassella et al., 2002). 
Dermatophyte diseases, such as athlete’s foot, are also affected by the 
development of drug resistance and there are concerns with toxicity of the 
commonly used antifungal drugs, like azole derivatives, which can have adverse 
effects to patients, including hepatoxicity and gastrointestinal disturbances and 
have long treatment durations (Regev-Shoshani et al., 2013). The issues related 
to skin infections, their prevention and treatment have sparked interest in natural 
products within the UK and around the world, one of the oldest types of medicine, 
as an alternative to standard pharmaceutical products.  
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4.1.2 EOs  
 
Plant products have often been used as alternatives to medicines over the 
years and EOs are one of the most popular natural products, often used in 
dermatology; EOs are often used in the treatment of fungal skin infections and 
generally their popularity has been growing both in the United Kingdom and in 
the United States (Bakkali et al., 2008; Nazzaro et al., 2013; Solórzano-Santos 
and Miranda-Novales, 2012). Orchard and van Vuuren (2017) identified that 62% 
of EOs are used for the treatment of infections caused by bacteria, fungi or 
viruses; 20% of EO use was attributed to skin conditions such as dermatitis and 
eczema while the remaining use (18%) was linked to general skin maintenance 
(Orchard and van Vuuren, 2017). 
 
EOs are oily volatile and aromatic liquids that are formed in the organs of 
plants, commonly concentrated in specific regions such as leaves, fruit or bark. 
The antimicrobial properties of EOs have been known for centuries and their 
activity is directly correlated to the presence of bioactive compounds (alcohols, 
terpenes, esters, ketones, amines, sulphides and aldehydes), which are also 
responsible for the plant’s characteristic odour and flavour (Calo et al., 2015; 
Patel and Gogna, 2015). Some of these molecules are naturally present in the 
plant, whilst others are activated by enzymes as a mechanism of self-defence in 
response to biotic or abiotic stress (Nazzaro et al., 2013). Lemon EO is part of 
the family of Rutaceae; it is obtained from Citrus limon peel by cold pressing and 
its components include limonene, citral and linalool (Ali et al., 2015; Misharina et 
 97 
 
al., 2010; Peng et al., 2013). Citrus EOs are usually comprised by a mixture of 
components, including terpenes, aldehydes, alcohols and esters. The main 
component of citrus EOs is limonene, and other significant components include, 
α and β- pinene, γ-terpinene, terpinolene and sabine (Amorim et al., 2016). Litsea 
is an important genus in the Lauraceae family, found frequently in Asia, Austria 
and North and South America (Wong et al., 2014; Yang, K. et al., 2014). Litsea 
EO is extracted from L. cubeba, an evergreen tree found in Asia (Li et al., 2014; 
Zhang, 2012). It is used in traditional Chinese medicine for its carminative, 
diuretic, expectorant, stimulant, sedative and antiseptic properties; additionally, it 
has been found to have insect repellent activity (Yang et al., 2014). Its main 
component is citral (also referred to as neral or geranial); a study found that citral 
made up 87.4% of the overall litsea EO composition (Si et al., 2012). R. officinalis 
is an aromatic plant that belongs to the Lamiaceae family (Ali et al., 2015; de 
Barros Fernandes et al., 2014; Okoh et al., 2010; Ramos-e-Silva and Ribeiro de 
Castro, 2002). 
 
EOs can be used in blends/combinations of two or more EOs with the goal 
of creating a synergistic antimicrobial or therapeutic effect which is greater than 
the sum of the individual oils. The synergistic antimicrobial effect observed in 
some EO blends can be achieved through the following mechanisms: (1) 
enhancement of solubility and bioavailability; (2) EO could affect multiple targets 
of the bacterial cell; (3) inhibition of the mutation mechanism of the bacterial cell 
to the EO; or (4) inhibition of bacterial cell efflux pumps, resulting in accumulation 
of the EO inside the cell (Hemaiswarya et al., 2008; Orchard et al., 2017).    
 98 
 
 
Previous studies have found that EOs can create a synergistic 
antimicrobial effect when combined with other EOs and with other antimicrobials, 
and numerous studies have focused on blends of various EOs with mainly 
lavender, oregano or frankincense (de Rapper et al., 2012; Gutierrez et al., 2008; 
Orchard et al., 2017).  
 
4.1.3 EOs as Antimicrobials 
 
Many EOs have been found to have antibacterial and antifungal activity. A 
study by de Rapper et al (2013) found that lemon EO had activity against S. 
aureus at MIC of 3 mg/mL, though a different study by Prabuseenivasan et al 
(2006) reported MIC>12.80 mg/ml (de Rapper et al., 2013; Prabuseenivasan et 
al., 2006). Patchouli and geranium EOs have also been found antimicrobial 
against S. aureus with reported MICs of 1.7 µl and 5.4 respectively (Kwiatkowski 
et al., 2017). EOs have been able to also inhibit spore-forming bacteria like C. 
difficile, Mooyottu et al (2017) reported a significant reduction in sporulation 
(p<0.05) of C. difficile caused by carvacrol, a component found in some EOs like 
oregano and thyme (Mooyottu et al., 2017). Black seed oil has shown 
antimicrobial activity at 2% concentration against B. cereus and 2 strains of C. 
difficile, with ZOIs ≥ 15 mm (Aljarallah, 2016). 
 
 Citrus citratus (lemongrass) EO was found effective against fungi 
Aspergillus niger, Aspergillus flavus and Penicillium verrucosum with MICs 
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ranging from 0.006-0.03% (Viuda-Martos et al., 2008). Fennel seed EO has 
shown good antimicrobial activity against T. rubrum, T. mentagrophytes, 
Trichophyton tonsurans and Microsporum gypseum with MICs of 0.039 µl/ml and 
MFCs 0.078 µl/ml against both T. rubrum and T. tonsurans and MICs of 0.078 
µl/ml and MFCs of 0.156 µl/ml against T. mentagrophytes and M. gypseum (Zeng 
et al., 2015).  
 
Studies have evaluated the MICs of EOs against P. aeruginosa using the 
microdilution assay, reporting high MICs when using clove (5% v/v), lavender 
(>5% v/v), red thyme (>5% v/v), tea tree (5% v/v) EOs (Kavanaugh and Ribbeck, 
2012). A study on the activity of Allium sativum (garlic), Cinnamomum cassia 
(Chinese cinnamon) and peppermint EOs against P. aeruginosa, reports MIC and 
MBC values of >0.5% v/v each for peppermint EO and MIC/MBCs of 0.5%/>0.5% 
v/v respectively for garlic EO (Lang et al., 2016). The activity of 17 EOs on P. 
aeruginosa demonstrated that 14 of those exhibited low antimicrobial efficacy 
against the organism, with MIC and MBC ranging between 1.8 – 3.6% v/v. 
However, good activity against Gram-negatives has been observed by Cinnamon 
EOs; Barbosa et al (2015) demonstrated that Cinnamomum zeylanicum inhibited 
both E. coli and P. aeruginosa at low MIC values of 0.25 mg/ml 0.80 mg/ml 
respectively (Barbosa et al., 2015). Cinnamon bark EO has also demonstrated 
inhibition of various isolated strains of P. aeruginosa with the lowest MIC 
observed of 0.056% v/v and the highest MIC 0.225% v/v (Utchariyakiat et al., 
2016). This strong activity by cinnamon EO against P. aeruginosa has also been 
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reported on a study on various EOs from plants, with an MIC ≤1 μl/ml, though the 
antibacterial assay was only carried out in duplicate (Tarek et al., 2014).  
 
 
4.1.4 Methods for Determining the Antimicrobial Activity of EOs 
 
The first step in assessing the use of EOs for functional textile, is to 
determine whether they have any antimicrobial activity and to what degree; the 
diffusion method is one that is often employed in the screening of EOs. Two types 
of diffusion methods can be employed, the disc diffusion method is the most 
popular due to its simplicity, involving impregnating a filter paper disc with a 
known amount of EO which is then placed on the surface of previously inoculated 
agar. This is a popular method which has often been used for antibiotics, 
however, the volatile and hydrophobic nature of EOs could interfere with results 
and is therefore only used as a preliminary indication of activity. The agar 
diffusion method is the second type of diffusion method in which the paper disc 
is replaced by wells within the agar, into which the EO is inserted. The inhibition 
of the organism (or lack-thereof) is then observed after incubation of the plates, 
and the EO activity is determined by the zone of inhibition. These screening 
methods are not quantitative and serve to only give an indication of which EOs 
possess antimicrobial properties. These diffusion methods are often used as a 
screening tool and EOs which give interesting results are then carried forward 
and tested using dilution methods (Orchard and van Vuuren, 2017). 
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Dilution methods allow the quantitative measurement of an organism’s 
susceptibility to a given EO; calculations of the MIC of the EOs being tested are 
then carried out, giving a better understanding of how potent an EO is against a 
given microorganism. The microdilution method assay uses a 96 well microtiter 
plate in which EOs are serially diluted using a solvent such as dimethyl sulfoxide 
(DMSO) or Tween 80 in the dilution process due to solubility issues arising from 
the hydrophobic nature of EOs. The results of the assay can be read visually or 
by reading the optical density (OD) and the MIC is chosen as the lowest 
concentration in which the growth of the microorganism being tested is inhibited. 
The macrodilution method replaces the 96 well plate with individual test tubes 
and though this method gives comparable results, it is time consuming, tedious 
and uses much larger volumes of test media. In the agar dilution method, the EOs 
are serially diluted using a solvent and each dilution is mixed with a known 
amount of molten agar, inoculated, poured into plates and incubated. The dilution 
plate that shows absence of growth post-incubation is regarded as the MIC. 
Various classifications of activity for EOs using dilution methods have been 
developed; Agarwal et al (2010), for example, regards concentrations of 1.00% 
or less to be noteworthy MIC values, which is what has been followed for this 
present investigation (Agarwal et al., 2010). 
 
When bioactive drugs are combined, they have the potential to interact 
with a resulting synergistic, additive, indifferent or antagonistic effect. When a 
synergistic effect is observed, essentially a greater antimicrobial effect is 
observed when a combination of the substances is used compared to the 
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individual substances (Efferth and Koch, 2011). When a significant reduction in 
the antimicrobial effect of the substance is observed in combination compared to 
the individual substances, antagonism is conveyed (Hyldgaard et al., 2012).  This 
effect, however, has been limited to the pathogen being studied, therefore, 
synergistic blends cannot be assumed to have the same effect on all organisms 
(Orchard and van Vuuren, 2017). To determine what interactions result from the 
combination of antimicrobials, methods such as the checkerboard method are 
used. In the checkerboard method, the antimicrobial substances are combined 
and serially diluted in microplates, with dilutions ranging above and below the 
MIC of the individual components (Langeveld et al., 2014). After incubation, the 
plate is assessed for combinations that are inhibitory, allowing determination of 
synergism or lack thereof between the combinations. To interpret data from the 
checkerboard method, the  FIC index can be used in which the interaction is 
calculated according to Equation (1) when two-way interaction is assessed and 
Equation (2) when a three-way interaction is being assessed (Hossain et al., 
2016; Orchard and van Vuuren, 2017; Stein et al., 2015).  The FIC index method 
is one that is simple but with limitations, as it does not consider the different dose 
response two agents may have at the same concentration when 1:1 ratios are 
used. To evaluate this more accurately the isobole method can be used in which 
the contribution by each agent within a blend is evaluated along a line of additivity 
(a mathematical line); a straight line can be observed where there are indifferent 
or additive interactions, while a concave or convex curve will be observed for 
synergistic and antagonistic interactions respectively (Orchard and van Vuuren, 
2017; Owen and Laird, 2018; Rather et al., 2013). 
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Unlike the checkerboard method, time kill assays allow time-dependent 
antimicrobial effects to be determined, as the number of surviving cells are 
enumerated at various time points; once a >2 log(10) reduction is observed 
(compared to the most antimicrobial individual component) synergism is 
determined (Orchard and van Vuuren, 2017). The time-kill assay allows for 
greater reproducibility and sensitivity due to the quantitative nature of the results, 
but it is a time consuming and labour-intensive method (van-Vuuren and Viljoen, 
2011). 
In this chapter, ten EOs were screened for their MIC/MBCs and FICs 
against two Gram-negative bacterial organisms, E. coli and P. aeruginosa and 
two Gram-positive bacterial organisms S. aureus S. epidermidis and the 
dermatophyte T. rubrum.  
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4.2 Aims and Objectives 
 
The overall aim of this chapter is to determine the antimicrobial efficacy of 
a range of EOs against S. aureus, S. epidermidis, E. coli, P. aeruginosa and T. 
rubrum for potential use in a microencapsulation process. 
 
Objectives: 
 
• To screen a range of EOs against S. aureus, S. epidermidis, E. coli, 
P. aeruginosa and T. rubrum using the disc diffusion method to 
determine their antimicrobial activity; 
• To determine the MIC of the most antimicrobial EOs against S. 
aureus, S. epidermidis, E. coli, P. aeruginosa and T. rubrum, using 
the microdilution method; 
• To evaluate the synergistic relationship between the most 
antimicrobial EOs against S. aureus, S. epidermidis, E. coli, P. 
aeruginosa and T. rubrum using FIC indices.  
 
 
 
  
 105 
 
4.3 Results 
4.3.1 Screening EOs for Antimicrobial Activity 
 
The antimicrobial screening results show that S. aureus is the most 
sensitive bacterial organism to the EOs tested compared to S. epidermidis, E. 
coli and P. aeruginosa, with large zone of inhibition (>50 mm) observed for lemon, 
rosemary, rosewood and wild thyme (Table 4.1). The dermatophyte T. rubrum 
was the most sensitive organism overall, with eight out of the ten EOs tested 
resulting in complete inhibition (ZOI= 90.00 mm) of the fungi. Except bitter orange 
(ZOI= 81.17 mm) and sweet orange (ZOI= 46.50 mm). P. aeruginosa showed the 
greatest resistance to EOs; of the ten tested EOs, it was found to be resistant to 
rosewood, wild thyme, sweet orange and bitter orange EOs, with no zones of 
inhibition (ZOI) observed for each EO. Activity was observed by bergamot, 
citronella, lemon, litsea, peppermint and rosemary against P. aeruginosa but 
zones were significantly smaller compared to S. aureus, E. coli, S. epidermidis 
and T. rubrum (p≤0.05). Litsea, rosemary and lemon EOs exhibited the greatest 
antimicrobial activity against all the microorganisms tested, inhibiting S. aureus 
(ZOI 47.20 mm- 51.00 mm), P. aeruginosa (ZOIs 20.20 mm-23.80 mm), E. coli 
(ZOIs 41.30 mm-90.00 mm) and S. epidermidis (ZOIs 27 mm– 90 mm) and the 
dermatophyte T. rubrum (ZOIs 90.00 mm), and were therefore carried forward to 
determine MIC, MBC/MFC and FICs. None of the EOs tested enhanced the 
growth of the organisms and example of EO zones can been seen in Figure 4.1. 
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Table 4.1 Mean ZOI (mm) of ten EO against S. aureus, P. aeruginosa, E. 
coli, S. epidermidis and T. rubrum using the disc diffusion method (n=6 + 
SD). 
EO 
 
S. aureus* 
 
P. aeruginosa* E. coli* S. epidermidis* T. rubrum* 
Bergamot 29.30 ± 2.20 20.00 ± 0.00 46.80 ± 10.10 
 
47.33 ± 5.12 
 
 
90.00 ± 0.00 
 
Citronella 39.20 ± 2.20 20.30 ± 0.60 0.00 ± 0.00 
 
90.00 ± 0.00 
 
 
90.00 ± 0.00 
 
Lemon 51.00 ± 7.60 21.30 ± 1.50 41.30 ± 4.00 
 
27.00 ± 1.70 
 
 
90.00 ± 0.00 
 
Litsea 47.20 ± 3.70 20.20 ± 0.40 52.80 ± 2.90 
 
90.00 ± 0.00 
 
 
90.00 ± 0.00 
 
Bitter Orange 25.00 ± 2.00 0.00 ± 0.00 28.70 ± 1.63 46.19 ± 1.36 81.17 ± 10.01 
Sweet Orange 22.20 ± 0.80 0.00 ± 0.00 20.00 ± 0.00 
 
25.35 ± 1.92 
 
46.50 ± 3.73 
Peppermint 47.80 ± 1.80 20.40 ± 0.50 0.00 ± 0.00 
 
44.33 ± 8.02 
 
 
90.00 ± 0.00 
 
Rosemary 50.50 ± 12.90 23.80 ± 1.90 90.00 ± 0.00 
 
29.50 ± 2.70 
 
 
90.00 ± 0.00 
 
Rosewood 50.3 ± 10.90 0.00 ± 0.00 90.00 ± 0.00 
 
58.00 ± 4.69 
 
 
90.00 ± 0.00 
 
Wild Thyme 50.5 ± 12.80 0.00 ± 0.00 56.50 ± 6.20 43.33 ± 2.58 
 
90.00 ± 0.00 
 
*Controls were carried out for each organism to ensure growth was uninhibited 
by plain filter paper disk 
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4.3.2 Determination of MIC and MBC of EOs 
 
The lowest MICs and MBCs against all organisms tested were seen by 
litsea EO (Table 4.2) with the lowest MIC observed against S. epidermidis 
(MIC=0.6 μl/ml and MBC= 1.25 μl/ml). P. aeruginosa was still found to be the 
most resistant organism, with generally higher MICs and MBCs for the EOs 
compared to other organisms; litsea EO for example, was found to have an MIC 
of 10.0 μl/ml and an MBC of 20.0 μl/ml against the Gram-negative, which is 
noticeably higher compared to its MICs for the other organisms, such as S. 
aureus (MIC= 1.25 μl/ml and MBC= 2.5 μl/ml). Litsea was also the most effective 
of the three oils against the dermatophyte T. rubrum; its MIC against the fungus 
was 2.5 μl/ml and an MFC of 5 μl/ml, compared to lemon and rosemary which 
both had a higher MICs of 10 μl/ml and MFCs of 20 μl/ml. Overall, lemon EO was 
found to be the least antimicrobial against all four organisms compared to litsea 
Figure 4.1 Example of lemon EO disk diffusion zone against S. aureus 
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and rosemary EOs; against both P. aeruginosa and E. coli lemon EO was not 
bactericidal below 40 μl/ml. Against S. aureus and T. rubrum (the most EO-
susceptible microorganisms during screening) MICs of 20 μl/ml and 10 μl/ml and 
MBCs of 40 μl/ml  and 20 μl/ml respectively were observed by lemon EO (Table 
4.2).  
 
Table 4.2 MIC and MBC/MFC (μl /ml) of lemon, litsea and rosemary EOs 
against S. aureus, P. aeruginosa, E. coli, S. epidermidis and T. rubrum 
(n=6) 
EO S. aureus P. aeruginosa E. coli S. epidermidis T. rubrum 
 MIC MBC MIC MBC MIC MBC MIC MBC MIC MFC 
Lemon 20 40 >40 >40 40 >40 20 40 10 20 
Litsea 1.25 2.5 10 20 2.5 5 0.6 1.25 2.5 5 
Rosemary 5 10 20 40 2.5 5 >40 >40 10 20 
 
4.3.3 Assessment of the Synergism between EOs 
 
Synergistic interactions could be observed when double combinations of 
the EOs were used (Table 4.3); all double combinations between lemon, litsea 
and rosemary EOs were synergistic against S. aureus, with a combination 
between litsea (0.6 μl/ml) and rosemary (0.10 μl/ml) EOs giving a synergistic FICI 
of 0.5. The combination of litsea EO (0.10μl/ml) with lemon EO (0.10 μl/ml) and 
the combination of rosemary EO (0.10 μl/ml) with lemon EO (10 μl/ml) were also 
found to be synergistic against S. aureus, with FICI of 0.09 and 0.5 respectively 
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(Table 4.3). Similarly, synergistic interactions were found between all double 
combinations of rosemary, lemon and litsea EOs against E. coli. A triple 
combination of rosemary (0.6 μl/ml), litsea (0.6 μl/ml) and lemon (2.5 μl/ml) was 
also found to have a synergistic effect against E. coli (Table 4.4). For P. 
aeruginosa, synergistic interactions were only found between litsea (2.5 μl/ml) 
and lemon (2.5 μl/ml) EOs (FICI 0.31); all other combinations were found to be 
either antagonistic or additive. No synergistic interactions were observed 
between double combinations of the EOs against S. epidermidis (Table 4.3) and 
between triple combinations of the EOs against S. epidermidis, P. aeruginosa 
and S. aureus (Table 4.4). Synergistic interaction between litsea (0.6 μl/ml) and 
lemon (2.5 μl/ml) oils was observed against the dermatophyte T. rubrum (Table 
4.3). Noticeably, when synergism was observed, the MICs of the EOs combined 
had decreased, compared to the MIC of the EOs when they were used alone; 
MIC for litsea and lemon EOs against S. aureus for example were 1.25 and 20.0 
μl/ml respectively (Table 4.2) but synergistic blend was found at a lower 
concentration of 0.10 μl/ml for both EOs respectively (Table 4.3). Blends of litsea 
and rosemary were also synergistic against S. aureus with a decrease in 
individual MICs from 1.25 μl/ml and 5.0 μl/ml respectively (Table 4.2) to MICs in 
combination of 0.60 μl/ml and 0.10 μl/ml for litsea and rosemary EOs respectively 
(Table 4.3). 
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Table 4.3 Antimicrobial interactions between double combinations of 
lemon, litsea and rosemary EOs against S. aureus, P. aeruginosa, E. coli, 
S. epidermidis and T. rubrum (n=6) 
Organism EO 
MIC in 
combination 
(μl/ml) 
FICindex Interaction 
S. aureus Litsea 0.60 0.50 Synergistic 
 Rosemary 0.11   
 Litsea 0.10 0.09 Synergistic 
 Lemon 0.10   
 Rosemary 0.10 0.50 Synergistic 
 Lemon 10.0   
P. aeruginosa Litsea 40.0 4.06 Antagonistic 
 Rosemary 1.25   
 Litsea 2.5 0.31 Synergistic 
 Lemon 2.5   
 Rosemary 10.0 0.75 Additive 
 Lemon 10.0   
E. coli Litsea 0.10 0.28 Synergistic 
 Rosemary 0.60   
 Litsea 0.10 0.17 Synergistic 
 Lemon 5.0   
 Rosemary 0.10 0.17 Synergistic 
 Lemon 5.0   
S. epidermidis Litsea 0.60 1.25 No interaction 
 Rosemary 10   
 Litsea 1.25 2.15 No Interaction 
 Lemon 1.25   
 Rosemary 1.25 0.75 Additive 
 Lemon 1.25   
T. rubrum Litsea 0.60 1.24 No Interaction 
 Rosemary 10.0   
 Litsea 0.60 0.49 Synergistic 
 Lemon 2.50   
 Rosemary 0.60 0.56 Additive 
 Lemon 0.5   
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Triple combinations of litsea, lemon and rosemary EOs only showed 
synergism against E. coli (FICI= 0.50); the three EO blend had an additive effect 
against S. aureus (FICI= 0.66) and S. epidermidis (FICI= 0.79), and a non-
interactive effect against P. aeruginosa (Table 4.4). The isobologram for E. coli 
in Figure 4.2b shows a concave curve representing synergism when litsea (MIC 
in combination =0.60 μl/ml), lemon (MIC in combination=2.50 μl/ml) and rosemary 
(MIC in combination 0.60 μl/ml) blend was assessed. Isobolograms for S. aureus, 
S. epidermidis and P. aeruginosa show some concave curves at the end of two 
axis, representing the MIC of the individual oil; synergism between the three EOs 
is not observed, however, antagonism is clearly represented by the convex 
curves for S. aureus, S. epidermidis and P. aeruginosa (Figure 4.2).  
 
Non-synergistic 3-way combinations of the litsea, lemon and rosemary EO 
blend were still antimicrobial against S. aureus, P. aeruginosa, E. coli, S. 
epidermidis and T. rubrum and no antagonism was recorded (Table 4.4), 
however, blends of litsea and lemon EO showed synergism against four out of 
five organisms tested, and did not show antagonism against S. epidermidis 
(Table 4.3). 
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Table 4.4 Antimicrobial interactions between triple combinations of lemon, 
rosemary and litsea EOs against S. aureus, P. aeruginosa, E. coli and S. 
epidermidis (n=6). 
Organism EO 
MIC 
individually 
(μl/ml) 
MIC in 
combination 
(μl/ml) 
FICindex Interaction 
S. aureus Litsea 1.25 0.60   
 Rosemary 5.0 0.60 0.66 Additive 
 Lemon 20.0 1.25   
P. aeruginosa Litsea 10.0 10.0  
Non 
interactive  Rosemary 20.0 20.0 2.03 
 Lemon >40.0 1.25  
E. coli Litsea 2.5 0.60   
 Rosemary 2.5 0.60 0.50 Synergistic 
 Lemon 40.0 2.50   
S. epidermidis Litsea 0.6 0.10   
Rosemary >40.0 10.0 0.79 Additive 
Lemon 20.0 5.0   
 
Figure 4.2 Isobolograms showing 3-way interactions of litsea, lemon and rosemary 
EOs against a) P. aeruginosa, b)  E. coli, c) S. aureus and d) S. epidermidis 
A B
 
C D 
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4.4 Discussion 
 
Interest in investigating the antimicrobial ability of EOs has increased and 
their many potential uses have been explored in food preservation, 
pharmaceutics, natural therapies and cosmetics.  With the aim of developing a 
highly active EO-based nanoemulsion, the antimicrobial and antifungal properties 
of ten EOs were compared against two Gram-positive bacterial species, (S. 
aureus and S. epidermidis), two Gram-negatives (E. coli and P. aeruginosa) and 
a dermatophyte (T. rubrum) associated with skin conditions. The potential of EOs 
for use in various applications is suggested by their broad spectrum of 
antimicrobial activity, which is also evident in this investigation as EOs such as L. 
cubeba (litsea), C. limon (lemon) and R. officinalis (rosemary) showed activity 
against all organism tested (Table 4.1), with ZOIs ranging between 20.20-90.00 
mm for litsea EO, 21.30-90.00 mm for lemon EO and 23.80-90.00 mm for 
rosemary EO. The MICs were therefore determined for the antimicrobial activity 
of the 2 citrus EOs of litsea and lemon and the EO the rosemary herb.  
S. aureus is commonly found in wounds, and though many studies on EO 
activity focus on S. aureus there are still many oils that have not been tested 
against S. aureus and its resistant strain; Orchard and van Vuuren (2017) argue 
that only 55% of the EOs documented from the aromatherapeutic literature for 
use in dermatological infections have been tested against S. aureus. EOs of 
Boswellia spp. (frankincense), Eucalyptus spp. (eucalyptus), Lavandula 
augustifolia (lavender), tea tree, Mentha piperita (peppermint), basil, R. officinalis 
(rosemary) and T. vulgaris (thyme) are among the EOs most tested against S. 
 114 
 
aureus (de Rapper et al., 2013; Jiang et al., 2011; Orchard et al., 2017; Van 
Vuuren et al., 2010).  A study on lavender EO and other aromatherapeutic oils 
reported noteworthy MIC values for various EOs against S. aureus, including 
vetiver (MIC= 0.75 mg/ml), bay laurel (MIC= 0.83 mg/ml) and Indian sandalwood 
(MIC= 0.25 mg/ml) EOs (de Rapper et al 2013). L. cubeba was also tested in this 
study and was able to inhibit S. aureus growth at an MIC of 1.50 mg/ml, which 
notably was the same MIC against P. aeruginosa (de Rapper et al., 2013). In the 
present study, litsea EO exhibited higher antimicrobial activity than rosemary and 
lemon EOs; moderate activity was observed by litsea EO (Table 4.2) against E. 
coli and T. rubrum, with MIC and MBC/MFCs of 2.5 μl/ml and 5 μl/ml respectively 
for both organisms, however, stronger activity was observed against S. 
epidermidis (MIC= 0.6 μl/ml) and S. aureus (MIC= 1.25 μl/ml). Comparable 
results were generated in a study on leaf and fruit EOs of L. cubeba, in which an 
MIC of 1.25 mg/ml was observed against S. aureus, while an MIC of 10 mg/ml 
was recorded against E. coli (Saikia et al., 2013). Knowledge on the antimicrobial 
activity of L. cubeba (litsea) EO against microorganisms like dermatophytes and 
bacteria is still limited; a study on its activity using the toxic food method, showed 
that litsea EO was able to prolong the lag phase of E. coli for approximately 12 
hours at a concentration 0.0625% v/v, while at a concentration of 0.125% v/v, E. 
coli cells were killed within 2 hours, as shown by TEM (Li et al., 2014). S. 
epidermidis has been somewhat neglected in EO studies, possibly due to the lack 
of perceived threat, however, MRSE has become more problematic recently due 
to antimicrobial resistance (Opalchenova and Obreshkova, 2003). Numerous 
studies have assessed the activity of tea tree oil against S. epidermidis, and a 
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study by Yoon et al (2009) found that the EO was able to inhibit two antibiotic 
resistant strains of S. epidermidis (SK9 and SK19) at an MIC of 1.00 μl/ml against 
both strains (Bajpai et al., 2009).  
 
Dermatophytosis is a contagious fungal infection caused by a group of 
fungi known as dermatophytes; these filamentous fungi infect areas of the body 
that are rich in keratin and the dermatophyte T. rubrum has been previously been 
identified in studies as the major causative agent (n=39, 49.37%) isolated in 
dermatophyte related infections (Babayani et al., 2018). Symptoms of a 
dermatophyte infections are not usually life threatening, but treatment can be 
challenging, costly and cause side effects. Many anti-fungal agents are available, 
including azoles such as ketoconazole, fluconazole and itroconazole, but can 
present side effects such as those seen with the use of ketozonazole, which 
include nausea, abdominal pain and itching; when used long-term such drugs 
can be toxic thus limiting their use, this and the high cost of treatment signify a 
need to focus on development of new suitable alternatives to these antifungal 
agents (Ouf et al., 2016; Shin and Lim, 2004). Tinea pedis is usually treated 
topically therefore EO are suitable candidates for treatment but very few research 
and clinical studies have been dedicated to dermatophytes like T. rubrum, their 
infections and their susceptibility to EOs. Shin and Lim (2004) assessed the 
inhibition of T. rubrum by herb EOs by the disc diffusion method and found 
rosemary and thyme EO had inhibition zones of 33.0 ± 1.15 mm and >39.0 mm 
respectively; MIC /MFC observed for thyme was 1 mg/ml, while that of rosemary 
was 8 mg/ml (Shin and Lim, 2004). In contrast, thyme and rosemary EO in this 
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present study (Table 4.1) gave total inhibition of T. rubrum (90 ± 0 mm); MIC and 
MFC of both rosemary and lemon EOs against T. rubrum were 10 μl/ml and 20 
μl/ml respectively (Table 4.2). Comparable results have been reported for 
rosemary EO against T. rubrum with MIC and MFC of 8 mg/ml respectively (Shin 
and Lim, 2004). Sharma and Tripathi (2008) explain that the mode of action of 
EOs against dermatophytes involves loss of rigidity and integrity of the cell wall 
which causes loss of the cytoplasm and its components, eventually resulting in 
death of the mycelium (Sharma and Tripathi, 2008).  Much better activity was 
seen with litsea EO in this study, exhibiting up to a 4 times lower MIC and MFC 
of 2.5 μl/ml and 5.0 μl/ml respectively compared to lemon and rosemary EO. 
Similarly, a south African study on 59 commercial EOs reported L. cubeba (litsea) 
EO to have the best anti-dermatophyte activity, with a notable MIC of 0.09 mg/ml 
against T. mentagrophytes, compared to lemon (MIC=0.38 mg/ml) and rosemary 
(MIC = 0.75 mg/ml) EOs (Orchard et al., 2017). Fennel EO has also demonstrated 
ability to inhibit dermatophytes growth; its activity was assessed against 3 strains 
of T. rubrum with MIC and MFC and 0.039 μl/ml and 0.078 μl/ml reported against 
all 3 strains tested (Zeng et al., 2015). The difficulty in treating dermatophyte 
infections should be an incentive in further investigating EOs that show strong 
anti-dermatophyte activity; a randomized, controlled, double-blinded study on the 
treatment of interdigital tinea pedis using tea tree EO reported a mycological cure 
rate of 64% for those using a 50% tea tree EO solution twice daily for a four-week 
period, compared to a rate of 31% for the placebo group (Satchell et al., 2002). It 
would therefore be useful to observe more clinical studies on EOs such as litsea 
EO which prove to have strong antifungal activity.  
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The most robust of the organisms tested was P. aeruginosa, with no 
antimicrobial activity observed (Table 4.1) for sweet orange, bitter orange and 
wild thyme EOs. This is consistent with previous studies which have reported no 
inhibitory activity of orange EO and thyme EO (no inhibition zone diameter) 
against P. aeruginosa (Mahboubi et al., 2018; Vieira-Brock et al., 2017). 
Screening results in this investigation (Table 4.1) showed susceptibility of E. coli 
to herb EOs such as wild thyme and rosemary (56.5 mm and 90 mm respectively). 
This activity was also seen in findings by Sienkiewicz et al (2016) with thyme and 
rosemary EOs giving smaller ZOIs of 23 mm and 12 mm respectively, though the 
quantity of EOs used to impregnate the disks and the size of disks used is not 
mentioned in the study (Sienkiewicz et al., 2017). The antimicrobial activity of 
rosemary EO has also been assessed against a range of P. aeruginosa isolates 
with reported MIC values ranging between 5 and 40 μl/ml (Araby and El-Tablawy, 
2016; Gomes et al., 2012).  
 
Generally higher MICs were observed in the present study against P. 
aeruginosa for lemon, litsea and rosemary EOs (>40 μl/ml, 10 μl/ml and 20 μl/ml 
respectively) compared to other organisms (Table 4.2). Gram negative 
pathogens like P. aeruginosa and E. coli are of critical concern in the field of drug 
resistance being able to colonise wounds and cause infection (Alonso-Isa et al., 
2017; Cefalu et al., 2017). The low sensitivity of P. aeruginosa to EOs has also 
been observed in studies on various EOs against P. aeruginosa, with tested EOs 
of lemongrass, peppermint, caraway, anise, fennel, geranium, clove, and 
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lavender EOs having MICs >16 μl/ml the maximum concentration tested (Tarek 
et al., 2014).  
 
EOs are said to be able to penetrate the cell wall and cytoplasmic 
membranes of bacteria by disrupting the integrity of various layers of the 
membranes, which leads to disruption of the cell (Saikia et al., 2013). The 
generally low sensitivity to most EOs exhibited by Gram-negatives like P. 
aeruginosa has often been attributed to the lipopolysaccharide (LPS) rich outer 
membrane which serves to protect the cytoplasmic membrane against 
antimicrobial activity, increasing tolerance to hydrophobic EOs compared to 
Gram-positive organisms (Calo et al., 2015; Nazzaro et al., 2013; Zhang et al., 
2016). This is not always the case, as in this present study, the other Gram-
negative organism tested, E. coli, did not experience the same degree of 
resistance as P. aeruginosa to the same EOs. In the case of litsea EO, for 
example, an MIC of 2.5 μl/ml was required to inhibit E. coli, while P. aeruginosa 
showed greater resistance (MIC 10 μl/ml) by the same EO (Table 4.2). A study 
by Orchard and van Vuuren (2017) on commercial EOs reported equal sensitivity 
for Gram-positive S. aureus and Gram-negative E. coli to L. cubeba (litsea) EO 
(MIC= 1.00 mg/ml), whilst P. aeruginosa was more resistant (MIC= 1.50 mg/ml). 
Additionally, the study found Gram-negative E. coli and P. aeruginosa to be 
equally susceptible as Gram-positive S. epidermidis and S. aureus strains to 
Eucalyptus globulus (eucalyptus) EO (MIC= 2.00 mg/ml), Cinnamomum 
zeylanicum (cinnamon) EO (MIC= 1.00 mg/ml), Laurus nobilis (bay) EO (MIC= 
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1.00 mg/ml) and R. officinalis (rosemary) EO (MIC=2.00 mg/ml; Orchard et al., 
2017).  
 
In this present study, the focus was on assessing the potential activity of 
EOs used on their own and within blends rather than in conjunction with traditional 
antimicrobials as EOs can have the advantage of creating stronger antimicrobial 
activity of individual oils when used in a blend; litsea and lemon EO blend, in this 
present study, showed synergistic effect against P. aeruginosa (FICI= 0.31) at a 
1:1 ratio of 2.5 µl/ml concentration for both EOs. When this is compared to 
individual MIC for the EOs used individually (>40 µl/ml for lemon and 10 µl/ml for 
litsea EO), it is seen that blends have the potential to decrease possible toxicity 
by lowering the required dose of the antimicrobial agent and demonstrates that 
synergy is not necessarily shown only by EOs which have strong efficacy 
independently (Orchard et al., 2017). Greatest success with the blends of the 3 
tested EOs was seen against S. aureus with synergistic blends observed 
between double combinations for all 3 EOs (Table 4.3), with the most efficacious 
combination observed again between litsea and lemon at a 1:1 ratio (FICI= 0.09). 
A study investigated various 1:1 combinations of L. angustifolia (lavender) with 
other EOs and found that blends of lavender EO with C. zeylanicum (FICI= 0.50), 
C. limon (FICI=0.38), Daucus carota (FICI=0.50), Juniperus virginiana (FICI= 
0.50) and T. vulgaris (FICI= 0.40) all gave synergistic results (de Rapper et al., 
2013). In contrast, none of combinations of lavender and the 45 other EOs 
studied showed a synergistic effect against P. aeruginosa, while 31 out of the 45 
combinations were synergistic against the fungus C. albicans (de Rapper et al., 
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2013). It is therefore wrong to assume that synergistic EO blends seen against 
one pathogen will have the same effect on all; Orchard et al (2017) argues that 
synergistic antimicrobial activity is limited by the pathogen being tested (Orchard 
and van Vuuren, 2017). In this present study, for example, synergy was observed 
for litsea and lemon blends against dermatophyte T. rubrum (FICI= 0.49), Gram-
negative P. aeruginosa (FICI= 0.31) and E. coli (FICI= 0.17) and Gram-positive 
S. aureus (FICI= 0.09), but all 2-way blends of litsea, lemon and rosemary 
resulted in additive and indifferent interactions against S. epidermidis not further 
enhancing the activity of the individual EOs (Table 4.3). Triple combinations of 
the EOs in this study only showed synergism against E.coli with only one 
concentration combination give this effect as can be observed in the isobologram 
(Figure 4.2b); the three EO blend did not appear to have any added benefit for S. 
aureus, S. epidermidis and P. aeruginosa and antagonistic interactions can be 
observed in the isobolograms for each organism (Figure 4.2). Blends of litsea and 
lemon EO showed synergism against four out of five organisms tested (Table 4.3) 
and were still antimicrobial against S. epidermidis though non-synergistic (FICI= 
2.15). Thus the 3-way blends between litsea, lemon and rosemary EO were not 
carried forward for investigation. The MICs of litsea and lemon EO within the 
blend that were antimicrobial against each organism were 2.5 μl/ml and 5.0 μl/ml 
respectively, representing a litsea: lemon ratio of 1:2. This ratio was therefore 
carried forward into analysis and product development in Chapter 5 and Chapter 
6. 
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In the present study, the greatest antimicrobial synergistic effect (Table 
4.3) was observed between blends of litsea and lemon EO inhibiting the growth 
of dermatophyte T. rubrum (FICI= 0.49) at minimum concentrations of 0.60 µl/ml 
and 2.50 µl/ml for litsea and lemon oil respectively, within the blend. Few studies 
have focused on EO blends against dermatophyte pathogens; Cassella et al 
(2002) observed synergy between blends of Lavandula agustifolia (lavender) and 
tea tree EO against dermatophytes T. mentagrophytes (70% lavender/ 10% tea 
tree) and T. rubrum (10% v/v lavender/ 20% tea tree), resulting in complete 
inhibition (Cassella et al., 2002).  
 
Gutierrez et al (2008) suggest that the reason why EOs with moderate to 
poor individual antimicrobial efficacy, can result in an enhanced effect when 
combined, such as seen with P. aeruginosa in this study, lie within the mechanism 
of action and the composition of the EOs, as combinations with other EOs 
containing different chemical compounds which could increase their activity 
(Gutierrez et al., 2008). The differences in activity of EOs in this study and those 
found in literature can be attributed to the chemical diversity of EOs and are 
therefore to be expected (Nguyen et al., 2016). Variation in chemical composition 
of extracts and EOs from the same plants, is due to the different climates and 
environmental conditions that the plants are grown in such as soil, acidity and 
harvest times. This means that EOs that have been harvested form different 
plants may show variation in antimicrobial activity; additionally, different strains 
of an organism may show a difference in susceptibility (Tarek et al., 2014). Thus, 
the major chemical components of L. cubeba and C. limon have been analysed 
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in Chapter 5. In this present study no anaerobic organisms were tested as they 
were not among the organisms of interest.  
   
In conclusion EOs are undoubtedly promising natural antimicrobials which 
are able to inhibit the growth of Gram-positive and Gram-negative bacteria as 
well as dermatophytes such T. rubrum, for which there is a paucity of research in 
the published literature. The most effective EO (which worked against all four 
organisms) was litsea, with an average zone of inhibition (ZOI) of 4.7 cm against 
S. aureus, 2.0 cm against P. aeruginosa, 5.3 cm against E. coli and 4.3 cm 
against S. epidermidis. Lemon and rosemary EOs were the only other two EOs 
which were effective against P. aeruginosa with mean ZOI’s of 2.1cm and 2.4 cm 
respectively. Litsea, lemon and rosemary EOs were therefore carried forward to 
determine minimum inhibitory concentrations (MICs) and fractional inhibitory 
concentrations (FICs); MICs observed by litsea EO were lowest for all organisms 
ranging between 1.25 – 10 μl/ml. Blends of litsea and lemon showed synergy 
against S. aureus (FIC index = 0.09), P. aeruginosa (FIC index= 0.31), E. coli 
(FIC index =0.17) and T. rubrum (FIC index = 0.49). Blends of citrus EOs lemon 
and litsea were found to be potential antimicrobial agents for inhibiting the growth 
of S. aureus, P. aeruginosa, E. coli, S. epidermidis and T. rubrum for the 
treatment of skin infections and showed that EO can inhibit bacteria individually 
and synergistically (thus lowering concentration and any possible toxicity), 
making them good candidates for use in functional antimicrobial textiles. The 
potential encapsulation of EOs for use in functional textiles such as wound 
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dressings that are eco-friendly could be used effectively towards the treatment 
and prevention of infectious skin conditions and malodour.  
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Chapter 5. Encapsulation of Antimicrobial EO-blend of 
Litsea and Lemon 
 
5.1 Introduction  
 
EOs such as those of litsea and lemon, are mixture of highly complex, 
natural and volatile compounds produced by aromatic plants as secondary 
metabolites, such as of citral (Figure 5.1) and limonene (Figure 5.2). Their 
complex make-up of individual aroma compounds protects the plants from 
microorganisms in their environment, insects and herbivores and these 
compounds provide EOs their bactericidal, fungicidal and viricidal properties 
(Orchard and van Vuuren, 2017). The rise in the prevalence of antibiotic resistant 
pathogens observed in recent years, has led to increased interest in the 
development of functional textiles with antimicrobial properties. Synthetic 
antimicrobial agents such as QACs, triclosan and metals have been used to 
develop textiles with durable and effective antimicrobial activity against a range 
of microorganisms, however, environmental concerns related to these synthetic 
compounds (such as water pollution, bioaccumulation and non-biodegradability) 
have become a cause for concern (Ali et al., 2014; Tawiah et al., 2016; Windler 
et al., 2013).  
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Figure 5.1 Chemical structure of citral compound 
 
 
Figure 5.2 Chemical structure of Limonene isomers (R)-limonene (left) and 
(S)-limonene (right) 
 
Natural, plant-based ingredients like EOs have grown in popularity as they 
represent an eco-friendly and biodegradable alternative for use in antimicrobial 
textile finishing. EOs have found various uses within the fields of textiles, foods, 
pharmaceuticals, cosmetics and agrochemicals, however, challenges are faced 
with the application of these natural antimicrobials due to their volatility, sensitivity 
to light and air (which can cause degradation) and hydrophobicity (Bakry et al., 
2016). Suitable methods and formulations need to be employed with the aim of 
protecting the oil from volatilization and degradation, controlling its release rate 
and preventing unacceptable deterioration of the final product (Ali et al., 2014; 
Aziz et al., 2015; Bakry et al., 2016) For the successful formulation and 
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development of such EO-based products, microencapsulation can be a viable 
method that will preserve the functional and physicochemical properties of the oil 
and allow for greater durability of the final product (Aziz et al., 2015; Javid et al., 
2014).  
 
Microcapsules are based on a process by which small particles or droplets 
(the active agent) are coated by a natural or synthetic polymeric wall material or 
are embedded within a homogeneous or heterogeneous matrix (Bakry et al., 
2016; Calvo et al., 2011; Rodrigues, Sofia et al., 2008). Various 
microencapsulation techniques have been developed, including emulsification, 
complex-coacervation, spray drying, in situ polymerization, interfacial 
polymerization, air suspension coating, centrifugal extrusion (Bakry et al., 2016; 
Calvo et al., 2011; Rodrigues et al., 2008). The microencapsulation technique to 
be employed will depend on the intended final application and the desired 
microcapsule characteristics, such as particle size and shape, biocompatibility, 
permeability and degradability (Aziz et al., 2015; Cheng et al., 2009). Techniques 
such as spray drying may be unsuitable for EOs, due to the high temperatures 
(up to 200°C) used in the drying chamber; additionally, Nazzaro et al. (2011) 
confirmed that oxidation of the oil can occur due to the increased oxygen 
availability during the atomization process (Bakry et al., 2016; Nazzaro et al., 
2011). In this present study, the emulsification technique was used, as it allows 
for the encapsulation of the EOs in an aqueous final solution which can be used 
directly for easy and simple application on textiles. Emulsions are relatively 
simple to prepare, are low cost and do not involve the use of high temperatures. 
 127 
 
Various EOs have been encapsulated via emulsification, including those of 
rosemary, thyme, oregano, clove, cinnamon and lime (Campelo et al., 2017; 
Hosseini et al., 2013; Mohammadi et al., 2015; Pecarski et al., 2014; Purwanti et 
al., 2018; Turasan et al., 2015).  
 
Many products ranging from pharmaceutical, food, textile and other 
industries are based on emulsions. Emulsions are mixtures of at least two 
immiscible liquids (phases), usually water and oil, in which one of the phases is 
dispersed as small droplets within the other. When the oil phase is dispersed 
within an aqueous phase it forms an oil-in-water (O/W) emulsion, however, when 
the water phase is dispersed in an oil phase, a water-in-oil (W/O) emulsion is 
formed. Complex emulsions can also be formed, such as water-in-oil-in-water 
(W/O/W) and oil-in-water-in-oil (O/W/O) emulsions (Aulton and Taylor, 2017; 
Bakry et al., 2016; Campelo et al., 2017).  
 
Biopolymers, specifically natural occurring polysaccharides like chitosan 
and alginates, are becoming popular carriers in encapsulation processes. The 
deacetylated form of chitin, chitosan, has been used to protect compounds like 
EOs which are sensitive to temperature, oxygen and light, using methods like 
ionic gelation (Xu and Du, 2003) and spontaneous emulsification (Wilson et al., 
2010). Carvacrol-loaded chitosan nanoparticles were prepared using a two-step 
method combining emulsification and ionic gelation, and the resulting particles 
effectively inhibited the growth of E. coli, S. aureus and Bacillus cereus with an 
MIC of 0.257 mg/mL and MBC of 8.225, 4.113 and 2.056 mg/ml respectively 
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(Keawchaoon and Yoksan, 2011). Chitosan has also been used to successfully 
encapsulate oregano EO, showing a two-phase release profile (Hosseini et al., 
2013).  A study on the microencapsulation of citronella EO discovered that 
increasing the concentration of chitosan in the encapsulation significantly 
affected the encapsulation efficiency of the EO by decreasing it and that 
homogenization speed affected particle size (Hsieh et al., 2006). 
 
Alginates are natural polymers extracted from brown algae and have been 
widely used in the form of sodium alginate to encapsulate pharmaceutical actives 
and EO’s such as clove, thyme and cinnamon (Shinde and Nagarsenker, 2011; 
Soliman et al., 2013). The formulation of sodium alginate particles is achieved 
through cross-linking, such as ionic cross-linking; a study on lemon balm-loaded 
sodium alginate beads cross-linked with calcium chloride found that there was no 
interaction with the extract and its antioxidant activity was not affected by the 
encapsulation (Najafi-Soulari et al., 2016). Interest in polymers such as chitosan 
and sodium alginate have received interest in food, pharmaceutical and 
biomedical applications, such as drug delivery systems due to their favourable 
biodegradable, biocompatible and mucoadhesive properties (Pedro et al., 2009).  
 
Due to the rise in antibiotic resistance, the ecological concern created by 
current synthetic antimicrobials and the increased demand for eco-friendly 
antimicrobials and textile products, the development of ‘green’ formulations 
based on natural antimicrobials such as EOs and natural formulation ingredients 
such as biopolymers must explored, with the aim of developing safer, yet capable 
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functional textiles. The antimicrobial blend of litsea and lemon EOs is a potentially 
ideal alternative to synthetic compounds and the combination of biopolymers 
such as sodium alginate and chitosan are good candidates for a natural 
formulation that can be subsequently applied on textiles.    
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5.2 Aims and Objectives 
 
The aim of this chapter was to develop a formulation that would 
encapsulate an EO blend of C. limon (lemon) and L. cubeba (litsea) using an eco-
friendly technique suitable to use in coating textiles to render them antimicrobial. 
 
Objectives: 
 
• To encapsulate EOs within formulations that are eco-friendly and stable; 
• To assess the stability of the formulations both qualitatively and 
quantitatively; 
• To characterise and determine the physicochemical characteristics of the 
emulsions and its components including particle size, viscosity and 
thermal behaviour; 
• To determine the release kinetics of EOs from the formulation. 
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5.3 Results  
 
5.3.1 Antimicrobial Activity of Litsea-Lemon EO O/W Emulsions 
 
The in vitro antimicrobial activity of the final o/w formulations was assessed 
against E. coli, S. aureus and S. epidermidis (Table 5.2); it was observed that 
emulsions with a final concentration (FC) of chitosan greater than 1.0 % w/v were 
not able to inhibit the growth of S. aureus and S. epidermidis. The growth of E. 
coli was inhibited, although the ZOI decreased with increasing amounts of 
chitosan with a ZOI of 31.36 ± 4.12 mm for a chitosan FC of 1.25% w/v reducing 
to a ZOI of 16.41 ± 14.21 mm at the highest chitosan FC of 2.0% w/v. 
Formulations with CS FC ranging from 0.125 – 1.0% w/v inhibited all bacterial 
strains with ZOIs ranging from 22.73 mm to 46.09 mm (Table 5.2)  
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Table 5.1 Antimicrobial activity (inhibition zone, mm) of 30% litsea-lemon 
EO O/W emulsions of varying chitosan concentrations against S. 
epidermidis, E. coli and S. aureus. Disk diffusion (-) not carried out.  
Batch No. Chitosan (%w/v) 
S. 
epidermidis 
(mm) 
E. coli (mm) S. aureus (mm) 
F1 2.00 0.00 ± 0.00 16.41 ± 14.21 0.00 ± 0.00 
F2 1.25 0.00 ± 0.00 31.36 ± 4.12 0.00 ± 0.00 
B1 1.00 25.37 ± 1.64 38.00 ± 2.23 22.73 ± 1.15 
B2 0.75 24.35 ± 0.40 39.00 ± 1.50 24.82 ± 1.01 
B3 0.50 28.17 ± 2.75 44.00 ± 0.35 25.65 ± 0.67 
F6 0.25 29.87 ± 3.86 46.09 ± 1.55 28.41 ± 1.15 
F7 0.125 28.29 ± 4.20 41.83 ± 4.60 28.30 ± 2.50 
F8 0.05 - - - 
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The antimicrobial activity of the individual components outside of the 
emulsion were also assessed against E. coli, S. aureus and S. epidermidis 
(Figure 5.3). Results show that a 1% w/v chitosan solution possessed 
antimicrobial activity against all bacterial strains tested with mean ZOIs of 7.54 
mm, 7.99 mm and 8.46 mm against E. coli, S. aureus and S. epidermidis 
respectively. When comparing the EO blend ZOI with those of standards of the 
major compounds, citral showed greater ZOIs, ranging from 25.00-30.05 mm; in 
comparison both S- and R-limonene had lower ZOI, with their largest zones being 
10.63 mm and 18.54 mm respectively. The EO blend showed similar activity to 
that of pure citral standard with mean ZOIs ranging from 24.04 – 34.94 mm; no 
significant difference was observed between ZOI by the EO blend and those by 
citral (p≥0.05). Results from the disk diffusion (Figure 5.3) also showed that a 1% 
w/v solution of sodium alginate did not possess any antimicrobial activity against 
E. coli, S. aureus and S. epidermidis whilst there is an apparent small contribution 
of antimicrobial activity by chitosan, giving mean ZOIs of 7.54 mm, 7.99 mm and 
8.47 mm respectively. 
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Figure 5.3 Mean Zones of inhibition (mm) of chitosan (1% w/v), litsea and 
lemon EO blend (1:2), sodium alginate (1% w/v) citral, S-limonene and R-
limonene against E. coli, S. aureus and S. epidermidis ( n=3 , ± SD).  
 
5.3.2 Identification of Main Compounds of L. cubeba and C. limon  
 
GC-MS chromatograph of litsea EO revealed 3 characteristic major peaks 
at retention times (RT) of 9.33 min, 17.70 min and 18.84 min (Figure 5.4). Lemon 
EO GC-MS chromatograph revealed a characteristic major peak at RT 9.59 min 
and also showed two minor peaks at RT of 17.55 min and 18.61 min (Figure 5.5). 
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Figure 5.5 Gas chromatogram from GC-MS analysis of C. limon EO 
showing main peak of limonene compound 
 
GC-MS analysis of pure reference standards confirmed the identity of the 
main peaks observed in the litsea EO and lemon EO (Figure 5.4 and Figure 5.5) 
as citral and limonene. Citral showed a m/z of 152.1 with two distinctive peaks at 
 
Figure 5.4 Gas chromatogram from GC-MS analysis of L. cubeba 1:100 
in n-hexane showing major compound peaks at various retention times 
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RT 17.67 min and 18.61 min indicating the presence of both E/Z isomers ; 
limonene in turn showed a m/z of 136.1 at RT 9.55 min (Figure 5.6). 
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Figure 5.6 Gas chromatogram from GC-MS analysis of a pure 
standard of citral (A) pure limonene (B) and corresponding mass 
spectra for citral (C) and limonene (D).   
A 
B 
C 
D 
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These two compounds (citral and limonene) were subsequently used as 
markers for the quantification of the EOs within the emulsion formulations during 
storage stability studies and in-vitro release studies. Standard curves were 
created for both compounds at concentrations 0.78125 – 200 mM which can be 
seen in Figure 5.7 and Figure 5.8. Linear equations for citral and limonene are 
shown in Equations (9) and (10). 
 
 
 Linear equation:  𝑑𝑑 = 0.6083𝑥𝑥,  therefore 𝑥𝑥 = 𝑑𝑑0.6083 (9) 
y = 0.6083x
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Figure 5.7 Standard curve of citral concentrations 0.78125 – 200 mM 
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 Linear equation:  𝑑𝑑 = 1.1323𝑥𝑥,  therefore 𝑥𝑥 = 𝑑𝑑1.1323 (10) 
 
5.3.3 Rheology 
 
The viscosity profile of polymer solutions of 1% w/v chitosan (Figure 5.9) 
shows that the polymer solution exhibits shear thickening a non-Newtonian 
behaviour  where there is an increase in viscosity with increased shear rate, 
typical of non-Newtonian pseudoplastic behaviour.  At 20°C, the viscosity values 
of 1% w/v chitosan solution were 0.60 Pa. s at 0.05 s-1 and 2.19 Pa. s at 50 s-1.  
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Figure 5.8 Standard curve of limonene concentrations 0.78125 - 200 
mM 
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Figure 5.9 Influence of shear rate on the rheological curve of a 1% w/v 
chitosan solution at 20 ˚C 
 
Polymer solutions of 1% w/v sodium alginate (Figure 5.10) also showed 
shear thinning with a decrease in viscosity as shear rate increased.  The viscosity 
of the solution at 20°C was 25.75 Pa. s at 0.05 s-1 and 0.38 Pa. s at 10 s-1; after 
which the viscosity increased again being 3.46 Pa. s at 50 s-1.  
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Figure 5.10 Influence of shear rate on the rheological curve of a 1% w/v 
sodium alginate solution at 20 ˚C 
 
The flow behaviour of the emulsions containing 0.5% CS, 0.75% CS, and 
1.0% CS was also analysed at two different strains 0.3% and 1% (Figure 5.11). 
Pseudoplastic behaviour was observed by all the tested emulsions, with a 
decrease in viscosity as shear rate increased, at both strain values tested. 
Generally, higher viscosity values (58.65 Pa. s and 34 Pa. s at shear rate of 0.05 
s -1) were observed with B1 (1% CS) emulsions when tested at strain of 0.3% and 
1% respectively.   
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Figure 5.11 Influence of strain and shear rate on the rheological curve of 
emulsions containing 1.0 % chitosan (B1), 0.75% chitosan (B2) and 0.5% 
chitosan (B3) at 20°C 
 
 
5.3.4 Particle Size, Zeta Potential and Optical Microscopy 
 
The zeta potential (or ζ-potential) is a parameter commonly used to 
determine the electrostatic contribution to an emulsion’s stability. The results 
(Table 5.2) showed slightly negative values of ζ-potential for all three 
concentrations of CS; the most negative value was seen with 1% chitosan 
emulsion at -8.16 mV and the highest with 0.5% chitosan at -3.75 mV. The DLS 
results showed that the emulsions tested did not show a significant difference (p≥ 
0.05) in particle size between the emulsions of different chitosan concentrations. 
The average diameter for 0.5% CS, 0.75% CS and 1.0% CS were 1.146 µm, 
1.398 µm and 1.556 µm respectively (Table 5.2). There was no significant 
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increase (p≥0.05) in the PI related to the concentration of chitosan within the 
emulsions (Table 5.2). The shape of the particles for each emulsion (0.5 – 1% 
CS) can be observed in Figure 5.11. 
 
Table 5.2 Polydispersity index, particle size measurement and zeta 
potential measurement of litsea-lemon EO o/w emulsions containing 0.5-
1% w/v chitosan (± SD). 
Chitosan 
Concentration 
(%w/v) 
Particle size (µm)    
± SD 
Polydispersity Index 
± SD 
ζ Potential (mV)      
± SD 
0.05 1.146 ± 0.114 0.514 ± 0.025 -3.745 ± 0.078 
0.75 1.398 ± 0.293 0.495 ± 0.033 -5.290 ± 0.168 
1.00 1.556 ± 0.142 0.500 ± 0.02 -8.160 ± 1.344 
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Figure 5.12 Optical microscope photographs from a series of 30% litsea-
lemon EO o/w emulsions of varying chitosan concentrations: (a) 0.5%; (b) 
0.75%; (c) 1.0% after 24 h of storage at ambient temperature. 
 
5.3.5 FTIR spectroscopy 
 
FTIR spectroscopy is a method commonly used to examine the structure 
of polymers, EOs and compounds, and the interaction of the molecules involved. 
In the FT-IR spectra for lemon (Figure 5.13) the most characteristic absorptions 
that could be observed were present at 2917.17 cm-1, 1643.96 cm-1, 1435.74. cm-
1, 1376.25 cm-1, 885.51 cm-1 and 796.95 cm-1. Specifically, the peak at 2917.17 
cm-1 is due to the aromatic C-H stretching vibration, while the peaks at 1435.74. 
cm-1 and 1376.25 cm-1 could be attributed to the C-C stretch of the aromatic ring 
of limonene. The IR spectrum of litsea EO (Figure 5.13) was very similar to that 
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of lemon EO with characteristic peaks for litsea found at 2917.12 cm-1, 1672.42 
cm-1, 1439.97 cm-1, 1376.55 cm-1, 1194.05 cm-1 and 1120.13 cm-1. The peak at 
1672.42 cm-1 is very strong compared to lemon EO and can be attributed to the 
C=O double bond found in citral compound.  
 
 
 
The IR spectrum for limonene can be seen in (Figure 5.14) and the peak 
at 1643.96 cm-1 can be linked to the C=C double bond in the aromatic ring while 
the absorption of the ring C-H bending vibrations gave characteristic peaks at 
885.51 cm-1. The IR spectrum of citral can also be seen in (Figure 5.14) and 
similar to that found in the spectrum for litsea a strong C=O bond peak can be 
seen at 1670.75 cm-1. 
Figure 5.13 FTIR spectra of (A) litsea-lemon EO blend, (B) lemon EO 
and (C) litsea EO  
A 
B 
C 
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The IR spectrum of chitosan (Figure 5.15) showed a broad peak at 
3295.15 cm-1 and at 1021.21 cm-1. The broad peak appearing at 3295.15 cm-1 is 
due to stretching vibrations of O-H bonds while the peak at 1021.21 cm-1 
corresponds to the C-O stretching bands. The spectrum for sodium alginate 
(Figure 5.15) showed characteristic peaks at 3228.11 cm-1, 1591.83 cm-1, 
1406.09 cm-1 and 1023.39 cm-1. These peaks found at 3228.11 cm-1, can be 
attributed to the O-H stretching, those at 1591.83 cm-1 and 1406.09 cm-1 to COO- 
asymmetric and symmetric stretching. The peak at 1023.39 cm-1 can be attributed 
Figure 5.14 FTIR spectrum of a pure standards of limonene (A) and 
citral (B) 
A 
B 
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to guluronic units. When the physical mixture of chitosan and sodium alginate 
was analysed (Figure 5.15), the resulting spectrum showed only two broad peaks, 
the first at 3363.88 cm-1 corresponding to hydroxyl (O-H) groups and second peak 
at 1623.99 cm-1 corresponding to a carbonyl (C=O) group; the peak at the region 
of 1021.21- 1023.39 cm-1 showed a large decrease in intensity. 
A 
B 
C 
Figure 5.15 FTIR spectra of (A) CS powder, (B) SA and (C) a blend of CS and SA 
(1:1 ratio) 
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When the emulsions with chitosan concentrations of 0.5 -1% w/v were 
analysed by FTIR the resulting spectra showed the same characteristic two peaks 
seen in the spectrum for chitosan/sodium alginate physical mixture (Figure 5.16) 
any other characteristic peaks seen in the spectra of individual components 
disappeared or became more prominent possibly due to interactions of the 
chitosan and sodium alginate.  
 
 
 
Figure 5.16 FTIR spectra for 30% litsea-lemon EO emulsions of varying 
concentrations of chitosan (A) 0.5% w/v, (B) 0.75% w/v and (C) 1% w/v. 
A 
B 
C 
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5.3.6 Thermal Analysis by Differential Scanning Calorimetry (DSC) and 
Thermogravimetric Analysis (TGA) 
 
Thermal analysis was conducted on pure litsea and lemon EOs, reference 
standards of citral and limonene, the polymers of chitosan and sodium alginate 
and the emulsions. The TGA plots showed onset thermal transition points of 
62.17°C for formulation B1, 68.71°C for B2 and 64.04°C for B3, while their boiling 
points were observed to be 134.95°C, 136.64°C and 117.28°C respectively 
(Figure 5.17 a).  
 
Figure 5.17 TGA Thermograms for (A) emulsion formulations B1, B2 and B3 
and (B) emulsion raw components litsea EO (LIT), lemon EO (LEM), 1:2 litsea 
and lemon EO blend (BLEND), chitosan (CS), sodium alginate (SA), calcium 
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The thermal transitions seen in the TGA graphs for litsea and lemon shows 
that their weight loss onset is 118.14°C and 83.98°C respectively (Figure 5.17 b) 
and  when a physical mixture (blend) of the two oils was analysed, the onset of 
the blend was 86.58°C (Figure 5.17 b).   
 
The DSC profile for raw CS was characterised by a large endothermic 
event at 126.99°C and a large exothermic peak at 317.73°C (Figure 5.18 b). The 
thermogram for SA showed a broad endothermic peak from 97.07°C to 170.80°C 
and another broad exothermic peak from 209.02°C to 276.21°C, while CCH 
showed a small endothermic event at 54.22°C and three clustered endothermic 
peaks with the largest being at 211.41°C (Figure 5.18 b). When a physical mixture 
of CS, SA and CCH was analysed, the resulting thermogram showed a sharp 
endothermic event at 50.75°C, (also observed in CCH) and a broad endothermic 
event at 158.37°C (also observed in SA and CS thermograms); the exothermic 
peak observed in the thermogram of CS was no longer present (Figure 5.18 b). 
Thermograms for individual oils showed a sharp endothermic peak at 228.50°C 
for lemon EO while a similar endothermic peak was observed at 232.93°C for 
litsea EO; when a blend of the EOs was analysed these sharp peaks were no 
longer present, with the only a small broad peak observable at 66.42°C (Figure 
5.18 c).  
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Figure 5.18 DSC thermogram for (A) emulsion formulations B1, B2 and 
B3; (B) for raw solid components of emulsions chitosan, calcium 
chloride and sodium alginate and a physical mixture of each; and (C) 
litsea  and lemon EOs and their blend. 
A 
B 
C 
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The DSC profiles for all three emulsion formulations revealed sharp 
endothermic peaks at 134.95°C and 136.64°C for formulation B1 and B2 
respectively; B1 formulation also showed a smaller broad peak between 58.75°C 
and 104.84°C before this sharp peak (Figure 5.18 a). A much smaller 
endothermic peak was observed for formulation B3 at a lower temperature of 
117.28°C (Figure 5.18 a). 
 
5.3.7 Release Studies  
 
Results on the investigation of the release of the main compounds (citral 
and limonene) of the encapsulated litsea and lemon EOs showed that the 
emulsions of 1% CS are characterised by a large burst effect as a rapid release 
of citral is observed (Figure 5.19) and limonene (Figure 5.20) is observed within 
10 min of the release test for emulsions of 1% CS (B1), with 70.11% of limonene 
released. Formulations B2 and B3 demonstrated a much smaller burst effect for 
citral and limonene (Figure 5.19 and Figure 5.20). Limonene in formulation B1 
was completely released within 30 min, while in formulations with lower CS 
concentration B2 and B3 only 21.66 % and 15.53 % of limonene respectively was 
released (Figure 5.20). In comparison, after 30 min, only 1.68% and 1.21% of 
citral was released from B2 and B3 formulations respectively (Figure 5.19). 
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Figure 5.19 Release of citral compound from a litsea-lemon EO O/W 
emulsions of 0.5-1% CS concentration over 50 min in acetate buffer (pH 5) 
with 2% Tween 80 at 32°C 
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Figure 5.20 Release of limonene compound from a litsea-lemon EO o/w 
emulsions of 0.5-1% CS concentration over 50 min in acetate buffer (pH 5) with 
2% Tween 80 at 32°C 
 154 
 
5.3.8 Physical Stability of Litsea-Lemon EO O/W Emulsions 
5.3.8.1 Creaming and Accelerated Creaming Stability  
 
The results of this study showed that when the litsea-lemon EO o/w 
emulsions without surfactants were stored over a period of 5 weeks, the  % CI for 
emulsions with 0.75% w/v CS and 1% w/v CS showed very similar trends with % 
CI of 13.33% and 12.66% respectively after 14 days of storage (Figure 5.21). 
Emulsions with 0.5% w/v CS exhibited low stability, with an average CI of 54.67% 
recorded by day 5.   
 
 
 When  the emulsions were subjected to centrifugal force to predict the 
long term stability of the emulsion (months) it was seen that all emulsions showed 
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Figure 5.21 % CI of 30% litsea/lemon o/w emulsions at different chitosan 
concentrations (0.5 – 1% w/v) over 5 weeks of storage at ambient temperature 
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low stability to the applied stress as over 60% creaming index was recorded for 
all 3 emulsions within 3 cycles (15 min) of centrifugation (Figure 5.22).  
 
 
5.3.9 Chemical Stability During Storage 
 
The chemical stability of the emulsions over time was also assessed by 
comparing the quantified amount of citral present within emulsion with 1.0 % CS 
(B1), 0.75% CS (B2) and 0.5% CS (B3) within 28 days, stored at 15°C and at 
40°C (Figure 5.23). Large fluctuations in concentrations of limonene and citral 
were observed, only results of citral concentration from 0 hour (time 0) and 28 
days are shown; the results in Figure 5.23 show that the presence of citral in 
formulation B1 when stored at 15°C significantly decreased (p≤0.05) from 136.81 
mM to 0.02 mM, while when stored at 40°C there was an increase in citral 
concentration after 28 days from 114.33 mM to 254.23 mM. There was a small 
Figure 5.22 % CI over time of 30% EO emulsions at different CS 
concentrations after 2 hours of centrifugation 
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decrease (13.82 mM) in citral concentration after 28 days for formulation B2 
stored at 15°C, but a large decrease when it was stored at 40°C from 222.85 mM 
to 20.23 mM. The presence of citral within formulation B3 significantly increased 
(p≤0.05) when stored at 15°C going from 224.67 mM to 482.08 mM, while when 
stored at 40°C it decreased to 76.51 mM (Figure 5.23).  
 
  
Figure 5.23 Changes in concentration of citral in emulsion formulations B1, B2 
and B3 stored at 15°C and 40°C for 28 days 
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5.4 Discussion 
 
All the emulsions tested showed a non- Newtonian behaviour where there 
was a decrease in viscosity when shear rate was increased. The concentration 
of CS influenced emulsion viscosity, and it was seen that a higher concentration 
lead to higher viscosity (Figure 5.11). A reduction in particle mean diameter was 
observed with decreased amount of CS in the formulation (Table 5.2); it is 
imaginable that due to the higher viscosity of formulations with higher CS 
concentrations the homogenisation process was able to better reduce the particle 
size of a less viscous emulsion. A fixed homogenization pressure was used and 
Garcia et al (2012) reported a linear relationship between particle mean diameter 
and emulsion viscosity in their studies (Garcia et al., 2012). The average particle 
size of formulations B1, B2 and B3 was 1.556 µm, 1.398 µm and 1.146 µm 
respectively with a nearly neutral zeta potential, which may be attributable to the 
low pH (less than 5) of the emulsions (Table 5.2);  Wasupalli and Verma (2018) 
recorded zeta potential measurements of -1.87 ± 0.87 mV  for self-assembled 
complexes of sodium alginate and chitosan prepared at pH 5.5 but highly 
negative values (-23.67 ± 2.08 mV) when prepared at pH 8.5 (Wasupalli and 
Verma, 2018).   
 
When the presence of citral and limonene within the emulsion formulations 
was assessed, results showed that higher concentration of citral could be 
extracted from each formulation compared to limonene, with average citral 
concentrations observed in B1, B2 and B3 ranging from 114.33-244 mmol/ml 
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while limonene concentrations ranged from 2.21-10.77 mmol/ml (results not 
shown). A complete release (100%) of limonene was observed in formulation B1 
within 30 min (Figure 5.21) compared to 5.45 % of citral released from B1 after 
30 min (Figure 5.19).  A general trend could be observed as release of citral and 
limonene from all batches was characterised by an initial rapid burst release, 
followed by a slowed sustained release (Figure 5.19 and Figure 5.20). A similar 
profile was observed by Kotronia et al (2017) when assessing the in vitro release 
of oregano EO from a  β-cyclodextrin complex; the profile was characterized by 
a burst effect within the first 1 hour and 45 min and then a slower release rate 
over 10 days (Kotronia et al., 2017).  The release of tea tree EO from topical 
formulations has also been assessed by Sgorbini et al (2017) where the markers 
1,8-cineole, 4-terpineol and α-terpineol maximum release from a 30% ointment 
were 32.2%, 10.1% and 7.7% within 50 hours (Sgorbini et al., 2017). 
 
Limonene is prone to autoxidation when exposed to air for prolonged 
periods, forming hydroperoxides which can further break down into by-products 
such as carveol acetate and limonene oxide (Djordjevic et al., 2007; Kern et al., 
2014). When the chemical stability of the emulsions was assessed at 15 ºC and 
40 ºC within 28 days limonene could only be recovered at extremely low 
concentrations or not at all with fluctuating concentrations observed (results not 
shown); citral concentrations after 28 days varied with each formulation with 
nearly a 200% increase observed for formulation B1 when stored at 40 ºC but 
complete decrease (100%) when stored at 15 ºC (Figure 5.23). The irregular 
variation in the compounds at both studied temperatures could be attributed to 
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the nature of the compounds as changes in temperature, humidity, light can all 
affect their concentration; strategies to prevent degradation have been 
suggested, including reduction of temperature during storage and alteration of 
oxygen pressure, however, these methods may be impractical (Djordjevic et al., 
2007; Sharma and Lee, 2016). As expected from storage stability studies, after 
28 days, the emulsions experienced cracking (an irreversible separation of the oil 
phase) at both 15ºC and 40ºC indicating physical instability and were discoloured 
at 40 ºC indicating a reaction such as oxidation could have occurred. TGA is an 
important method to determine the degradation properties of formulations and 
individually assess their components; thermograms for B1, B2 and B3 showed 
that all 3 emulsions displayed almost identical profiles with Figure 5.17a showing 
significant weight loss (over 90%) between  62 -110 ºC for B1, 68 -113 ºC for B2 
and 64- 112 ºC for B3. Though only 1 thermal event can be seen in the TGA 
thermograms, DSC analysis profiles, showed 2 endothermic events after 0 ºC for 
B1 which did not present in the TGA results (Figure 5.18).  
 
Formulations with CS concentration ranging from 0.5 to 1% were carried 
forward for analysis due to their visual physical stability (no phase separation 
within 24 hours) and their antimicrobial activity against S. aureus, E. coli and S. 
epidermidis. The most sensitive bacterial strain was E. coli against all three 
formulations B1 (1% CS), B2 (0.75 % CS) and B3 (0.5 % CS) with the largest ZOI 
observed of 44.00 mm by B3 (Table 5.1). A study by Din et al (2014) on clove 
and cumin EOs emulsions, on the other hand, found the at E. coli was the least 
sensitive organism to cumin emulsion and S. aureus the most sensitive with a 
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ZOI of 16.6 mm for a 25% v/v cumin emulsion (Din et al., 2015). Oregano EO has 
also been encapsulated by emulsification and the system was stabilised by 
cellulose nanocrystals prepared from microcrystalline cellulose, its antimicrobial 
activity was evaluated against E. coli and S. aureus and found to have MICs of 
12.5 µl/ml for both organism (Zhou et al., 2018). Many encapsulations of EOs by 
emulsification reported in literature have involved nanoemulsions; Lu et al (2018) 
developed a nanoemulsion with citral EO and found that S. aureus was the most 
susceptible organism tested with an average ZOI of 19.2 mm, whilst E. coli and 
P. aeruginosa gave zones of 9.4 mm and 6.2 mm respectively (Lu et al., 2018).  
 
The main compounds identified in litsea and lemon EOs were limonene 
and citral (Figure 5.6). It has been reported that citral has the ability penetrate the 
lipid structure of bacterial cell walls causing denaturation of proteins and damage 
to the cell wall leading to death of the cell (Lu et al., 2018). When assessing the 
individual antimicrobial activity of the emulsion ingredients against S. aureus, E. 
coli and S. epidermidis, the EO blend (litsea and lemon EO, 1:2 ratio) and citral 
standard had similar activity with ZOIs range of 24.00 mm to 34.94 mm for the 
blend and a range of 25.00-30.05 for citral, compared to limonene standards 
which gave ZOIs between 6.97 – 18.54 mm (Figure 5.3). Both the EO blend and 
citral had greater activity against E. coli (Figure 5.3), this agrees with the results 
from the assessed antimicrobial activity of the emulsions which also found E. coli 
to be the most susceptible organism (Table 5.1).  
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The physical stability of the emulsions formulations developed in this 
present study renders them more suitable for a “fresh application” type of use; it 
was observed that emulsions with lower concentration of CS experienced poorer 
physical stability, with emulsions of 0.5% CS concentration giving a CI of 54.67% 
recorded by day 5 (Figure 5.21). Emulsions with higher CS concentration showed 
increased stability, indicating that the stability of the emulsion is reliant on the 
concentration of CS within the system. Creaming is an undesirable phenomenon 
in emulsions and generally occurs due to gravitational or centrifugal forces that 
lead to the agglomeration of droplets and therefore an increase in particle size as 
they accumulate at the top of system (Mcclements, 2007). According to 
McClements (2007) the stability of an emulsion to separation can be improved by 
reducing the droplet size. In this study emulsions samples with CS concentration 
above 0.5% did not exhibit any visible instability for the first 7 hours (Figure 5.21). 
Garcia et al (2012) found that a basil EO emulsion formulated with gum Arabic 
did not exhibit any creaming in the first 24 h (Garcia et al., 2012). Moschakis et 
al (2016) observed that a sunflower emulsion was stable and did not exhibit any 
creaming process over 7 days (Moschakis et al., 2016). Although creaming is an 
undesirable process, unlike cracking, it is a reversible process that can often be 
reversed by simple shaking which re-disperses the product, much like a 
suspension system, allowing for use of the formulation for its intended application 
(such as textile padding) for a period of time. Emulsion formulations based on 
EOs, which are prone to changes in composition and chemical degradation, 
therefore could be tailored to fresh application (using the formulation within 24 
hours of production) such as the treatment of textiles which could then be 
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packaged in ways that protect the product from environmental conditions that can 
lead to degradation.   
 
In conclusion, the microencapsulation via emulsification of plant EOs only 
using crosslinked chitosan and sodium alginate is a toxic free method which 
excludes toxic chemicals and is based on only natural products. Natural chitosan-
sodium alginate emulsions encapsulating a synergistic antimicrobial blend of 
litsea and lemon EOs were formulated and the resulting emulsion provides an 
eco-friendly antimicrobial finishing for the treatment of textiles. 
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Chapter 6. Treatment of Cotton and Polyester Textiles 
with Microencapsulated Antimicrobial Litsea-Lemon EO 
Blend 
6.1 Introduction 
The development of antimicrobial textiles has become an active and 
important research area, with a variety of possible applications and functions for 
antimicrobial textiles being explored for their ability to address many problems, 
ranging from preventing spread of infectious diseases (more importantly those 
that are drug-resistant) to addressing issues like body odour on sportswear attire. 
Textiles can be favourable environments for bacteria, fungi and moulds due to 
their large surface area and humidity, warmth and a high source of nutrients 
making them desirable for their growth of microorganisms (Ibrahim and Abd El-
Salam, 2015).  
 Antimicrobial finishes are applied to textiles for the purpose of (1) 
controlling the spread of disease, (2) preventing odour caused by perspiration, 
stains and soiling on fabric and (3) controlling damage of fabric caused by 
decomposition (Yip and Luk, 2016). Textiles that inhibit the growth of 
microorganisms are called biostatic functional textiles, they control the growth 
and spread of bacteria (bacteriostats) and fungi (fungistats) while those that kill 
bacteria and fungi are called biocidal textiles (bactericides and fungicides). 
Biostatic textiles may be more tailored to controlling body odour on sportswear or 
in the preservation of textile items, while biocidal textiles will be more suited to 
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medical applications and providing antimicrobial protection to humans by 
eliminating pathogens completely and quickly upon contact (Sun, 2016). 
 
The use of effective antimicrobial agents that are safe, biodegradable, 
environmentally non-toxic, cost-effective and with selective activity towards 
microbes (without causing microbial resistance) is now in higher demand as 
consumer preference is becoming increasingly geared towards natural 
antimicrobials. However, textiles treated with natural and plant-based agents are 
still in the development stage whilst commercially available antimicrobial textiles 
are treated by synthetic compounds like triclosan, QAC, silver and 
polybiguanides (Zhao et al., 2016). Studies have reported good activity by 
triclosan, with an MIC50 (MIC required to inhibit 50% of isolates) of 0.12 µg/ml 
observed against S. aureus clinical isolates (Schmid and Kaplan, 2004). The 
halogenated-phenol triclosan is regularly used as a textile finish in the production 
of antimicrobial socks and household textiles, with triclosan coated textiles 
showing good antibacterial activity even after 50 washes (Orhan et al., 2007). 
Similarly, Ranganath and Sarkar (2014) observed that after 50 washes, a 
triclosan treated polyester-cotton fabric blend maintained activity, with 100% 
reduction of S. aureus and E. coli reported (Ranganath and Sarkar, 2014). 
Dhiman and Chakraborty (2015) evaluated the antimicrobial activity of triclosan 
finished cotton against S. aureus and E. coli with 100% reduction observed 
against both organisms; after 5 washes antimicrobial activity was retained with a 
reduction of >98% observed for both S. aureus and E. coli (Dhiman and 
Chakraborty, 2015). QAC treatments have also been reported as durable with a 
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study on QAC treated cotton and polyester garments reporting maintained activity 
after 10 washes against S. aureus and E. coli (Saad and Gabr, 2015). 
However, synthetic compounds that have been used to provide durable 
antibacterial activity on textiles, have been found to have a toxic effect on humans 
and the environment, and have raised concerns over bacterial resistance, 
allergies and side effects for users (Alihosseini, 2016; Hilgenberg et al., 2016).  
There have been various reports of bacterial resistance to triclosan and health 
concerns have been raised on its potential to disrupt the thyroid in humans, as 
well as environmental concerns due to toxic products formed during degradation 
and thus the use of triclosan as an antimicrobial for textiles has reduced (Dann 
and Hontela, 2011; Gao and Cranston, 2008; Yazdankhah et al., 2006).  
 
 Due to their bioactivity, low toxicity and biocompatibility, natural products 
such as EOs, have gained increased interest for both medical and cosmetic 
textiles, with a growing demand for textiles that provide antimicrobial ability, 
insecticidal properties, pleasant odours, UV protection and the promotion of 
health and fitness (Alihosseini, 2016). The main challenges faced with the 
application of natural products like EOs is their durability, shelf-life and 
antimicrobial efficiency which is why further research must be carried out to 
evaluate their use in the formation of bioactive textiles (Ali et al., 2014). Other 
methods involve, chemical modification of the fabric fibres, coating, spraying, 
grafting and microencapsulation. Microcapsules can be applied to the textile 
fibres using the pad-dry-cure method, also used by Dhiman and Chakraborty 
(2015) to develop triclosan and cotton finished cotton; spraying, impregnation or 
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screen printing-techniques can also be used (Ali et al., 2014; Dhiman and 
Chakraborty, 2015). The pad-dry-cure method is also used to impart mosquito 
repellency to fabric; EOs like citronella have been microencapsulated and applied 
using the pad-dry-cure method to confer mosquito repellent properties to cotton 
fabric (Specos et al., 2010).   
 
Test methods commonly used to test antimicrobial textiles finishes include 
the parallel streak method (AATC 147), this is an inexpensive and quick method 
to determine whether a fabric sample displays antimicrobial activity. In this 
method, samples are laid on inoculated agar plates in parallel streaks across the 
width of the plate.  This method is non-quantitative, and therefore prevents results 
by other antimicrobial finishes to be reliably compared. An arguably better method 
is the agar-diffusion method used in BS EN ISO 20645:2004 which allows a ZOI 
to be determined due to use of circular fabric samples and total inoculation of the 
agar surface by spreading. Though this method is semi-quantitative, it does not 
allow for distinction between inhibition and kill of the microorganism.  Quantitative 
methods such as AATCC 100, BS ISO 13629-2:2014 and BS EN ISO 
20743:2013 allow quantitative measurement of the fabric samples bactericidal or 
fungicidal ability and include the quenching (neutralisation) of the antimicrobial 
agent as a control. The textile samples are saturated with the test inoculum and 
bacterial or fungal enumerations are recorded at the start of the experiment and 
after a contact period of 24 hour for bacterial strain and 48-hour contact for fungal 
spores.  In this chapter, cotton and polyester fabric samples were treated with a 
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1% CS litsea-lemon EO blend emulsion using the soak-pad-dry method; the 
treated fabric samples were also investigated for mosquito repellent properties.  
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6.2 Aims and Objectives 
 
The overall aim of this chapter was to assess the antimicrobial efficacy of 
fabric (polyester and cotton) when treated with a 1% CS litsea and lemon EO 
blend (1:2 ratio) emulsion against E. coli, S. aureus, S. epidermidis, type and their 
antibiotic resistant and clinical isolates and the dermatophyte T. rubrum  
 
Objectives: 
 
• To qualitatively determine the antimicrobial efficacy of polyester and cotton 
EO-treated fabrics against E. coli, S. aureus, S. epidermidis and their 
antibiotic resistant/clinical isolates and T. rubrum using adapted BS EN 
ISO 20645:2004 standard;  
• To quantify the efficacy of polyester and cotton treated with EO emulsion 
in the reduction of E. coli, S. aureus, S. epidermidis, T. rubrum using 
adapted BS EN ISO 20743:2013 standard; 
• To quantify the efficacy of the EO emulsion in reducing E. coli, S. aureus, 
S. epidermidis, T. rubrum over time; 
• To assess the durability of treated polyester and cotton fabrics to standard 
washing and its antimicrobial activity post-wash. 
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6.3 Results 
 
6.3.1 Quantification and Distribution of Major EO Components on Polyester and 
Cotton Fabric Treated with 1% CS Emulsion 
 
The percentage liquid pick up was calculated for both treated polyester 
and treated cotton for three different emulsion with varying concentrations of CS 
(B1= 1%; B2= 0.75%; B3= 0.5%). The results (Figure 6.1) show that cotton has 
a higher absorbency for the emulsion compared to polyester; the most viscous 
emulsion B1 (1% CS) achieved an average liquid pick up of 112.89 ± 1.59 % 
compared to polyester’s average wet pick up of 97.45 ± 5.97 when also treated 
with B1. Very similar liquid pick-up was achieved for cotton fabric treated with B2 
and B3 emulsions, with a liquid pick up of 107.38 ± 4.77% and 107.81 ± 0.76% 
respectively. The liquid pick up for cotton fabric was significantly higher than 
polyester for treatment B1 (p≤0.05), B2 (p≤0.05) and B3 (p≤0.05). No significant 
differences in % LPU were found within treatments for both cotton and polyester 
(p≥0.05). 
 
 170 
 
 
Figure 6.1 Percentage LPU for cotton and polyester fabric treated with 
emulsions of different chitosan concentration (n=3, ± SD) 
 
Quantification of the main components citral and limonene on treated 
cotton and polyester fabric was carried out on different areas of fabric samples 
(1, 4 and 16 cm2) at 24 h and 1 week post treatment (PT), with significant 
differences in the concentration of limonene (p≤0.05) on polyester fabric 
observed (Figure 6.2a) and in the concentration of citral 24 h PT and 1 week PT 
(p≤0.05). Differences in the concentration of citral and extracted from cotton 
(Figure 6.2b) 24 h PT compared to 1 week PT were also significantly different for 
fabric samples of area 16 cm2 for limonene and citral (p≤0.05).  
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a) 
 b) 
 
Figure 6.2 Mean concentration (mM) of limonene (LIM) and citral (CIT) 
compounds extracted from a) treated polyester and b) treated cotton samples of 
different areas 24 h and 1 week post-treatment (PT) (n=3, ± SD) 
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6.3.2 Toxicity Test and Dilution Neutralisation Validation for Treated Fabric  
 
Neutraliser efficacy test (Figure 6.3) results show that the neutraliser was 
able to quench the activity of the antimicrobial emulsion, with no significant 
difference (p≥0.05) observed between mean log10 CFU/ml of neutralised 
emulsion compared to the control for E. coli, S. aureus, S. epidermidis and T. 
rubrum. The efficiency of the neutraliser was also tested using the DNV test for 
both polyester and cotton treated fabric. E. coli, S. aureus, S. epidermidis and T. 
rubrum growth was not affected by the testing conditions and both treated cotton 
and polyester fabric samples were successfully neutralised (Figure 6.4) with no 
statistical significance (p≥0.05) found between mean log10 CFU/ml of control 
compared to treated fabric samples subjected to neutraliser for E. coli, S. aureus, 
S. epidermidis and T. rubrum which differed by >1 log(10) for all organisms.  
 
Figure 6.3 Mean log10 CFU/ml of E. coli, S. aureus, S. epidermidis and T. 
rubrum after neutraliser efficacy test (NE) compared to control (n=4, ± SD) 
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Figure 6.4 Mean log10 CFU/ml of E. coli, S. aureus, S. epidermidis and T. 
rubrum under conditions control test (CC), polyester (PE DNV) and cotton 
(COT DNV) dilution neutralisation test compared to control (n=4, ± SD) 
 
6.3.3 Qualitative Determination of Antibacterial and Antifungal Activity of 
Emulsion Treated Polyester and Cotton Fabric post 40°C Wash 
 
Zones of inhibition were recorded to assess antibacterial and antifungal 
ability of emulsion treated fabric samples and results (Table 6.1) showed that 
cotton fabric treated by all 3 emulsions was able to inhibit the growth of E. coli, S. 
aureus, S. epidermidis, and T. rubrum 24 hour post-treatment, with leaching 
observed against E. coli when fabric was treated with B2 and B3 emulsions with 
ZOI of 4.58 ± 1.69 mm and 0.81 ± 0.60 mm respectively. Leaching was also 
observed by cotton treated with B2 emulsion (24 h post-treatment) against S. 
epidermidis with a ZOI of 1.43 ± 0.96 mm. E. coli appeared to be the most 
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ZOIs of 4.64 ± 1.86 mm for B1 treatment, 2.96 ± 2.20 mm for B2 and 1.62 ± 0.36 
mm for B3, after 24 hours.  S. epidermidis showed weak susceptibility to polyester 
treated fabric, when tested after 24 h, as growth was observed under fabric 
treated with B1 and B3. T. rubrum was inhibited by both cotton and polyester for 
all treatments, with no growth underneath the fabric, no leaching was observed 
(no zone beyond the fabric diameter).  
 
Activity of the fabric was retained and improved significantly after 1 week 
of storage (Table 6.1) with larger zones of inhibition observed by both cotton and 
polyester samples compared to when fabric was tested 24 h post-treatment. The 
greatest inhibition was recorded by polyester treated fabric with zones of 19.43 ± 
5.46 mm against E. coli, 22.31 ± 6.97 mm against S. aureus, 9.31 ± 0.51 mm 
against S. epidermidis and 65.74 ± 1.05 mm against T. rubrum. There was a 
significant increase in activity (p≤0.05) by cotton fabric after 1 week against E. 
coli increasing from an average of 4.58 mm to 9.26 mm.  
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Table 6.1 ZOIs (mm) for treated cotton and polyester 24h and 1 week post 
treatment against E. coli, S. aureus, S. epidermidis and T. rubrum (+) = 
growth underneath fabric (-) = no growth underneath fabric. (n=6, ± SD) 
 
Growth under fabric ZOI (mm) 
Fabric  E. coli 
S. 
aureus 
S. 
epidermidis 
T. 
rubrum E. coli S. aureus S. epidermidis 
T. 
rubrum 
24 hr Post-treatment       
Cotton          
B1 
Treated - - - - 0 0 0 0 
B2 
Treated - - - - 4.58±1.69 0 1.43±0.96 0 
B3 
Treated - - - - 0.81±0.60 0 0 0 
Control + + + + 0 0 0 0 
Polyester         
B1 
Treated - - + - 4.64±1.86 0 0 0 
B2 
Treated - - - - 2.96±2.20 0 0 0 
B3 
Treated - - + - 1.62±0.36 2.64±2.29 0 0 
Control + + + + 0 0 0 0 
1 week Post-treatment       
Cotton         
B1 
Treated - - - - 
9.26 ± 
0.30 
9.48 ± 
4.81 4.22 ± 2.23 
64.96 
± 1.28 
 Control + + + + 0 0 0 0 
Polyester         
B1 
Treated - - - - 
19.43 ± 
5.46 
22.31 ± 
6.97 9.31 ± 0.51 
65.74 
± 1.05 
Control + + + + 0 0 0 0 
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The activity of cotton and polyester fabric treated with 1% CS EO emulsion 
was screened against MRSA strain and clinical isolates of E. coli and S. 
epidermidis at 24 h and 1-week post treatment (Table 6.2), antimicrobial activity 
was again preserved after 1 week but with a reduction in the zones of inhibition 
observed against MRSA with polyester samples giving zones of 17.64 ± 1.93 mm 
after 24h and 1.21 ± 0.71mm, 1 week post-treatment. S. epidermidis was also 
inhibited by both cotton and polyester treated fabric at both time points with the 
greatest zone observed after 24 h for both cotton (13.29 ± 8.25 mm) and polyester 
(15.03 ± 6.70 mm) samples.  
 
The assessment of activity of treated cotton and polyester fabric after a 
standard 40°C wash showed that both fabrics were unable maintain their activity 
against all bacteria after post-wash. Activity was maintained for treated cotton 
against T. rubrum which resulted in a mean ZOI of 0.52 ± 0.24 mm. 
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Table 6.2 ZOIs (mm) for E. coli (clinical strain 390685Q), MRSA (antibiotic 
strain NCTC 12497) and S. epidermidis (clinical strain PLO 21862) by 
treated cotton and polyester 24h and 1 week-post treatment. (+)= growth 
underneath fabric, (-) = no growth underneath fabric. (n=6, ± SD) 
 
 
Growth under fabric Zone of inhibition (mm) 
Fabric type E. coli 
(390685Q) 
MRSA 
(NCTC 
12497) 
S. 
epidermidis 
(PLO 
21862) 
E. coli 
(390685Q) 
MRSA 
(NCTC 
12497) 
S. 
epidermidis 
(PLO 
21862) 
24 hr Post-treatment      
Cotton       
B1 Treated - - - 0 7.65 ± 2.22 13.29 ± 8.25 
Control + + + 0 0 0 
Polyester       
B1 Treated + - - 0 17.64 ± 1.93 15.03 ± 6.70 
Control + + + 0 0 0 
1 week Post - treatment      
Cotton       
B1 Treated - - - 0.87 ± 0.71 
2.44 ± 
0.48 1.18 ± 0.32 
Control + + + 0 0 0 
Polyester       
B1 Treated - - - 0.53 ± 0.47 
1.21 ± 
0.71 1.10 ± 0.44 
Control + + + 0 0 0 
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6.3.4 Quantitative Determination of Antibacterial and Antifungal Activity of 1% 
CS Emulsion-Treated Polyester and Cotton 
 
Quantitative determination of the antibacterial and antifungal activity of the 
treated fabric is essential as the screening (qualitative) of the fabric by disc 
diffusion only gives an indication of antimicrobial activity. The ability for the fabric 
to reduce bacterial and fungal load was demonstrated using the challenge test 
(Figure 6.5), the greatest inhibition was observed for S. epidermidis with a mean 
reduction of 6.69 log10 CFU/ml by polyester at 0 min and 6.56 log10 CFU/ml by 
cotton fabric at 0 min. S. aureus growth was reduced by only 0.37 log10 CFU/ml 
by polyester at 0 min but was able to reduce by 8.11 log10 CFU/ml after 24h, 
whilst cotton was able to reduce S. aureus growth by 6.96 log10 CFU/ml after 0 
min CT. The greatest reduction was observed for  E. coli (Figure 6.5) and T. 
rubrum (Figure 6.6) by treated polyester and cotton was seen after CTs of 24h 
and 48h respectively, with highest mean reduction observed for E. coli of 8.91 
log10 CFU/ml by cotton; T. rubrum growth was reduced by 6.76 log10 CFU/ml and 
6.79 log10 CFU/ml by cotton and polyester respectively after 48 h. Difference in 
mean reductions between cotton and polyester were found to be statistically 
significant, with a significant reduction observed by polyester and cotton for S. 
aureus and E. coli at 24 h and by T. rubrum at 48h (p≤ 0.05).  
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a) 
 
b)  
 
Figure 6.5 Mean reduction from an initial inoculum of 8 log10 CFU/ml of E. coli, S. 
aureus and S. epidermidis in the presence of a) polyester and b) cotton ( n=4, ± 
SD) 
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Figure 6.6 Mean reduction from an initial inoculum of 7 log10 CFU/ml of T. rubrum 
in the presence of polyester and cotton (n=4, ± SD) 
 
 
6.3.5 Antibacterial and Antifungal Activity of a 1% CS EO-Emulsion (Time-Kill 
Assay) 
 
Time-kill studies were performed on E. coli, S. aureus, S. epidermidis and 
T. rubrum using emulsion B1 (1% CS) diluted to 1% v/v. S. epidermidis bacterial 
load was completely reduced after a CT of < 2 min, with a reduction of 7.31 log10 
CFU/ml observed (Figure 6.7); S. aureus was reduced by 3.36 log10 CFU/ml after 
0 min and by 7.54 log10 CFU/ml after 5 min of CT. The emulsion did not reduce 
T. rubrum as rapidly (Figure 6.6) when compared with results from the bacterial 
strains (Figure 6.7) with complete reduction (7.13 log10 CFU/ml) observed after 2 
hours (120 min) of CT with the emulsion.    
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Figure 6.7 Mean reduction from initial inoculum of 7 log10 CFU/ml of E. coli, S. 
aureus and S. epidermidis at CTs 0 min and 5 min with 1% CS EO emulsion (n=4, 
± SD) 
 
 
Figure 6.8 Mean reduction from initial spore inoculum of 7 log10 CFU/ml of 
T. rubrum at various CTs with 1% CS EO emulsion (n=4, ± SD) 
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6.3.6 Evaluation of Repellency of Litsea-Lemon EO Blend and Emulsion 
Treated Cotton Fabric against Aedes aegypti Mosquitos 
 
Results from the mosquito repellency study showed that when cotton 
samples were simply impregnated with the litsea-lemon EO blend (1:2 ratio), 
average recorded repellency against A. aegypti mosquitos was 52.94%. When 
cotton samples were treated with 1% CS litsea-lemon EO emulsion, repellency 
increased to 71.43% against A. aegypti, which was a 18.49% increase in 
repellency. 
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6.4 Discussion 
 
The overall aim of this chapter was to investigate the antimicrobial activity 
of a lemon and litsea EO-emulsion as an antimicrobial finish for natural (100% 
cotton) and synthetic (100% polyester) textiles against microorganisms related to 
skin infection. Results from Figure 6.1 demonstrate that both polyester and cotton 
were able to achieve high levels of percentage liquid pick up (up to 112.89%) of 
the antimicrobial emulsion by controlling paddling pressure, with cotton samples 
having significantly higher absorbency for the emulsion compared to polyester 
samples (p≤0.05). Although the emulsions (B1, B2 and B3) used to treat the fabric 
samples differed in viscosity due to the concentration of chitosan used for 
microencapsulation of EOs, there was no significant difference in the percentage 
pick up observed by both cotton and polyester between the three treatments, with 
all three emulsions allowing for high %LPU of 94.5-112.9% (Figure 6.1). The 
absorbency of the fabric to a finishing treatment is greatly dependent on the type 
of fibres and the state of the textile before the treatment, which is why scouring 
is used as a textile cleaning process. Scouring is an important pre-treatment 
process, especially when dealing with natural fibres, which are more prone to the 
presence of natural impurities such as oils, waxes, fats, pectic acids and minerals 
that can contribute in giving the fabric hydrophobic qualities (Marechal et al., 
2012) . Loom state cotton, for example, will contain up to 12% of natural impurities 
of total weight of the fibre, including wax; when waxes on fabric is not removed it 
leads to a non-uniform absorption of finishes during wet-processing; therefore, 
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the water absorbency of a fabric needs to be improved by scouring process 
before finishing (Choudhury, 2006; Karmakar, 1999). 
 
Screening of the finished fabric samples showed that both treated cotton 
and treated polyester displayed antimicrobial activity against all test 
microorganism with bacteriostatic activity displayed against E. coli, S. aureus, S. 
epidermidis and fungistatic activity against T. rubrum (Table 6.1). The only 
exception found with B1 emulsion treated polyester against S. epidermidis which 
was unable to inhibit the growth of S. epidermidis (growth observed underneath 
fabric coupon). Greater inhibition was observed for MRSA (antibiotic resistant 
strain NCTC 12497) and S. epidermidis (clinical isolate PLO 21862) with ZOIs 
between 7.65 and 17.64 mm observed for MRSA and ZOI 13.29 -15.03 mm for 
S. epidermidis (Table 6.2).  No leaching was recorded (no ZOI) for E. coli (clinical 
strain 390685Q) for both cotton and polyester though bacteriostatic activity was 
still observed directly underneath the fabric samples. A recurring pattern 
observed in the results is the increase of leaching ability of the encapsulated EOs 
from the treated textiles, which is represented by the increased ZOIs after 1 week 
of storage compared to those recorded from testing of 1 day old fabric (24h) as 
seen in Table 6.1 and Table 6.2. This suggests that there is a change occurring 
within the treated fabric with storage that allows for greater release of 
encapsulated EOs from the textiles; after 1 week of storage, polyester and cotton 
fabric showed an increased ZOI from 0 mm for both, to 64.96 ± 1.28 mm and 
65.74 ± 1.05 mm respectively, against T. rubrum. Due to storage of the fabric at 
room temperature it is possible that changes in the composition of the 
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encapsulated EO may have occurred over time; Mehdizadeh et al (2017) reported 
higher increase in compounds of cumin EO with lower boiling points when stored 
at room temperature (Mehdizadeh et al., 2017). It is therefore possible that the 
same may have occurred with the EO blend within the emulsion during the 
storage period, therefore increasing the activity. Untreated (control) fabric 
samples clearly displayed no antimicrobial activity, failing to inhibit the growth of 
antibiotic resistant, clinical and type strains of bacteria and the dermatophyte T. 
rubrum within the area in contact with the textile sample. A study by Walentowska 
et al (2013) on the antimicrobial activity of linen-cotton blended fabric (55% linen 
and 45% cotton) found that the growth of the moulds A. niger, Chaetomium 
globosum, Gliocladium virens, Paecilomyces variotii and Penicillium 
ochrochloron was completely inhibited when  the fabric blend was treated with 
8% thyme EO in methanol, and by comparison control samples (untreated fabric) 
were completely covered by moulds and the fabric was decomposed 
(Walentowska and Foksowicz-Flaczyk, 2013). 
 
The three emulsions used to treat the fabric in the preliminary screening, 
differed in the concentration of CS used to formulate the emulsion, however, the 
emulsion presented similar ability to inhibit the test microorganisms, except with 
PE against E. coli where ZOI decreased as the concentration of CS decreased 
giving ZOI for B1 (1% CS), B2 (0.75% CS) and B3 (0.5% CS) of 4.64 ± 1.86 cm, 
2.96 ± 2.20 cm and 1.62 ± 0.36 cm respectively (Table 6.1). The emulsion with 
the highest concentration of CS (1%) was therefore used for further treatments 
and investigations. Incongruity of some of the results may be attributed to the 
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agar diffusion method, although it is often used for assessing bacteriostatic and 
fungistatic activity of finished textiles; weaknesses in the method can be 
highlighted as it does not allow for quantitative analysis as it cannot differentiate 
cell death and inhibition of growth and makes it more difficult to make 
comparisons with other types of fabric finishes. 
 
Many EOs are antimicrobial but do not gain attention due to poor 
antimicrobial longevity caused by their volatile nature (Javid et al., 2014). The 
microencapsulation of natural compounds is used to improve the durability on 
fabrics of natural agents like EOs and the process involves encapsulating the 
EOs by using a polymeric wall material such as chitosan, sodium alginate or 
combinations of polymers; the resulting finish can then be applied onto textile 
materials using different methods. The encapsulation of litsea and lemon EO 
showed promising results; when diluted to 1% v/v the emulsion was able to 
completely reduce the bacterial load by 7-log after a zero CT for S. epidermidis 
and within 5 minutes of CT for E. coli and S. aureus (Figure 6.7). In comparison 
the kill time was slower for T. rubrum and the emulsion was able to completely 
inactivate the dermatophyte spores after 120 minutes of CT (Figure 6.8). Tian et 
al (2016) carried out a time-kill investigation on a 10% cinnamaldehyde 
nanoemulsion and reported that it was only able to reduce the bacterial load of 
E. coli by less than 1-log after 4 hours of CT, and between 4-9 hours bacterial 
load returned to nearly initial levels (Tian et al., 2016). A 0.25% lemon-myrtle oil 
emulsion formulated by Buranasuksombat et al (2011), however, was able to 
achieve a 2-log reduction in bacterial count of E. coli and Bacillus cereus after a 
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zero-CT, these increased to a total reduction (around 8-log) after 15 min of CT 
(Buranasuksombat et al., 2011).  
 
Textile challenge test results show that treated polyester and cotton fabric 
possessed good antimicrobial activity, with complete reduction of bacterial cells 
achieved by both treated fabrics after 24 h CT for all test bacterial organisms - E. 
coli, S. aureus and S. epidermidis (Figure 6.7). In line with results seen with the 
nanoemulsion-time kill, S. epidermidis was most susceptible to treated fabrics, 
achieving over 6-log reduction after zero CT. T. rubrum spores were completely 
inactivated by treated fabrics after 48 h CT, with about 7-log reduction achieved 
(Figure 6.6). Time-kill bioassays for EO treated textiles have not been widely 
reported within the literature, though a study on 100% woven cotton treated with 
geranium EO reported a reduction of S. aureus of 100% for cotton treated with 
pure geranium extract, a reduction of 92% and 94% for cotton treated with 
microencapsulated geranium EO by coacervation-spray drying and spray drying 
respectively (Thilagavathi and Kannaian, 2010). Similarly, a study by Khodary et 
al (2017) treated cotton wound dressing with microencapsulated geranium leaves 
extract using the pad-dry-cure method observed a 100% reduction after a 4-hour 
CT for both E. coli and S. aureus (Khodary et al., 2017). Aloe vera is another eco-
friendly and naturally occurring antibacterial agent that has been investigated for 
use as textile finish; Ali et al (2014) conducted a study on Aloe vera gel (3% w/v) 
finished cotton fabric and observed over 90% reduction of E. coli and S. aureus, 
this increased to 99% with increasing concentration (up to 7%) of Aloe vera (Ali 
et al., 2014). Quantitative antimicrobial tests have also been carried out on cotton 
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fabric coated with plant extracts of pomegranate, neem and turmeric, with E. coli 
reduction at 3% concentration of 62.83%, 30.66% and 37.48% respectively, all of 
which increase with a 5% concentration to reductions of 82.42%, 39.77% and 
46.65% respectively (Mahesh et al., 2011).  
 
More studies are required on natural fabric finishes activity against 
dermatophytes like T. rubrum; it was reported by Ovidiu et al (2016) that a cotton 
(56%) and polyester (44%) blend treated with rosemary EO and orange EO 
achieved a maximum reduction rate of for dermatophyte Epidermophyton 
floccosom of 56.99% by the rosemary EO treatment and 92.48% by orange EO 
treatment (Ovidiu et al., 2016). Results achieved in this study using the control 
(untreated fabric) samples (Figure 6.4) showed that the control fabric did not 
possess any antimicrobial properties, which is important when assessing whether 
the activity observed is solely attributable to the finishing treatment; these results 
complement those from the qualitative screening of the treated fabric (Table 6.1) 
where growth of all organisms was not visually inhibited by the untreated fabric 
coupons. A study by Ghayempour and Mortazavi (2015) on cotton fabric treated 
with peppermint oil loaded nanocapsules also reported a 100% bacterial 
reduction for both S. aureus and E. coli, however the untreated fabric appeared 
to possess antibacterial activity with a reduction of 66% and 65% observed for S. 
aureus and E. coli respectively (Ghayempour and Mortazavi, 2015).   
 
The wash tests suggest that currently the microencapsulated EOs would 
only be suitable for single use; this is not surprising because the emulsion is water 
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soluble. Single use antimicrobial textiles could be utilised for wound care, 
however further studies on toxicity would need to be carried out to determine the 
human sensitivity to the EO blend when used topically. Reports of sensitivity have 
also been published for peppermint EO by Nair (2001) and it has been argued 
that this sensitivity could be attributed to a lack of selectivity of EO compared to 
antibiotics which have selective toxicity against pathogens, thus sparing the 
hosts’ cells (Nair, 2001; Owen and Laird, 2018). A clinical trial by Aspres and 
Freeman (2004) which used tea tree EO determined that at a concentration of 
5% the pure EO could cause irritation, however, a different study by Veien et al 
(2004) did not record any irritation when a patch test was carried out with 10% 
tea tree EO (Aspres and Freeman, 2004; Veien et al., 2004). Orchard and van 
Vuuren (2017) also argue that patch tests are not fairly indicative of real-world 
use of an EO containing  product as there are reports of only mild sensitivity for 
tea tree EO (Caelli et al., 2000b; Dryden et al., 2004; Enshaieh et al., 2007; 
Orchard and van Vuuren, 2017). Due to potential variation in toxicity between 
batches of EOs, published toxicity results on EOs cannot be considered 
individually and therefore standardised methods for EOs need to be developed 
for successful application of novel EO based formulations (Orchard and van 
Vuuren, 2017; Owen and Laird, 2018).  
 
Nevertheless, EO also show promise within other fields, as shown by the 
mosquito repellency results with 71.43% repellency observed when cotton 
samples treated with 1% CS emulsion were tested. When a neat blend of 1:2 
litsea-lemon EO blend was used to impregnate cotton samples and tested for 
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repellency however, the repellency effect was reduced to 52.94%, indicating the 
importance of encapsulating EOs, as the results can be linked to the high volatility 
of EO components such as limonene and citral; limonene itself has been 
previously explored for insecticidal activity with cotton samples (Hebeish et al., 
2008). Interestingly, a study by Trongtokit et al (2005) on the repellency of EOs 
to mosquito bites to A. aegypti reported 0% repellency by undiluted litsea EO, 
and at concentrations of 10% and 50%, though the method used in this study was 
the arm-in-cage test (Trongtokit et al., 2005).  
 
The new regulations by the EU Directive 98/8/EC, have now enforced the 
elimination and withdrawal from the market of many commonly used biocides and 
products which are based on substances which are exceptionally toxic to humans 
and the environment. Research into eco-friendly antimicrobial agents for textiles 
has therefore been on the increase for use in the finishing process of textiles, 
such as medical and health-care textiles, as the use of plants in the creation of 
biocides can results in low-cost, eco-friendly and very effective biocides and 
antimicrobial fabrics. The litsea and lemon EOs encapsulated in a CS and SA 
emulsion in this study showed good antimicrobial activity during in-vitro time kill 
assays with a 7 log(10) reduction at time 0 against E. coli and after a contact time 
of 5 min against S. aureus. A 100% reduction was also achieved for T. rubrum 
after 120 min of contact time. This activity was retained upon application of the 
emulsion on synthetic and natural textiles, with the best results seen for treated 
cotton showing a >6-fold reduction of S. aureus and E. coli (p≤0.05), indicating 
that EOs show promise in their use as finishing for the creation of eco-friendly 
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functional antimicrobial textiles and potential in the development of mosquito-
repellent textiles.  
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Chapter 7. Discussion  
 
EOs have many actual uses in food preservation, pharmaceutics, natural 
therapies and cosmetics. The antimicrobial and antifungal properties of ten EOs 
were compared against two Gram-positive bacterial species (S. aureus and S. 
epidermidis), two Gram-negatives (E. coli and P. aeruginosa) and a 
dermatophyte (T. rubrum) associated with skin conditions, with an aim to develop 
an effective EO-based emulsion. S. aureus and most specifically Methicillin-
resistant strains can be found to colonise the skin and wounds of 63-90% of 
patients and have been carefully monitored in hospitals (Caelli et al., 2000a; 
CDC, 2014; Gallagher et al., 2017). S. aureus has developed resistance against 
erythromycin, quinolones, mupirocin, tetracycline and vancomycin (Boucher et 
al., 2009); many EO investigations have focused on one specific EO (M. 
alternifolia) against S. aureus, and though they have shown great promise, other 
EOs like C. limon  and L. cubeba used in this study, and their blends, have mostly 
been neglected MRSE has become a problematic microorganisms due to 
multidrug resistance; chamomile and oregano are among the EOs that have 
shown good in vitro activity against S. epidermidis (Opalchenova and 
Obreshkova, 2003; Orchard and van Vuuren, 2017). Gram-negative bacteria also 
present a serious threat with regards to antibiotic resistance and especially P. 
aeruginosa and E. coli (Boucher et al, 2009; CDC, 2013); they are often found to 
colonise wounds caused by multidrug resistance (Sienkiewicz et al., 2014; 
Sienkiewicz et al., 2017).  
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A number of EOs have antimicrobial activity against E. coli and P. 
aeruginosa with the majority of studies focusing on E. coli (Orchard and van 
Vuuren, 2017). Gram-negative pathogens appear to be more resistant to EO 
inhibition compared to Gram-positive bacteria and this has also been 
demonstrated in this present study the inhibition of P. aeruginosa required higher 
MICs for lemon, litsea and rosemary EOs (>40 μl/ml, 10 μl/ml and 20 μl/ml 
respectively) compared to S. aureus and S. epidermidis which, for example, gave 
lowest MICs of 1.25 μl/ml and 0.6 μl/ml for litsea (Table 4.2). The low sensitivity 
of P. aeruginosa to EOs has also been observed in studies on various EOs 
against P. aeruginosa, including lemongrass, peppermint, caraway, anise, fennel, 
geranium, clove, and lavender EOs having MICs >16 μl/ml, which was the 
maximum concentration tested (Tarek et al., 2014). There is 10-20% risk of a 
person contacting a dermatophyte infection, including tinea pedis and treatment 
is costly and onerous due to resistance and side effects (Bajpai et al., 2009). EOs 
present a good option to treat human fungal infections, though only tea tree EO 
has been extensively investigated against dermatophyte infections (Orchard and 
van Vuuren, 2017); in this study T. rubrum showed high sensitivity to cotton and 
PE fabric when treated with a 1% CS encapsulated litsea-lemon EO blend 
emulsion (Figure 6.6). 
 
The potential of EOs for use in various applications is therefore suggested 
by their broad spectrum of antimicrobial activity, evident in this investigation as 
EOs such as litsea, lemon and rosemary showed activity against all organism 
tested (Table 4.1). When litsea and lemon EO were combined at a 1:2 ratio, 
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synergism was noted (Table 4.3) against S. aureus, E. coli and T. rubrum, 
reducing the MICs of the individual EOs; most other combinations gave 
antagonistic or additive effects. Synergism between EOs is essential when trying 
to prevent antimicrobial resistance and increasing the antimicrobial activity, 
however not all combinations will be synergistic. A study on 45 EOs combined 
with L. angustifolia by de Rapper et al (2013), observed that majority of the 
combinations resulted in indifferent or additive interactions and the few 
synergistic interactions were mostly against C. albicans (de Rapper et al., 2013). 
A study on the commercial product “Olbas” and the individual EOs in the product 
were tested separately and in combination and found that there was no further 
enhancement in the antimicrobial activity when combined (Hamoud et al., 2012).  
 
The litsea and lemon EO blend (1:2 ratio) in this present study was 
encapsulated with CS and SA (as emulsifiers and stabilizers) within an emulsion. 
The main challenges faced with the application of natural products like EOs is 
their durability, shelf-life and antimicrobial efficiency which is why further research 
must be carried out to evaluate their use in the formation of bioactive textiles (Ali 
et al., 2014). CS concentration within the emulsions had an effect  on the physical 
stability of the emulsion, with CS concentrations of 0.75% and 1% showing 
moderate stability over 14 days and a CI of about 10% compared with the lowest 
CS concentration formulation (0.5%) displaying a CI of over 50% within 5 days of 
storage (Figure 5.21). Though creaming was observed within 24 hours for all 
emulsion formulations, this is reversible by simple shaking of the emulsion which 
disperses the droplets again, which are still surrounded by a protective film and 
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behave as a single drop. This could be seen by the observation of microscope 
images of shaken emulsions over 24 hours post- preparation (Figure 5.12) where 
the droplets observed showed individual droplets surrounded a dark CS-SA film 
layer indicating the emulsion was easily re-dispersible. This re-dispersibility of the 
emulsion allowed for the emulsions to be successfully used for treatment of the 
fabric despite creaming and stability and though differences in viscosity (Figure 
5.11) of the three emulsion formulations were observed this was not reflected in 
the percentage LPU by cotton and polyester (Figure 6.1) as no significant 
difference was observed in LPU between the three formulations.  
 
Citral and limonene, the main compounds present in litsea and lemon EOs 
respectively are linked to the antimicrobial activity of the two EOs; when citral and 
limonene were screened for activity against bacteria, results showed that citral 
has greater antimicrobial activity against S. aureus, S. epidermidis and E. coli 
(Figure 5.3). Citral is a mixture of two geometric isomers, neral and geranial and 
both those isomers are present in both litsea and lemon EOs as identified by GC-
MS and shown in Figure 5.4 and Figure 5.5; this may explain the synergistic effect 
experienced by the blend of the two EOs (Table 4.3). Citral vapour has been 
reported to have antimicrobial activity against S. aureus isolates, with mean ZOI 
of 5.91 cm and a reduction of 2.03 log10 for MSSA 110 isolate; the study also 
reported no activity of citral both by disc diffusion and in-vitro against P. 
aeruginosa (Phillips et al., 2012). MICs between 0.03-0.06% v/v have been 
determined for citral against E coli O157, S. aureus, B. cereus, Campylobacter 
jejuni and Lysteria monocytogenes in both vapour and neat form (Fisher and 
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Philips, 2008). Citral has been recently encapsulated into nanostructured lipid 
carriers to improve and prolong its efficiency and a study by Mokarizadeh et al 
(2017) reported lower MIC/MBCs for citral against S. aureus, B. cereus, E. coli 
and C. albicans when encapsulated (Mokarizadeh et al., 2017). The higher 
presence of citral was also observed when the presence of citral and limonene 
on the samples of treated cotton and polyester was quantified (Figure 6.2). When 
the in vitro release of the EO was assessed using citral and limonene as markers, 
the release profiles were characterised by an initial rapid burst release, followed 
by a slowed sustained release (Figure 5.19 and Figure 5.20). The same release 
profile was observed by Esmaelli and Asgari (2015) for Carum copticum EO and 
chitosan nanoparticles and by Kotronia et al (2017) for oregano EO-β-
cyclodextrin complexes (Esmaeili and Asgari, 2015; Kotronia et al., 2017). 
 
Citral and limone are both vulnerable to oxidation (Djordjevic et al., 2007) 
and when the long term chemical stability of the emulsions over 28 days at 15 ºC 
and 40ºC was assessed citral concentrations after 28 days varied greatly with a 
nearly 200% increase observed for formulation B1 at 40ºC  but a complete 
decrease (100%) at 15ºC (Figure 5.23); limonene in turn could only be recovered 
at extremely low concentrations or not at all with fluctuating concentrations 
observed (results not shown). Turek and Stintzing (2012) reported degradation 
of EO component (α-terpinene) in rosemary EO when stored at 38°C (Turek and 
Stintzing, 2012).The storage temperatures used in this study (15°C and 40°C) did 
not have any significant effect on the chemical stability of the EOs within the 
emulsion; though higher temperatures than 40°C were not tested during storage, 
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DSC and TGA results showed that the EOs (individually and their blend), citral, 
limonene and the emulsions had boiling points far above 40°C and therefore 
higher stability testing temperature were unlikely to give significantly different 
results (Figure 5.17 and Figure 5.18). 
 
 A different encapsulating method and further stability tests would need 
therefore need to be carried out e.g. at 4ºC and in an oxygen regulated 
environment to assess whether these parameters would have a positive effect on 
the chemical stability of the encapsulated EOs. Due the chemical instability of the 
EOs, only fresh emulsions were used during the treatment and analysis of cotton 
and polyester fabric; notably, when changes in the presence of citral and 
limonene within the treated fabric were evaluated a significant difference was 
seen in the presence of limonene and citral on treated cotton at 24h PT treatment 
and their presence on the fabric 1 week PT (Figure 6.2). 
 
The antimicrobial activity of the treated fabric against E. coli, S. aureus, S. 
epidermidis and T. rubrum test strains and E. coli (clinical isolate 390685Q), S. 
epidermidis (clinical isolate PLO 21862) and MRSA (antibiotic resistant strain 
NCTC 12497) showed an increase after 1 week of storage for type strains (Table 
6.1) but a reduction for MRSA and S. epidermidis clinical isolate (Table 6.2) for 
both cotton and polyester. There is strong evidence that this difference in 
antimicrobial activity retention observed between type and clinical strains in Table 
6.1 and Table 6.2 cannot be attributed to homogeneity in the distribution of the 
emulsion within the fabrics as quantification of citral and limonene within the fabric 
 198 
 
demonstrated that there is a proportional decrease in the concentration of the 
compounds within the fabric as the sample size decreased (Figure 6.2). 
Concentration of the compounds was proportional to the size of the samples even 
after 1 week of storage suggesting that there is a direct relationship between the 
entrapment of the EOs (within the emulsion) on the fabric and the fabric area 
(Figure 6.2). This in turn suggests that the treatment of the fabric will also be 
potentially successful at both a small and larger scale, making the method 
scalable.  
 
When testing for the durability of the fabric to a standard 40°C wash cycle, 
both polyester and cotton were not able to withstand the washing conditions and 
the activity of the fabric was not retained (with the exception of cotton against T. 
rubrum); this may indicate that the formulation and fabric treatment method may 
be more suitable to a single-use product rather than a reusable one.  Single-use 
cotton fabric treated with microencapsulated mixtures of lavender, fennel and 
laurel EOs has been developed for use in bee-repellency (Eyupoglu et al., 2018). 
 
7.1 Future Studies 
 
Further research is needed, including an investigation on whether the 
litsea/lemon EO-blend is able to enhance the action of antibiotics against 
pathogenic wound bacteria such as was explored in a study which found that 
synergistic effects were found for basil, clary sage and rosemary EOs with 
antibiotics (Sienkiewicz et al, 2017). To minimize creaming, the droplet size 
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needs to be reduced to a nano scale (20-200 nm) in order to keep the difference 
in the density of the two phases (the oil phase and aqueous/polymer phase) as 
small as possible, by increasing the viscosity of the continuous phase. A method 
such as ultrasonic emulsification could be explored, in which high-intensity 
ultrasound waves are applied and can have the advantage of smaller droplet size, 
lower polydispersity and therefore higher physical stability of the emulsion 
(Hashtjin and Abbasi, 2015). 
 
The potential for dual-function textiles means further exploration of other 
possible applications of the treated fabrics also needs to be evaluated, including 
more robust tests such as the arm-in-cage test for the evaluation of mosquito 
repellency (Trongtokit et al., 2005). The EOs of litsea and lemon were 
successfully applied onto cotton and polymer fabric using an eco-friendly method 
without any toxic fixing agents such as formaldehyde, although when tested for 
washing durability the activity was not retained apart from the dermatophyte 
which was highly sensitive to the EO blend. The use of eco-friendly pigment 
binders (e.g. poly-acrylate) post-treatment could be investigated to see if the 
durability of the treated fabric is improved post-wash.  
 
This study showed promising results for the use of EOs in the finishing of 
textiles, although the results from the wash durability test suggests that the fabric 
treatment antimicrobial activity is temporary and possibly more suited to single 
use. To solve this problem, the use of a binder would be employed. Research 
into an eco-friendly binder compatible with the wall materials used in the 
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encapsulation process would need to be further investigated to improve the 
staying ability of the encapsulated EOs post-wash. Sensitivity tests on skin would 
also need to be carried out to assess skin tolerance to the treated fabric.  
 
7.2 Conclusion 
 
In conclusion, this study has shown that the encapsulation process of the 
EOs tested can be considered as an inexpensive and efficient technique to 
maintain the antifungal and antibacterial activity of the EOs and enable the 
application of the EOs onto fabrics. The treatment of fabric has shown to have a 
potential application in the use of antimicrobial wound dressing or sportswear to 
aid in the combat of bacterial and fungal pathogens. With the rapid prevalence 
and emergence of antibiotic resistant clinical and community pathogens, limited 
number of antimicrobial agents  available for the treatment of skin infections by 
multi drug resistant strains, the use of the litsea/lemon EO blend both as an 
emulsion and embedded within fabric could be the answer to problems within the 
clinical arena and sports industry.  
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Appendix I Bacterial and Fungal Growth Curves 
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Figure Appendix II: Growth curves of a) E. coli, b) S. aureus, c) S. 
epidermidis at 37 C and radial growth of d) T. rubrum at 30 C. 
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Appendix II Wash Cycle Temperature Log  
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Figure Appendix  II: Fabric wash cycle temperature log   
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Appendix III Anova Output 
Tests of Normality 
 
Organisms (Fabric) 
Kolmogorov-Smirnova 
Shapiro-
Wilk 
Statistic df Sig. Statistic 
ZOI 1 Week Clinical Isolates E. coli (C-1W) .207 6 .200* .881 
MRSA (C-1W) .191 6 .200* .960 
S. epidermidis (C-1W) .193 6 .200* .892 
E. coli (P-1W) .232 6 .200* .892 
MRSA (P-1W) .173 6 .200* .909 
S. epidermidis (P-1W) .170 6 .200* .956 
 
Tests of Normality 
 
Organisms (Fabric) 
Shapiro-Wilka 
df Sig. 
ZOI 1 Week Clinical Isolates E. coli (C-1W) 6 .274 
MRSA (C-1W) 6 .818 
S. epidermidis (C-1W) 6 .331 
E. coli (P-1W) 6 .327 
MRSA (P-1W) 6 .429 
S. epidermidis (P-1W) 6 .785 
 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Descriptives 
ZOI 1 Week Clinical Isolates   
 N Mean Std. Deviation Std. Error 
95% Confidence 
Interval for Mean 
Lower Bound 
E. coli (C-1W) 6 .8733 .70625 .28832 .1322 
MRSA (C-1W) 6 2.4400 .48054 .19618 1.9357 
S. epidermidis (C-1W) 6 1.1817 .32084 .13098 .8450 
E. coli (P-1W) 6 .5267 .46543 .19001 .0382 
MRSA (P-1W) 6 1.2117 .71205 .29069 .4644 
S. epidermidis (P-1W) 6 1.0967 .44947 .18350 .6250 
Total 36 1.2217 .78244 .13041 .9569 
 
Descriptives 
ZOI 1 Week Clinical Isolates   
 
95% Confidence Interval for 
Mean 
Minimum Maximum Upper Bound 
E. coli (C-1W) 1.6145 .10 1.72 
MRSA (C-1W) 2.9443 1.66 3.02 
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S. epidermidis (C-1W) 1.5184 .86 1.62 
E. coli (P-1W) 1.0151 .10 1.28 
MRSA (P-1W) 1.9589 .10 1.89 
S. epidermidis (P-1W) 1.5684 .44 1.62 
Total 1.4864 .10 3.02 
 
 
Test of Homogeneity of Variances 
 Levene Statistic df1 df2 
ZOI 1 Week Clinical Isolates Based on Mean 1.090 5 30 
Based on Median .906 5 30 
Based on Median and with 
adjusted df 
.906 5 24.372 
Based on trimmed mean 1.063 5 30 
 
Test of Homogeneity of Variances 
 Sig. 
ZOI 1 Week Clinical Isolates Based on Mean .386 
Based on Median .490 
Based on Median and with adjusted df .493 
Based on trimmed mean .400 
 
 
ANOVA 
ZOI 1 Week Clinical Isolates   
 Sum of Squares df Mean Square F Sig. 
Between Groups 12.636 5 2.527 8.624 .000 
Within Groups 8.792 30 .293   
Total 21.428 35    
 
 
Multiple Comparisons 
Dependent Variable:   ZOI 1 Week Clinical Isolates   
 (I) Organisms 
(Fabric) 
(J) Organisms 
(Fabric) 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Tukey HSD E. coli (C-1W) MRSA (C-1W) -1.56667* .31254 .000 -2.5173 -.6160 
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S. epidermidis (C-
1W) 
-.30833 .31254 .919 -1.2590 .6423 
E. coli (P-1W) .34667 .31254 .874 -.6040 1.2973 
MRSA (P-1W) -.33833 .31254 .884 -1.2890 .6123 
S. epidermidis (P-
1W) 
-.22333 .31254 .979 -1.1740 .7273 
MRSA (C-1W) E. coli (C-1W) 1.56667* .31254 .000 .6160 2.5173 
S. epidermidis (C-
1W) 
1.25833* .31254 .004 .3077 2.2090 
E. coli (P-1W) 1.91333* .31254 .000 .9627 2.8640 
MRSA (P-1W) 1.22833* .31254 .006 .2777 2.1790 
S. epidermidis (P-
1W) 
1.34333* .31254 .002 .3927 2.2940 
S. epidermidis (C-
1W) 
E. coli (C-1W) .30833 .31254 .919 -.6423 1.2590 
MRSA (C-1W) -1.25833* .31254 .004 -2.2090 -.3077 
E. coli (P-1W) .65500 .31254 .316 -.2956 1.6056 
MRSA (P-1W) -.03000 .31254 1.000 -.9806 .9206 
S. epidermidis (P-
1W) 
.08500 .31254 1.000 -.8656 1.0356 
E. coli (P-1W) E. coli (C-1W) -.34667 .31254 .874 -1.2973 .6040 
MRSA (C-1W) -1.91333* .31254 .000 -2.8640 -.9627 
S. epidermidis (C-
1W) 
-.65500 .31254 .316 -1.6056 .2956 
MRSA (P-1W) -.68500 .31254 .271 -1.6356 .2656 
S. epidermidis (P-
1W) 
-.57000 .31254 .467 -1.5206 .3806 
MRSA (P-1W) E. coli (C-1W) .33833 .31254 .884 -.6123 1.2890 
MRSA (C-1W) -1.22833* .31254 .006 -2.1790 -.2777 
S. epidermidis (C-
1W) 
.03000 .31254 1.000 -.9206 .9806 
E. coli (P-1W) .68500 .31254 .271 -.2656 1.6356 
S. epidermidis (P-
1W) 
.11500 .31254 .999 -.8356 1.0656 
S. epidermidis (P-
1W) 
E. coli (C-1W) .22333 .31254 .979 -.7273 1.1740 
MRSA (C-1W) -1.34333* .31254 .002 -2.2940 -.3927 
S. epidermidis (C-
1W) 
-.08500 .31254 1.000 -1.0356 .8656 
E. coli (P-1W) .57000 .31254 .467 -.3806 1.5206 
MRSA (P-1W) -.11500 .31254 .999 -1.0656 .8356 
Games-
Howell 
E. coli (C-1W) MRSA (C-1W) -1.56667* .34874 .014 -2.8114 -.3219 
S. epidermidis (C-
1W) 
-.30833 .31668 .913 -1.5094 .8927 
E. coli (P-1W) .34667 .34531 .905 -.8910 1.5843 
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MRSA (P-1W) -.33833 .40943 .956 -1.7604 1.0838 
S. epidermidis (P-
1W) 
-.22333 .34176 .983 -1.4542 1.0076 
MRSA (C-1W) E. coli (C-1W) 1.56667* .34874 .014 .3219 2.8114 
S. epidermidis (C-
1W) 
1.25833* .23589 .005 .4143 2.1023 
E. coli (P-1W) 1.91333* .27311 .000 .9645 2.8621 
MRSA (P-1W) 1.22833 .35070 .055 -.0247 2.4814 
S. epidermidis (P-
1W) 
1.34333* .26862 .005 .4095 2.2772 
S. epidermidis (C-
1W) 
E. coli (C-1W) .30833 .31668 .913 -.8927 1.5094 
MRSA (C-1W) -1.25833* .23589 .005 -2.1023 -.4143 
E. coli (P-1W) .65500 .23078 .139 -.1673 1.4773 
MRSA (P-1W) -.03000 .31884 1.000 -1.2408 1.1808 
S. epidermidis (P-
1W) 
.08500 .22545 .999 -.7149 .8849 
E. coli (P-1W) E. coli (C-1W) -.34667 .34531 .905 -1.5843 .8910 
MRSA (C-1W) -1.91333* .27311 .000 -2.8621 -.9645 
S. epidermidis (C-
1W) 
-.65500 .23078 .139 -1.4773 .1673 
MRSA (P-1W) -.68500 .34729 .425 -1.9312 .5612 
S. epidermidis (P-
1W) 
-.57000 .26415 .333 -1.4877 .3477 
MRSA (P-1W) E. coli (C-1W) .33833 .40943 .956 -1.0838 1.7604 
MRSA (C-1W) -1.22833 .35070 .055 -2.4814 .0247 
S. epidermidis (C-
1W) 
.03000 .31884 1.000 -1.1808 1.2408 
E. coli (P-1W) .68500 .34729 .425 -.5612 1.9312 
S. epidermidis (P-
1W) 
.11500 .34376 .999 -1.1245 1.3545 
S. epidermidis (P-
1W) 
E. coli (C-1W) .22333 .34176 .983 -1.0076 1.4542 
MRSA (C-1W) -1.34333* .26862 .005 -2.2772 -.4095 
S. epidermidis (C-
1W) 
-.08500 .22545 .999 -.8849 .7149 
E. coli (P-1W) .57000 .26415 .333 -.3477 1.4877 
MRSA (P-1W) -.11500 .34376 .999 -1.3545 1.1245 
 
*. The mean difference is significant at the 0.05 level. 
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Appendix IV Ross Y-Tube Olfactometer  
 
Table Appendix IV Modifications to Ross Y-Tube Olfactometer compared 
to WHO Olfactometer 
 Ross Y-tube 
Olfactometer 
WHO Y-tube 
Olfactometer 
Material Acrylic Acrylic 
Base leg length  50.0cm 45.72 cm 
Holding port 21.0 cm 21.00 cm 
Trapping port 15.4 cm 10.16 cm 
Collar 20 cm 5.08 cm 
Decision Chamber  YES NO 
 
 
 
 
 
